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O genoma é um livro 
Tem 23 capítulos, chamados cromossomas 
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Cada história é feita de parágrafos, chamados exões, 
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Cada parágrafo é feito de palavras, chamadas codões 
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Introduction 
1.1. Spermatogenesis and Y chromosome 
Human spermatogenesis is a long and complex process requiring about 70 
days and involving a succession of different cell types, generated by mitotic and 
meiotic divisions (Clermont 1966, Dym 1994). In the initial stages, 
spermatogonia are divided via mitoses, giving rise to primary spermatocytes, 
which in turn undergo the first meiotic division leading to secondary 
spermatocytes. Through the second meiosis these cells produce haploid cells 
(round spermatids), which elongate during the spermiogenesis process 
(elongated spermatids) and finally are differentiated into mature spermatozoa, 
by condensation of the chromatin, substitution of histones by protamines and 
formation of the acrosome and other sperm components (fig. 1). However, our 
knowledge of the mechanisms regulating spermatogenesis is still poor, and only 
recently research has focused on the identification of genes specifically involved 
in its regulation (Hecht 1995). 
Figure 1 - Schematic representation of human spermatogenesis (Sousa ef al. 2000). BL -
Basal lamina; SC - Sertoli cell; SGA/B - Spermatogonia A and B; SC1 - Primary spermatocytes; 
SC2 - Secondary spermatocytes; Sa - Round spermatides; Sd - long spermatides; Sz -
spermatozoa. 
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The human Y chromosome shows only one third the size of the X chromosome 
and constitutes 1% of the haploid human genome with an estimated average 
size of 60Mb (Morton 1991). Cytogenetically, the human Y chromosome 
consists of a heterochromatic region and an euchromatic region. The 
heterochromatic region (Yq12) represents two thirds of the long arm (Yq), is 
mainly composed of repetitive satellite DNA - DYZ1 and DYZ2 - having, 
respectively, about 5000 and 2000 sequence copies. The size of this region 
varies extensively in different males (Unnerus et al. 1967). The size of the 
euchromatic region including the short arm (Yp11), centromere and proximal 
long arm (Yq11 ) is quite constant among healthy men. With the exception of the 
small pseudoautosomal regions (PARs) at the top of both arms (Burgoyne 
1998), genetic linkage analysis for the Y chromosome is impossible because of 
the lack of meiotic recombination. Consequently, the identification of Y-linked 
genes depends on physical mapping of deletions occurring naturally. To date, 
two extensive deletion maps of the Y chromosome have been constructed 
(Vollrath et al. 1992, Vogt et al. 1996). Vollrath established the first STS interval 
map of the human Y chromosome. Using 110 STS loci, he was able to 
subdivide Yq11 into 23 intervals (5A-5Q and 6A-6F) (Vollrath et al. 1992). This 
was later used for gene mapping (fig. 2). The Vogt STS-map (fig. 3) divides 
Yq11 into 25 intervals (D1-D25), and is based on PCR analysis and DNA blot 
experiments (Vogt etal. 1996). 
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Figure 2 - Interval map of the human Y chromosome according to Lahn & Page (1997). 
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(1996). 
The Y chromosome has long been considered as a wasteland devoid of genetic 
material. This idea was supported by data showing that the euchromatic, non-
recombining region of this chromosome is full of Y-specific repeats (Vollrath et 
al. 1992). These sequences were assumed to be functionally inactive 
(Charlesworth 1991) but, from recent studies, it emerges that the human Y 
chromosome is far from being a land of nearly dead or degenerate genes but 
contains multiple genes that are ubiquitously expressed and those with a testis-
specific expression (fig. 4). 
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At the beginning of my thesis work, in 2000, little was known about the origins 
and mechanisms of the molecular rearrangements in Yq11 resulting in deletions 
and loss of Y-specific genetic material. Y chromosomal rearrangements and 
possibly the loss of genetic material are expected to occur during meiosis 
associated with sex chromosomal sister chromatid exchanges. Further deletion 
possibilities can occur on spermatid development (Edwards & Bishop 1997), in 
the spermatozoa of the germ line of the patients' fathers or de novo during early 
embryogenesis. Other mechanisms leading to Y deletions could be related to 
the specific patterns of DNA condensation and packing occurring during 
spermiogenesis. 
Recently, Y chromosome became completely sequenced and the male-specific 
region of the Y chromosome (MSY) was defined as a mosaic of 
heterochromatic sequences and three classes of euchromatic sequences: X-
transposed, X-degenerate and ampliconic. The ampliconic class represents 
about 30% of the euchromatic region of MSY (Skaletsky et al. 2003). 
1.2. Azoospermia Factor(s) (AZF) 
The observation that loss of most distal euchromatic region of the long arm of 
the Y chromosome is associated with severe oligozoospermia or azoospermia 
was the first evidence that genetic defects on the Y chromosome can affect 
spermatogenesis (Tiepolo & Zuffardi 1976). These authors examined the 
karyotype of 1170 men with azoospermia; six men from this patient group had 
large deletions, including the entire heterochromatic region (Yq12), and an 
undefined amount of adjacent euchromatic part (Yq11). In two cases, the 
authors demonstrated that the fathers of patients with deletions carried a normal 
Y chromosome, indicating that these mutations were de novo events. This 
suggested that deletions were the cause of the azoospermia and it was 
postulated that a genetic factor located in Yq11 was important for male germ 
cell development. This gene or gene cluster was defined as "Azoospermia 
Factor" {AZF). However, the genetic complexity of the AZF locus could only be 
revealed with the development of molecular deletion mapping. These studies 
enabled the detection of interstitial sub-microscopic deletions not visible at the 
cytogenetic level and detectable only by Sequence Tagged Sites (STS)-PCR or 
6 
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Southern hybridisation. Such deletions were called microdeletions. Molecular 
mapping analysis on patients with microdeletions confirmed that AZF resides in 
Yq11 and further assigned this AZF locus to interval 6 at band Yq11.23 (Vogt et 
al. 1992). Heterogeneity in the histology of testis sections from patients with 
different deletions in Yq11 complicated the original hypothesis of a single locus 
for spermatogenesis in Yq, suggesting the presence of more than one AZF 
locus in Yq11 (Vogt et al. 1993). 
Indeed the observed microdeletions are associated to a wide range of 
histological profiles, from Sertoli cell-only syndrome (SCOS) to spermatogenic 
arrest (SGA) and severe hypospermatogenesis: deletions in proximal Yq11 (D3-
D6) result in type I SCOS, with no germ cells being visible in all tubules of testis 
sections, whereas microdeletion in middle Yq11 (D13-D16) revealed 
spermatogenic arrest. In this case, populations of spermatogonia and 
spermatocytes were normal in all testis tubules. No post-meiotic germ cells 
could be detected, indicating that the disruption of spermatogenesis occurred 
before or during meiosis at the spermatocyte stage. Finally, microdeletions in 
distal Yq11 (D20-D22) are associated with a variable phenotype, ranging from 
type II SCOS (absence of germ cells in most testis tubules) to 
hypospermatogenesis (presence of all germ cell types, albeit in reduced 
numbers). Based on these results, Vogt etal. (1996) proposed the presence of 
three spermatogenesis loci in Yq11 designated as AZFa, AZFb and AZFc, from 
proximal to distal Yq (fig. 3). 
According to Vogt et al. (1997), AZFa, located on D3-D6, corresponds to the 
deletion interval 5C of the Vollrath map, AZFb spans the interval D13-D16 and 
corresponds to interval 50-6B of the Vollrath map and AZFc, located on D20-
D22, corresponds to interval 6C-6E of the Vollrath map. Several genes located 
in AZF regions are expressed in the testis and could therefore be considered as 
"AZF candidate genes". 
The first AZF candidate gene - RBMY (RNA binding motif in Y chromosome) -
was isolated in 1993 (Ma etal. 1993) from a region later shown to correspond to 
AZFb. In 1995, a second AZF candidate gene - DAZ (Deleted in Azoospermia) -
was described as a single copy gene identified on the AZFc region (Reijo et al. 
1995). However, a homologous gene designed as SPGY (Spermatogenesis 
gene locus on the Y) and mapped to the same Y region was described as a 
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multicopy gene (Maiwald et al. 1996). Both genes encode testis specific RNA 
binding proteins. DAZ contains seven tandem repeats of a 72 nucleotide unit, 
known as exon 7 of DAZ (Saxena et al. 1996); SPGY contains at least 12 of 
these repeats. Further studies revealed that these 2 genes belong to the same 
family and because the name DAZ was published first, DAZ was renamed 
DAZ\ and SPGY became DAZ2 (Vogt et al. 1997). Only recently the structure 
of AZFa and its gene content was described, having at least 3 genes - USP9Y 
(Ubiquitin specific protease 9 on Y chromosome), DBY (DEAD box polypeptide 
on Y chromosome) and UTY (Ubiquitously transcribed tetratricopeptide on Y 
chromosome) - considered to be AZFa candidates (Brown et al. 1998, Mazeyrat 
et al. 1998, Sargent étal. 1999, Sun étal. 1999). 
1.3. AZFc candidate genes 
Microdeletions involve frequently the AZFc region, with such deletions being 
responsible for 10-15% of idiopathic azoospermia and 5-10% of severe 
oligozoospermia. 
At the beginning of this work (2000), three different Y gene families were 
mapped to the AZFc locus, expressing in human testis and being candidates for 
AZFc: the basic protein Y2 (BPY2), the chromodomain Y1 (CDY1) and the 
deleted in azoospermia {DAZ) gene family (Lahn & Page 1997, Vogt 1998, fig. 
2). 
The BPY2 gene codes for a 106-residue basic protein (Lahn & Page 1997), 
spans 21 kb of genomic sequence and consist of 9 exons. A cDNA sequence 
(GeneBank AF000980) was identified as testis specific and positive clones for 
BPY2 were sequenced and compared to this cDNA in order to detect 
intron/exon junctions (Stuppia era/. 2000). 
The human chromodomain Y (CDY) is a gene family with, at least, three 
members named CDY1 major, CDY1 minor and CDY2. The CDY family 
encodes a protein containing a chromatin-binding domain and a potential CoA-
substrate catalytic domain (Lahn & Page 1999). Most of the putative protein 
encoded by the CDY1 minor transcript is identical to that encoded by the major 
transcript except that its carboxyl terminus is divergent. The CDY1 genes are 
mapped to interval 6F and the CDY2 to interval 5L of the Y chromosome (fig. 2). 
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Although it is not yet known the exact number of CDY copies present in the 
human Y chromosome, it has been demonstrated that CDY is specifically 
expressed in adult testis. It was speculated that CDY might modify chromatin 
during spermatogenesis with its deletion contributing to spermatogenic defects 
observed in AZFc-deleted men (Ma et al. 2000). Recently it was shown that 
proteins of these genes have in vitro HAT (histone acetyltransferase) activity. 
The expression pattern and subcellular localisation of the CDY proteins were 
consistent with a role in mediating histone H4 hyperacetylation during spermatid 
maturation (Lahn et al. 2002). 
1.4. DAZ gene family 
DAZ (Deleted in Azoospermia) locus was the first described in this region. DAZ 
is found only on the Y chromosome in humans and Old World monkeys 
(Saxena et al. 1996, Shan et al. 1996, Gromoll et al. 1999). In all other 
mammals it is represented as a single copy gene, autosomally located (Reijo et 
al. 1996, Cooke et al. 1996). DAZ was acquired by the Y chromosome from this 
autosomal homologue DAZIA. 
In model organisms, genetic studies have demonstrated that autosomal DAZ 
homologues play essential roles in germ cell development (Eberhart et al. 
1996). In Drosophila, males mutant for the DAZ homologue boule are infertile 
with germ cell arrest at the G2/M transition into meiosis I (Burgoyne 1996, 
Eberhart et al. 1996). The mouse homologue of boule is located on 
chromosome 17 (Cooke et al. 1996) and it was designated DAZIa (Daz like 
autosomal). In mice, the disruption of the Dazh gene leads to germ cell loss 
before birth, rendering both males and females infertile (Ruggiu et al. 1997), 
and a human DAZ transgene can partially rescue the sterile phenotype of a 
knockout mouse for the homologous gene Dazl (Slee et al. 1999/ 
DAZ encodes a testis-specific protein with a RNA recognition motif (RRM) at the 
N-terminus and an auxiliary C-terminal domain containing different number of 
repeats of a 24 amino acid unit, the so called DAZ repeats (Reijo et al. 1995, 
Saxena et al. 1996). The DAZ transcription unit seems to contain different 
number and composition of exons and to span about 42 kb. Exon 1 contains the 
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initiator codon, exons 2 to 5 encode the RNA­binding domain and each exon 7 
variants encodes a DAZ repeat (Saxena et al. 1996, fig. 5). 
DAZ transcription is restricted to the germ line (Reijo et al. 1995), occurring in 
spermatocytes and early spermatids (Vogt 1996), with the presence of several 
DAZ transcripts belonging to the same individual and differing in both the copy 
number and the order of the DAZ repeats suggesting that more than one DAZ 
gene is transcribed (Yen era/. 1997). 
The exact number of the DAZ genes in the family is still not clear due to the 
extremely high similarity (>99%) among the members of the DAZ gene family 
(Saxena et al. 1996). However, at least three copies have been indicated by 
Southern blotting or restriction mapping (Yen et al. 1997, 1998) and seven 
copies, representing either genes or pseudogenes, were proposed by fibre­
FISH techniques (Glãser et al. 1998). Therefore, the main problem in 
understanding the biological function of DAZ and the genotype­phenotype 
relation arose from the multicopy nature of this gene. 
DAZ genes are deleted in about 15% of non­obstructive azoospermic or 
severely oligospermic males (13%) and are expressed exclusively in germ cells 
(Menke era/. 1997, Habermann etal. 1998). 
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Figure 5 ­ First exon­intron structure for a DAZ gene copy. a-DAZ transcription unit with the 
exons numbered above it; b­Pseudoexons within DAZ; c­Sequence backbone with each arrow 
showing a 2.4 kb repeat unit and a 6 kb LINE element in between 2 tandem repeat units; d­
Three cosmids from which sequence was derived. The nucleotide differences are listed, giving 
already an indication for the existence of more than one gene copy; e­Localisation of p49f and 
p49a (Reproduced from Saxena ef al. 1996). 
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Deletions of DAZ genes in infertile patients are generally screened by PCR on 
genomic DNA isolated from peripheral leukocytes, using STS markers that 
cannot distinguish the different copies (Reijo era/. 1995, 1996). Therefore, only 
deletions removing the whole DAZ gene cluster can be detected. Intragenic 
deletions, point mutations or partial DAZ deletions (involving only some DAZ 
copies) cannot be determined by this method and there is the possibility that the 
frequency of DAZ gene abnormalities in fertile men might be underestimated. 
Since DAZ genes seem to be distinguished only by small nucleotide variations, 
the only way to develop a gene copy specific marker system would be the 
establishment of the so called DAZ deletion haplogroups. 
1.5. Y-chromosomal haplogroups and DYS1/DAZ locus 
An increasing number of informative Y polymorphic markers, i.e. base-pair 
substitutions, insertion/deletion events, microsatellites, minisatellites and repeat 
variabilities, have been now isolated (Underhill et al. 1997, 2000, Rosser et al. 
2000). Both biallelic variants and insertion/deletion polymorphisms were 
recognised as unique molecular events in human evolution and can therefore 
be used to define deep-rooted phylogenetically related variant pattern called 
haplogroups (fig. 6). 
Microsatellites or short tandem repeats (STR) are more variable and define the 
variation within distinct haplogroups, allowing the establishment of Y-
chromosomal pedigrees developed during human evolution (Jobling et al. 
1998). 
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Figure 6 - Y-chromosomal haplogroups according to Underhill ef al. (2000). The 131 numbered 
compound haplotypes were constructed from 218 mutations, indicated on segments. 
Haplotypes are assorted into 10 groups (l-X). 
One of the first Y chromosome polymorphic systems used for population studies 
was the DYS1 locus detected by probes 49a/49f and Southern blots (Ngo ef al. 
1986). These probes recognised up to 18 fragments in Taq\ digested genomic 
DNA, named A to R, 8 of which could be present, absent or present in different 
sizes (Ngo et al. 1986, fig. 7). Nowadays we know that the p49a and p49f 
probes are 6kb distant from each other and are located in the DAZ locus 
(Saxena et al. 2000). Therefore the p49a,f haplotypes define individual Y 
chromosomes (fig. 7). 
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1 2 3 4 5 6 ? 8 9 10 
Figure 7 - Electrophoretic patterns of human male genomic DNA digested with Taq\ and 
hybridised with p49a/f, according to Ngo ef al. (1986). The different DNA fragment sizes are 
named A to R. The variations shown by the B, C, F and I fragments consist in their presence or 
absence, whereas A and D fragments also show differences in size and are named respectively 
A1 to A6 from the smallest to the bigger size and D1 bigger than D2. Lanes 1-7, 9, 10 show 
patterns from different haplotypes. Lane 8 presents a female pattern with only fragments K and 
L being present. 
1.6. LINE transposable elements in the DAZ locus 
Transposable elements are segments of DNA with the ability to move from one 
place to another in the genome. They fall into two main classes: 
retrotransposons, which move by reverse transcription of an RNA intermediate, 
and transposons, which move by a process of excision and insertion (Wright & 
Finnegan2001). 
All transposable elements are repeated within the genomes in which they are 
found, since transposition usually leads to an increase in copy number, either 
because its mechanism is intrinsically replicative or because of secondary 
events such as the repair of double-stranded breaks generated during 
transposition (Wright & Finnegan 2001). 
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Retrotransposons can be further divided in retrotransposons with long terminal 
repeats­ (LTRs) at their ends, equivalent to those of retrovirus, and 
retrotransposons with no repeats also called LINE elements (Wright fk Hnnegan 
2001). 
UNE­1 elements (Lis) are found In all mammalian genomes (Fanning & Singer 
1987) and can be distinguished by several structural features. Typically, full­
length elements are between 5 and 7 kb long, have no terminal repeats, 
possess one or two long open reading frames (ORFs) on the strand that 
terminates in a 3' A­rich segment and are surrounded by variabie­length target 
site duplications (Swergold 1990), 
ATG 
I l ' ■ ~HBS%3 
S'­UTR ORF1 ORF2 3'­UTR. 
Figure 8 ­ Lin© stwcuira containing two ORFs (ORF1 and ORF2) flanked by two untranslated 
region (5' UTR and 3' UTR), according to Swergold (1990). The dark bar between ORF1 and 
ORF2 represents the spacer DNA that separates the two ORFs. The start codon (ATG) is 
shown within ORF1. 
The human L1 consensus sequence (Scott 1987) has a 5' untranslated region 
(UTR) with an internal promotor, 2 open reading frames (ORF1 and ORF2) and 
a 3' UTR which terminates in a poly A tail (Scott 1987). ORF1 encodes a 40kDa 
nucleic acid binding protein, while ORF2 encodes a protein with endonuclease 
(Feng era/. 1996) and reverse transcriptase activities (Mathias et al. 1991) 
The most commonly proposed mechanism of L1 transposition involves (i) 
synthesis of full­length, polydenylated transcripts, (ii) reverse transcription of the 
RNA by an L1­encoded enzyme and (iii) insertion into staggered chromosomal 
breaks (Swergold 1990). 
The DAZ gene locus contains a full­length L1 element spanning 6.1 kb, 
between exon 7X and 7Y of each DAZ gene copy (fig. 5). 
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1.7. Methylation and acetylation of DNA and chromatin 
DNA methylation is one of the features that organises and controls the 
expression of genetic information, also having an important role in DNA repair 
and genome stability (Jost 1993). Methylation of cytosines in certain regions of 
genes can inhibit gene expression and artificial demethylation of genes has 
been shown to result in gene reactivation (Chen et al. 1976). Differentially 
methylated regions are key elements in the tissue-specific transcriptional 
regulation of genes. Methylation was proposed to contribute to the reduction of 
background expression and to result into the division of complex genomes into 
transcriptional active and non-transcriptional active regions (Grunau et al. 
2000). 
Mammalian cells possess the capacity to epigenetically modify their genomes 
via the covalent addition of a methyl group to the 5-position of the cytosine ring 
within the context of a CpG dinucleotide (Bird 1992). Certain regions of the 
genome, often clustered at the 5' ends of genes, possess a high CpG frequency 
(70%) and have been termed CpG islands. DNA methylation can cause an 
increase in mutation rates and heritage of methylation silenced genes are 
driven through changes in promoters that are associated with CpG islands 
(Rideout et al. 1990). 
In vertebrates, 60-90% of all CpG are methylated and many of the remaining 
non-methylated CpGs (about 15% of all CpGs in human DNA) are found in CpG 
islands, which usually include functional promoters (Ng & Bird 1999). 
Whereas a number of studies gave evidence for a correlation between the 
expression state and methylation strength, others showed that demethylation 
does not necessarily result in transcriptional activation and that the promoter 
region of inactive genes can be unmethylated. Thus, (de)methylation is 
apparently no general mechanism to determine tissue-specific gene expression. 
Early experiments demonstrated that artificially (5-azacytidine) methylated DNA 
can adopt a distinct chromatin structure upon integration into the genome 
(Keshet et al. 1986). This conformation renders the DNA refractory to nuclease 
action. On the other hand, unmethylated CpG islands, associated to promoters 
of many genes, possess a nuclease-sensitive chromatin structure differing from 
the bulk of the methylated genome (Tazi & Bird 1990). 
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Besides DNA methylation, also chromatin methylation and acetylation is known 
nowadays to remodel the chromatin for silencing a transcriptional unit (Wolffe & 
Pruss 1996). 
In mammals, chromatin remodelling occurs during spermatogenesis, whereby 
histones are displaced from chromatin, first by transition proteins and later by 
protamines (Wouters-Tyrou et al. 1998). With protamines, DNA in mature 
spermatozoa is packaged into an extremely condensed, functionally inert 
configuration (Balhorn 1982). Several evidences led to the view that chromatin 
remodelling during spermatogenesis is facilitated by hyperacetylation of histone 
H4. In numerous vertebrates, H4 hyperacetylation correlates to the occurrence 
of the histone-to-protamine transition in spermatogenesis. Extensive H4 
hyperacetylation occurs in the testis of species where histone are replaced by 
protamines during spermiogenesis, but not in species that completely retain 
somatic-type histones in mature spermatozoa (Kennedy & Davies 1980). The 
postulated role of histone hyperacetylation in facilitating histone displacement is 
consistent with the general perception that histone acetylation results in a more 
open chromation structure and hence easier access by regulatory proteins. 
Indeed, it has been observed in the trout that H4 hyperacetylation during 
spermiogenesis results in a highly relaxed chromatin configuration (Christensen 
era/. 1984). 
The acetylation of N-terminal lysine residues in core histones has been 
implicated in three distinct cellular processes. The first is the deposition of free 
histones onto newly synthesised DNA (Parthun et al. 1996), the second is the 
regulation of gene expression and the third is the displacement of histones by 
transition proteins and protamines during vertebrate spermatogenesis (Meistrich 
etal. 1992). 
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1.8. Aims of this research 
1. Establishment of a contig map of BAC and PAC clones isolated from the 
AZFc region and analysis of their repetitive substructure. 
2. Mapping of exon-structures of the AZFc gene families using BAC sequence 
contig (after sequences became available in GenBank). 
3. Design of molecular methods able to distinguish the different copies of the 
AZFc gene families. Analyses of their deletions in men with normal fertility 
(AZFc gene number polymorphism). 
4. Identifying of the copies of the DAZ gene family with a putative function in 
human spermatogenesis. 
5. Mapping of conserved transposable elements in the DAZ gene family. 
6. Mapping of DAZ gene promoter domain in functional DAZ gene copies. 
7. DAZ gene expression analyses in testicular tumour cell lines, as a molecular 
model for functional DAZ promoter analyses. 
8. Origins and mechanisms of the molecular rearrangements in the AZFc 
region resulting in deletions and loss of variable Y-specific genetic material. 
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2.1. Media for bacterial cultures 
LB-Medium 
LB-Agar for Agar plates 
Ampicillin 
Chloramphenicol 
X-Gal 
IPTG 
2.2. Agarose gel electrophoresis 
Agarose 
10xTAE(DNAgel) 
10 x MOPS (RNA gel) 
Loading buffer Orange G 
lOgNaCI 
10 g Bacto Tryptone (Becton Dickinson) 
5 g Yeast Extract (GIBCO BRL) 
ad 1 I dH20, autoclave 
Add 15 g/l Agar to LB-Medium, 
(Select Agar, Becton Dickinson) 
solution in dH20, sterile filter, 
aliquots at -20°C 
stock concentration: 50 mg/ml 
work concentration: 100//g/ml 
solution in 100% Ethanol, sterile filter, 
aliquots at -20°C 
stock concentration: 12.5 mg/ml 
work concentration: 12.5 //g/ml 
solution in 100% Ethanol 
aliquots at -20°C 
stock concentration: 50 mg/ml 
work concentration: 40 //g/ml 
solution in dH20, sterile filter, 
aliquots at -20°C 
stock concentration: 1 M 
Work concentration: 0.5mM 
Seakerrr LE-Agarose (FMC) 
LMP Agarose (FMC) 
40 mM Tris-Acetate pH 7.8 
1 mM EDTA 
20 mM MOPS 
5 mM Na-acetate 
1 mM EDTA 
pH7.0 
20 ml Glycerin (87%) 
1 ml 1 M Tris, pH 7.5 
0.1 g Orange G (AppliChem) 
up to 100 ml withdH20 
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Loading buffer Bromophenol blue 
RNA dye loading buffer 
Ethidium bromide 
0.5% Bromophenol blue 
50% Glycerin 
50 mM EDTA 
up to 100mlwithdH2O 
Novagen 
# 70606-3 
10 mg/ml Sigma 
Molecular Weight Markers (MBI Fermentas) 
Gene Ruler™ 100bp DNA ladder plus 3000 / 2000 /1500 /1200 /1031 / 900 / 
800 / 700 / 600 / 500 / 400 / 300 / 200 / 
100 bp 
Gene Ruler™ 1kb DNA ladder 
Lambda DNA / Hind III Marker 
10000 / 8000 / 6000 / 5000 / 4000 / 3500 
/ 3000 / 2500 / 2000 /1500 /1000 / 750 / 
500 / 250 bp 
23130 / 9416 / 6557 / 4361 / 2322 / 2027 
/ 564 bp 
2.3. Plasmid, PAC- and BAC-DNA isolation (Alkaline lysis) 
Solutions from Qiagen® Plasmid Mini-prep kit (# 12125) and from Qiagenq 
Large-construct kit (# 12462): 
Resuspension buffer (P1) 
Lysis buffer (P2) 
Neutralisation buffer (P3) 
Equilibration buffer (QBT) 
Wash buffer (QC) 
Elution buffer(QF) 
50mM Tris-HCI, pH 8.0 
10 mM EDTA 
100ug/mlRNaseA 
Store at 2-8 °C 
200mMNaOH, 1%SDS 
3 M Na-Acetate, pH 5.5 
750 mM NaCI 
50 mM MOPS, pH 7.0 
15% Isopropanol 
0.15% Triton® X-100 
1 M NaCI 
50 mM MOPS, pH 7.0 
15% Isopropanol 
1.25 M NaCI 
50 mM Tris-HCI, pH 8.5 
15% Isopropanol 
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Qiagen® Large-Construct Kit: 
Reaction buffer (EX) 
ATP-dependent Exonuclease 
Exonuclease-buffer 
ATP 
50 mM Tris-HCI, pH 8.5 
10 mM MgCI2 
lyophilised, resuspended in 225/vl of 
Exonuclease-buffer 
20 mM KCI 
20 mM Na-Acetate, pH 7.5 
Stock-solution: 100 mM in dH20 
Store at -20°C in 300 //I Aliquots 
2.4. Genomic DNA isolation 
Lysis buffer 
SDS 
SE-buffer 
Proteinase K 
TE-buffer(10:1) 
155mMNH4CI 
10mMKHCO3 
0.1 mM EDTA 
pH7.4 
20% in dH20 
75 mM NaCI 
25 mM EDTA 
pH8.0 
10 mg/ml Proteinase K in SE-buffer 
10 mM Tris-HCI, pH 8.0 
1 mM EDTA 
All solutions were sterile filtered (0.2 |xm Millipore) or autoclaved. 
QIAquick Gel Extraction kit 
QIAquick PCR purification kit 
Qiagen® # 28704 
Qiagen® #28106 
2.5. RNA isolation 
QIAamp® RNA blood Mini kit 
Rnase-Free DNase set 
Qiagen® # 52304 
Qiagen® # 79254 
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2.6. DNA-blot and radioactive hybridisation 
2.6.1. Labelling 
dATG-Mix 
oc 32P-dCTP 
Hexanucleotides mixture 
Probe Cleaning 
2.6.2. Blotting 
Depurination solution 
Denaturation solution 
Neutralisation solution 
Nylon membrane (Hybond-N+) 
2.6.3. Hybridisation 
Church-buffer 
Salmon Sperm DNA 
20% SDS (Sodium Dodecyl Sulfate) 
20 x SSC 
Wash buffer I 
Wash buffer II 
Strip-solution 
(mild strip) 
Strip-solution II 
(strong strip) 
33 mM dATP (Hybaid) 
33 mM dTTP (Hybaid) 
33 mM cGTP (Hybaid) 
SA 3000 Ci/mMol (Amersham Pharmacia 
Biotech) 
2.5 mg/ul (Amersham Pharmacia Biotech) 
Sephadex®-G50 (NICK™ Column, 
Amersham Pharmacia Biotech) #52-2076-00 
0.25 M HCI 
0.5MNaOH/1.5MNaCI 
1 MTris(pH8)/1.5MNaCI 
Amersham Pharmacia Biotech # RPN 203B 
0.5 M Na2HP04, 1 mM EDTA, 
pH 7.2 with H3PO4 
7% SDS 
10 mg/ml Sigma # D1626 
20 g in 100mldH2O 
3 M NaCI / 0.3 M Na-citrate, pH 7.0 
2xSSC 
0.1% SDS 
1xSSC 
0.1% SDS 
1 mM Tris-HCI, pH 8.0 
1 mM EDTA, pH 8.0 
0.5 % SDS 
0.5% SDS in dH20 
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2.7. Enzymes 
Klenow-Fragment (2U//vl) 
and 10 x reaction buffer 
Proteinase K (Boehringer) 
RNase A (Boehringer) 
Tag DNA-Polymerase (5U//yl) 
and 10 x PCR-buffer 
T4 DNA-Ligase (3U///I) 
and respective 10x buffer 
Restriction-Endonucleases 
A/7 III 5U///I 
Dde I 10U///I 
Fspl 5U///I 
H/ial 10U///I 
Mlu\ 10U///I 
A/i/l 10U///I 
C/al 10U///I 
Dra\ 10U///I 
EcoRV 10U///I 
Hae III 10U///I 
Hind\\\ 10U///I 
HpaW 10U///I 
Mbo\ 10U///I 
Msp\ 20U///I 
Taq\ 10U///I 
MBI Fermentas 
# EP0054 
20 mg/ml solution in 10 mM Tris-HCI, 
pH8.0/10mMNaCI 
10 mg/ml solution in 10 mM Tris-HCI, 
pH8.0/15mMNaCI 
15 min boiled, for DNase inactivation, 
Store aliquots at -20°C 
Gibco-BRL® 
#18038 
Promega 
#M1801 
New England Biolabs 
#R0541S 
#R0175S 
#R0135S 
#R0139S 
#R0198 
MBI Fermentas 
#ER0011 
# ER0141 
# ER0221 
# ER0301 
#ER0151 
# ER0501 
#ER0511 
# ER0811 
# ER0541 
# ER0671 
All enzymes are supplied with the respective 10X reaction buffer. 
2.8. cDNA synthesis 
Superscript™ First-Strand Synthesis System for RT-PCR Invitrogen #11904 
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2.9. Oligonucleotide/ Primer pairs (Interactiva - Thermo Hybaid) 
Locus Forward Primer (5'-3') Reverse Primer (5'-3') PCR (bp ) T m 
(°C) 
CDY1(p5) CAGCCCGAGGGATAGAATCCATG GCTGCTTTATATCCCAACAGAGG 450 55 
CDY1 (p6) TCCAATTGTACTGGAAGAATGTAAG GAAGCGTTTGTGCCACTATAAAGTC 700 55 
CDY1 (p7) GGGCGAAAGCTGACAGCAA GCTATGAAGATGGATTAGGGCA 396 70 
BPY2 GTCCATAGTGGGCTTGCTGA GCTTGTTCCACATATGGCACA 854 70 
E1F1AY CTCTGTAGTCAGCCTCTTC GACTCCTTTCTGGCGGTTAC 90 60 
XKRY CACTCATGGAGAAGGGTAGG GTCACACTCAGCCTCTTTAC 94 60 
SY153 GCATCCTCATTTTATGTCCA CAACCCAAAAGCACTGAGTA 140 57 
S R Y - S Y 1 4 GAATATTCCCGCTCTCCGGA GCTGGTGCTCCATTCTTGAG 470 66.5 
DAZsY152 AAGACAGTCTGCCATGTTTCA ACAGGAGGGTACTTAGCAGT 125 66.5 
Y-DAZ3 3' GCTAGAACCAAATATTCTGGAT ACTCCTCAGACACTCTATTAGTT 260 66.5 
5' ÚTR DAZ ACGTAGCCTTCTTTCCAAAGCCGTAGG CAGTGTTTCACCCACCACTTCTGG 3000 70 
3'UTR DAZ GAGCACCAGAGCCCTTTTGCTAT CTTCAACAAAGACAAAAATTT 607 62 
DAZ RRM3 CTGCTTAGCATTCTTCTATTATCTGT ACGCAACTCTCACTGCTACATAGG 473 66 
TPTE ACAATAGAGACTCATCTGAGTAG AGACTCGATAGCGGCATGGA 273 62 
TPTE screen AAAAGTATGTTAGAACGACTTTC GAAAGTCGTTCTAACATACTTTT 1700 60 
DAZ SY254 GGGTGTTACCAGAAGGCAAA GAACCGTATCTACCAAAGCAGC 400 62/65 
SY158 CTCAGAAGTCCTCCTAATAGTTCC ACAGTGGTTTGTAGCGGGTA 231 60 
DYZ2sY159 TACATGTTATGTGCTATGCC CACATTATATAATATGTATGTTGTC 461 58 
DYZ1 SY160 TACGGGTCTCGAATGGAATA TCATTGCATTCCTTTCCATT 236 62 
SY167 GAAGGCATTAAGACATAAAGCA ACTTTTGATATGAAAACAAACTTCA 117 62 
DAZ intron3 CACTGCCCTAATCCTAGCACA TCTTCTGGACATCCACGTCA 252 67 
5'DAZ CACAGGCACTCAGTAACTATCTC CAGTGTTTCACCCACCACTTCTGG 710 66.5 
THE-DAZ GACAACACCACCGTACTCCA -SY579 AGGAAGGAAGTGGAGGGAAA 133 65 
DAZ cDNA CACGTTCAGTCTGCTGCAAA (ex6-2) GAGGAGGAGGATTAACTACC (ex6) 412/907 60 
DAZ cDNA TAATTATCAGTCTGCTGCAAA (exl-2) GAGGAGGAGGATTAACTACC (ex6) 412/907 60 
DAZ cDNA CACGTTCAGGCACACACTA (ex6-l) GAGGAGGAGGATTAACTACC (ex6) 412/907 60 
DAZ Line GTGTATTCATGTATGCTACTG CACTGGGAGATATACCTAAT 480 62 
DAZ Prom. ACGTAGCCTTCTTTCCAAAGCCGTAGG CAGTGTTTCACCCACCACTTCTGG 3000 70 
DAZex1-2 CGATAAGCATTTCTTCCCTCTACC CGATAAGCATTTCTTCCCTCTACC 1300 66.8 
DAZ cDNA AGCAAAGGAGACATATCCTA (ex8-7G) TGAGAGGATCCAACAGATTT 240 56 
DAZRRM CTGCTTAGCATTCTTCTATTATCTGT ACGCAACTCTCACTGCTACATAGG 1863 68 
SY143 GCAGGATGAGAAGCAGGTAG CCGTGTGCTGGAGACTAATC 311 62 
DAZ1 GGAAGCTGCTTTGGTAGATAC TAGGTTTCAGTGTTTGGATTCCG 1300 57/65 
U3-SY139 TTCAGAGGAATCATGTGGGT AATGTTTCATCACCATTATCCC 120/123 59 
DAZ-SNV I CAGTGTTTCACCCACCACTTCTGG CACAGGCACTCAGTAACTATCTC 709 66.5 
DAZ-SNV II GGAAGCTGCTTTGGTAGATAC GACATCCACGTCATTAACAAACG 674 65 
DAZ-SNV III GTGTGGCACATATGCCTATAAA TTGGTACATCCAGATGCAGAT 301 63 
DAZ-SNV IV CTTCCTCATCTTTCTTGACTT TTATTTATTCCTCAAAAAGGTG 660 57 
DAZ-SNV V TGGTTAATAAAGGGAAGGTGI I I I TCTCCAGGACAGGAAAATCC 270 65 
DAZ-SNV VI GGGCCTAGTCTCTAGATCATT GCTAGAACCAAATATTCTGGAT 431 64 
AZFC-U3 ACTACCATTTCTGGAAGCCG - sY1192 CTCCCTTGGTTCATGCCATT 255 64 
AZFC-U2-T2 TCATTTGTGTCCTTCTCTTGGA - sY1197 CTAAGCCAGGAACTTGCCAC 453 60 
AZFcPU/1.2 CTGATTTGGAAACTCGTCCC - sY1190 CTGAAGAGATTGTGAAATGG 700 57 
AZFcb4 ACCTAAGGGAACCCAGGAGA - sY1054 CGACACTTTTGGGAAGTTTCA 340 60 
AZFcb4 CCGACTTCCACAATGGCT - sY1201 GGGAGAAAAGTTCTGCACG 677 64 
Yellow SNV ACAGTAGGGATGCCAATAAGATGG TGGCTCAGGCTGAGCCTGAGGCAT 467 70 
BPY2-SNV I GTGTCTCTTGTGTCTGGACC TCACTTCACCCGGGTACAGT 470 62 
CSPG4L-SNV GCCGAGTGGTGGCATGTGCA TGCCAAGGAGCTGGAAGGTGA 380 66 
GOLGA2LY TGGGCCTGTTGCTTCTAGGGTT ACAGGGAGGATGCTGCTGCTGTCACA 531 64 
TTY-4 SNVI GAGCCCTGCCTGCAGACA GTATATGGCATAATTTCACCTG 540 58 
DAZ1/4 CACGTTCAGTCTGCTGCAAA (ex6-2) CCACAGATTTCTCCTTTGCT 1.2-1.7 kb 60 
7A CTCAGCACGTTCAGGCTTAT (ex6-7A) CCACAGATTTCTCCTTTGCT 1400 65 
7B CTCAGCACGTTCAGGCTTAC (ex6-7B) CCACAGATTTCTCCTTTGCT 650-1000 65 
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DAZ-short TCAGTTCCATGTATACAATTAC TCAAAACCAGCAACTTCCCATG 254 60 
DAZBis ATTTGATAGAAAGGAGTTTAAGT TCACCATAATAATAACAAACAAC 674 58 
DAZL GATGTTAGGATGGATGAAACTG AAGCCGGAGGTACAACATAG 490 60 
DBX GAAGCTACTAGAGGTTTCTAC TCTCAACATCACTGAAACTTTC u 420 64 
CDNADAZ Primer used for DAZ RT experiences TCAAAACCAGCAACTTCCCATG - 42 
Table I - Primer pairs used in this work 
2.10. DNA sources 
2.10.1. Human PAC- and BAC-DNA clones 
All BAC-DAZ clones belonging to the "RPCI-11 Human Male BAC" library are 
from RZPD - Deutsches Ressourcenzentrum fur Genomforschung GmbH, 
Heubnerweg 6, D-14059 Berlin, www.rzpd.de - library nr. 753. The creator was 
Kazutoy Osoegawa, Minako Tateno (Shizuya et al. 1992). 
The BAC-DAZ clones belonging to the "CTA/CTB Human Male BAC" library are 
from Research Genetics, 2130 Memorial Parkway SW, Huntsville, AL 35801, 
USA (Shizuya et al. 1992). 
RPCI-11428D10 TPTE AC019099 
RPCI-11 557B9 TPTE AC013734 
CTB 352E14 DAZ 2 not sequenced 
CTA132B16 DAZ3 not sequenced 
CTB 546E5 DAZ4 not sequenced 
CTA 148114 DAZ1 AF164343 
RPCI-11 290O3 DAZ 3/4a AC010089 
RPCI-11 140H23 DAZ 1/2a AC053490 
RPCI-11 539D10 DAZ4a AC006338 
RPCI-11 226N11 DAZ 2 AC006990 
RPCI-11 26D12 DAZ 4 AC006982 
RPCI-11 263A15 DAZ 2/1a AC007039 
BAC K1020 DAZ 4 ? not sequenced 
Table II - BACs used in this work 
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The Human PAC-DAZ clones are from RZPD, library nr. 704, established by 
Pieter de Jong and P. loannou from the Roswell Park Cancer Institute, USA 
(Pierce et ai 1992). 
Name | Clone Specificity Acession nr. | 
G19633 PAC4C not sequenced 
G19660 PAC 12C not sequenced 
K07760 PAC 18F L D A Z 4 not sequenced 
D061100 PAC 21C DAZ3 not sequenced 
0131180 PAC 26 D DAZ 2 not sequenced 
Table III - PACs used in this work 
2.10.2. Human genomic DNA 
All the FM (Fertile Men) samples were from normal fertile males. 
All OZ (Oligozoospermic men) samples were from infertile males with normal 
karyotype and with sperm concentration < 10 millions/ml. 
2.10.3. Vectors 
2.10.3.1. pCR® 2.1 -TOPO® vector 
This vector was used for TOPO® cloning reactions using PCR products {DAZ 
1.1, 1.8 and 1.9 probes), RT-PCR products and DAZ transcripts from cell lines. 
The map below (fig 9) shows the features of this vector and the sequence 
surrounding the TOPO® cloning site. 
TOPO® TA Cloning kit, Invitrogen, # K 4500-01 
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. AGC 
CCC BKT 
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M13 For»rangl MOii Ptimgf 
Comments for pCR®2,,1-TQPOej 
3008 nucleotides 
LacZa fragment: bases 1-571 
M13 reversa priming site: basas 205-221 
Multiple darling site: bases 234-357 
Ï 7 promoter/priming site: basas 384-383 
M13 Forward (-20) priming site: bases 391-403 
M13 Forward (-40) priming site: basas 411-425 
Figure 9 - Vector pCR® 2.1-TOPO<s 
.©, 2.10.3.2. pBluescripr II SK (+/-) 
The inserts cloned in this vector (fig 10) were DAZL1-cDNAs, CT52Y, CT351Y 
and CT355Y, from the Human Testis Large Insert cDNA Library HL5503u 
(Clontech), containing the mRNA from normal, whole testes pooled from 25 
Caucasians. 
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Figure 10 ­ Vector pBluescript® Il SK (+/­) 
2.10.3.3. pBACe3.6 vector 
This pUC plasmid is currently used for BACs and PACs inserts in the range of 
100­150 kb. The map below (fig. 11) shows the pBACe3.6 main features 
(Frengen et al. 1999). This vector has a cloning area to allow positive selection 
for inserts containing BAC clones through inclusion of the SACB II gene from 
P1 vector and disrupted the BamHI cloning site with a fragment containing a 
pUC plasmid (Pierce et al. 1992). All the BACs used in this work were cloned in 
this vector. 
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Not 1(11456) 
BtrnH I (1) 
Sac II (8) 
' ScoRl(lff) 
Sac I (20) 
"MB I (22) 
PBR322 
PUC­LINK 
jipa LI (166) 
Apa LI (2012) 
Apa LI (2509) 
Mu I (2790) 
\sac I (2800) 
£«?R I (2802) 
•ac II (2810) 
Sa«HI(2811) 
Not I (2850) 
Figure 11 ­ Vector pBACe3.6 
2.10.3.4. pCYPAC2 vector 
The map below shows the pCYPAC2 main features (fig. 12). This vector has 
been constructed for the cloning of large DNA fragments following 
electroporation, by inserting a pUC plasmid into the BamHI cloning site (Pierce 
et a/. 1992). All the PACs used in this work were cloned in this vector. 
NOTI (10720) 
\ BAMHI(1) 
SacB Prom otor 
\ \ ,3CAI (21) PUC-LINK 
P1 Lytic Replicon ^ ^ ^ 
SP6 
^ . S C A I (2723) 
ig^BAMHI (2739) 
^ ^ ~ ^ N O T I (2778) 
XHOI (13985) // ■P----^ 
PCYPAC2 
18754 bp LoxP 
^Hf SacBII gene 
KANAMYCIN \ 
P1 Plasmid Replicon 
SACII (10141) / 
XHOI (9158) 
PUC-Link is stuffor fragment, boing replaced by insert ONA during cloning. 
Vector fragment does not contain sites for AscI, SnaBI, Sacl & Sfil. 
Figure 12 ­ Vector pCYPAC2 
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2.10.4. Probes 
CT52Y(EcoRI-Avall) cDNA DAZ 7 variants 800 bp 
CT351 A23 (Hind III) cDNA DAZ(ex1-ex7) 2kb 
DAZ1.1 genomic DAZ(ex1-ex2) 1.4 kb 
DAZ1.8 genomic RRM (incl 7G) 1.8 kb 
49f genomic DAZ (ex 4,5,6,7B) 2.8 kb 
DAZ1.9 genomic Putative promoter 1.9 kb 
Table IV - Probes used in this work 
2.11. Cell culture 
RPMI 1640 
(without L-Glutamine) 
Dulbecco's Modified Eagle Medium (DMEM) 
(1000 mg/l glucose) 
Fetal Bovine Serum (FBS) 
(heat inactivation at 56°C for 30 min. and sterile filter) 
L-Glutamine 200 mM 
Antibiotic-Antimycotic solution 
(Pen-Strep-Amp) 
Trypsin-EDTA solution 10 X 
Non-Essential-Aminoacids (NEA) 
2ft-Mercaptoethanol (2R-ME) 
5'-Azacytidine 
(4-amino-1 -R-D-ribofuranosyl-5-triazin-2[1 H]-one 
Trichostatin A (4,6-Dimethyl-7-(p.dimethylaminophenil) 
-7-oxohepta-2,4,dienohydroxamic acid) 
Na-bisulfite 
Hydroquinone 
Wizard® DNA Clean-Up system 
Gibco-BRL® 
#31870 
Gibco-BRL® 
#31885 
Gibco-BRL® 
#12476 
Gibco-BRL® 
#15039 
Gibco-BRL® 
#15240-062 
Gibco-BRL® 
# 35400 
Gibco-BRL® 
#11140 
Gibco-BRL® 
#31350 
Sigma 
# A2385 
Sigma 
# T8552 
Sigma # S-9000 
Sigma 
# H-9003 
Promega 
# A7280 
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2.12. Photographie material 
Autoradiography 
X-ray films X-OMAT AR (XAR-5), Kodak 
Developer G153 Developer, Agfa 
Fixative G354 RapidFixer, Agfa 
2.13. In silico - Sequence analysis 
2.13.1. Databank 
Data Bank from National Center for Biotechnology Information (NCBI), 
National Institutes of Health, National Library of Medicine, National Institutes 
of Health (NIH), Washington, USA 
http://www.ncbi.nlm.nih.gov 
2.13.2. Software for sequence analysis 
HUSAR (Heidelberg Unix Sequenz Analysis Resources) 
The Biocomputing Service Group, DKFZ Heidelberg, Germany 
http://genome-dkfz-heidelberg.de 
http://genius.embnet.dkfz-heidelberg.de/menu/w2h/w2hdfz/index.html 
Clustal and GAP - Comparing homologies among sequences 
Map and Mapsort - Restrictions analysis and translation 
BLAST (Basic Local Alignment Search Tool, Altschul et al. 1990. 1997) 
National Center for Biotechnology Information, Bethesda, Maryland, USA 
http://www.ncbi.nlm.nih.gov/BLAST/ 
NIX (Identity unknown nucleic seguences) 
UK Human Genome Mapping Project Resource Centre, MRC, UK 
http://www.hgmp.mrc.ac.uk/menu-bin/Nix/ 
Repbase (Genetic Information Research Institut) 
http://www.girinst.org/ 
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DNA-fraqment analysis 
Dnafrag Version 3.03 (Schaffer etal. 1981) 
Programmed by John Nash 
Copyright © National Research Council of Canada, 1991. 
2.14. Strains and cell lines 
2.14.1. Bacterial strains 
The bacterial strains were obtained by transforming the E. coli hosts given 
below with the corresponding recombinant plasmids: 
• E. coli TOP10F' One Shot® Chemically Competent cells - F' /aclq TniO 
(Tef) mcrA A(mrr-hsdRMS-mcrBC) <|>80/acZAM15 A/acX74 recA1 deoR ara 
D139 A(ara-/eu)7697 galU galK rpsL (StrR) endA1 nupG. This strain over 
expresses the Lac repressor (/aclq gene). This strain contains the F episome 
and can be used for single-strand rescue of plasmid DNA containing an f1 
origin - Invitrogen # K4550 
• DH5oc™-T1R - F- (j)80/acZAM15 A(/acZYA-argF)U169 deoR recA1 endA1 
/7sdR17(rk",mk+) phoA supE44 thiA gyrA96 re/A1 tonA. This strain is used for 
general cloning and blue/white screening without IPTG. Strain is resistance 
to bacteriophage T1 - Invitrogen # K4520. 
2.14.2. Human cell lines 
The NT2/D1 cell line is a human germ-cell cancer cell line initially obtained 
from Prof. P. Andrews, Sheffield, UK, growing as a monolayer in DMEM 
supplemented with 10% FBS, 0.1 mM 2G-ME and 1% Pen-Strep-Amp (Andrews 
1984). 
The Ep2102 cell line is a human germ-cell cancer cell line initially obtained 
from Prof. P. Andrews, Sheffield, UK, growing in DMEM supplemented with 
10% FBS and 1% Pen-Strep-Amp (Andrews 1984). 
The Du-145 cell line is a human prostate cancer cell line obtained from DKFZ 
(Deutsches Krebsforschungszentrum), Heidelberg, Germany, growing as a 
monolayer in DMEM supplemented with 10% FBS and 1% Pen-Strep-Amp. 
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The LNCaP cell line is a human prostate cancer cell line obtained from DKFZ 
(Deutsches Krebsforschungszentrum), Heidelberg, Germany, growing as a 
monolayer in RPMI 1640 supplemented with 10% FBS, 1% L-Glutamine, 1% 
Pen-Strep-Amp and 1% NEA (Webber et al. 1996). 
2.15. Sequencing 
BigDye™ Terminator Cycle Sequencing 
v2.0 kit 
Applied Biosystems 
#4314414 
MicroSpin™ S-400 HR columns 
ABI PRISM® 310 Genetic Analyser 
Amersham Pharmacia Biotech 
Applied Biosystems 
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Methods 
3.1. Microbiology techniques 
3.1.1. Bacterial cultures 
The bacteria can be cultivated in agar or in liquid medium. The plate cultures 
containing isolated colonies can be stored at 4°C for long time. 
Culture in agar plates   
|» Add 15 g BACTO-Agar per litre LB medium and autoclave 
• After cooling down the medium (ca. 50°C) add the appropriate antibiotic and 
! poor the medium in Petri dishes 
• Spread the bacteria on the plates and incubate for 12 to 20 hours at 37°C 
Culture in liquid medium   
[• The liquid cultures can be performed in volumes from 5 to 500 ml 
• After autoclaving, cool the medium down (ca. 50°C) and add the appropriate 
antibiotic 
• Inoculate the medium with a single colony (from an agar plate culture) or 1:100 
j v/v dilution from a main culture 
• Incubate for 12 to 20 hours at 37°C with shaking 
• The bacterial concentration can be measured by optical density at 600 nm and 
the concentration is calculated by the formula: 10D6oo = 5,8 x 108 bacteria/ml 
3.1.2. Bacterial stocks (Glycerol stocks) 
The long time storage (years) of bacteria is done at -70°C in 15% glycerol. 
• Mix 0.5 ml overnight bacterial culture with 0.5 ml Glycerol 87% solution 
• For long time storage, store the tubes at -70°C 
3.1.3. Screening of genomic libraries 
The PAC- and BAC-DNA libraries from RZPD are the so-called XYZ genomic 
libraries and can be screened by a two-step PCR procedure. The BAC-DNA 
library contains 423 936 clones, grouped in 23 primary pools consisting of 
purified DNA from all clones from 8 microtiterplates of the genomic library. The 
identification of the desired clones is done by testing first the 23 primary pools. 
Once a positive signal with a primary pool is obtained, the corresponding 
secondary pool is sent. The secondary pools consist of individually pooled 
microtiterplates from the positive primary pool, as well as pooled rows and 
columns from all 8 microtiterplates of the positive primary pool. Each secondary 
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pool consists of 48 pools maintained in 384-well microtiterplates. The PCR 
screening of each secondary pool should result in 3 positive signals: the 
positive plate, the positive row and the positive column. With the combination of 
these 3 coordinates, the exact clone can be identified and acquired from the 
Resource Center (RZPD). 
For the PCR screening, the lyophilised BAC-DNA should be resuspended in 5//I 
dH20 from the microtiterplate wells and incubated at room temperature with 
shaking for 15 min. 1 //I from each suspension should be used for PCR reaction. 
For this work, the pools from RPCI-11 Human Male BAC library were screened 
with the DAZ marker sY254 (GenBank, ac. nr. G38349) to find the DAZ-BAC 
clones. 
3.2. Agarose gel electrophoresis 
The DNA and RNA can be separated by molecular weight by electrophoresis in 
an agarose gel electrophoresis. Agarose is a polymer of D-Galactose and 3,6-
anhydro-L-Galactose isolated from a red seaweed. Agarose gel is prepared by 
dissolving the powder in 1x TAE buffer. The DNA samples are mixed with the 
appropriate volume of loading buffer and the gel is loaded using 10 to 25ul final 
solution. Because DNA in solution is negatively charged, the DNA migrates 
under the influence of an electric field from the cathode to the anode. The DNA 
migration depends on the DNA size and conformation, buffer and agarose 
concentrations. 
The migration of linear, double strain DNA molecules in agarose matrix is 
invertely proportional to the size logarithms. The super-coiled and circular 
plasmidic DNA migrates faster than the corresponding relaxed molecule. 
The relative mobility is first depending on the agarose concentration on the gel. 
On table V are listed the optimal agarose gel concentrations for separating 
different sizes of DNA. 
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Agarose concentration DNA sizes [kb] 
[%w/v] 
0.3 5-60 
0.6 1-20 
0.7 0 .8-10 
0.9 0 .5 -7 
1.2 0 .4 -6 
1.5 0 . 2 - 3 
2.0 0 .1 -2 
Table V - Agarose concentration vs DNA fragment sizes. 
For RNA, samples (5 i^g) were denatured in loading buffer containing 50% 
formamide, 18% deionised formaldehyde and 0.02M MOPS, heated at 68°C for 
10 min., and then separated through a 1.2% agarose denaturing gel containing 
18% formaldehyde and 0.02M MOPS. The running gel buffer was 0.02M 
MOPS, pH 7.0. The electrophoresis was performed for 3h at 60V. 
For DNA and RNA visualisation, stain the agarose gel with 0,001% Ethidium 
bromid solution. Ethidium bromide intercalates between the bases and, under 
U.V. light (366 nm), emits light at visible wavelength (590 nm), allowing the 
nucleic acids to be seen. For documentation, a picture is taken from the gel on 
a U.V.-transilluminator. 
More precise size of each fragment on the gel can be estimated running, on the 
same conditions, a molecular weight marker (DNA or RNA-Ladder). 
3.3. DNA isolation 
3.3.1. From blood 
For DNA extraction from peripheral blood (Miller et a/. 1988), the main steps are 
the lysis of erythrocytes, disruption of cellular membranes, protein denaturation 
and DNA precipitation. 
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• Lysis 
• Mix 10 ml EDTA-blood with 30 ml lysis buffer (ice cold) and incubate on ice for 
30 min. 
• Centrifuge at 1500 rpm for 10 min. and wash the pellet with 10 ml lysis buffer to 
obtain a white pellet 
• Resuspend the pellet in 10 ml SE buffer (Nucleus-Lysis buffer), centrifuge and 
resuspend in 5 ml SE buffer (ice cold) 
• Add 40 pi Proteinase K (10 mg/ml in SE buffer) and 250 pi of 20% SDS 
• Mix gently and incubate O.N. at 37°C (the solution should be clear) 
• Salt precipitation 
• Fill up with SE buffer to a final volume of 15 ml 
• Precipitate cells debris with 3,3 ml saturated NaCI solution, mix by vortex and 
centrifuge at 3000 rpm for 15 min 
• Discard the pellet and precipitate genomic DNA from the supernatant with 0.1 
volume 3 M Na-Ac pH 7.0 and 1 volume Isopropanol 
• Invert the tube gently until the DNA strand appears 
• Hook the DNA and transfer to an eppendorf tube 
• Wash DNA with 500 pi 80% Ethanol and air-dry the pellet 
• Resuspend the DNA in TE buffer and put it in a rotor at 4°C 
3.3.2. Plasmid preparation from bacterial cultures 
3.3.2.1. DNA Mini-preps 
The Plasmid-DNA (till 20 pg) preparation was done using the Plasmid Mini Kit 
(Qiagen®, Hilden, Deutschland). Qiagen® plasmide purification protocols are 
based on a modified alkaline lysis procedure (Birnboim & Doly, 1979), followed 
by binding of plasmid DNA to Qiagen® anion-exchange resin, under appropriate 
low-salt and pH conditions. RNA, proteins and low molecular weight impurities 
are removed by a medium-salt wash. Plasmid DNA is eluted in a high-salt buffer 
and then concentrated and desalted by isopropanol precipitation. These 
protocols are optimised for use with cultures grown in standard Luria Bertani 
(LB) medium to a cell density of -1x109 cells/ml. 
• Start culture 
• Add 10 pi of Ampicillin stock solution to 5 ml LB medium 
• Pick a single colony from a streaked selective plate and inoculate a culture of 5 
ml LB medium 
• Incubate over night at 37°C with vigorous shaking (~ 300 rpm) 
• Harvest the bacterial cells by centrifugation at 6000 x g for 15 min at 4°C 
• Bacterial lysis 
• Resuspend the bacterial pellet in 0.3 ml buffer P1 (+RNase A) 
• Add 0.3 ml buffer P2, mix gently but thoroughly by inverting 4-6 times and 
incubate at room temperature for 5 min.  
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• Add 0,3 ml of chilled (4°C) buffer P3, mix immediately but gently by inverting 
and incubate on ice for 5 min. 
• Centrifuge at 11000x g for 10 min. and change supernatant to a new Eppendorf 
tube 
• Clean in a the Plasmid-DNA in a anion-exchanqe column 
• Equilibrate a Qiagen -tip 20 by applying 1 ml buffer QBT and allow the column 
to empty by gravity flow 
• Apply the supernatant (2 steps below) to the Qiagen®-tip and allow it to enter 
the resin by gravity flow 
• Wash the Qiagen®-tip with 4 x 1 ml buffer QC, to remove all contaminations 
from the plasmid preparation 
• Elute Plasmid-DNA with 0.8 ml buffer QF 
• Plasmid-DNA preparation 
• Precipitate the Plasmid-DNA by adding 0.56 ml (0,7 Volume) Isopropanol, mix 
and centrifuge at 11000 rpm for 30 min. Carefully decant the supernatant 
• Wash DNA pellet with 1 ml 70% Ethanol and centrifuge at 11000 rpm for 15 
min., decant the supernatant without disturbing the pellet 
• Air-dry DNA pellet for 5-10 min and resuspend the DNA in 30 ul TE buffer 
3.3.3. BAC-DNA preparation 
The genomic DNA extraction from large constructs (up to 250 kb) such as BACs 
(Bacterial Artificial Chromosomes) and PACs (Phage Artificial Chromosomes), 
was done using the QIAGEN® Large-Construct Kit (QIAGEN®, Hilden, 
Deutschland). The QIAGEN® Large-Construct kit protocols are based on a 
modified alkaline lysis procedure and an integrated ATP-dependent 
exonuclease digestion. This step ensures selective removal of contaminating 
genomic DNA as well as nicked or damaged large-construct DNA. Following the 
digestion step, large-construct DNA is bound QIAGEN® resin. RNA, proteins 
and low molecular weight impurities are removed by a medium-salt wash. 
Large-construct DNA is eluted in a high-salt buffer and then concentrated and 
desalted by isopropanol precipitation. 
• Start culture 
• Add 5 ul of Chloramphenicol stock solution (12,5 mg/ml) to 5 ml LB medium 
• Pick a single colony from a streaked selective plate and inoculate a starter 
culture of 5 ml LB medium/Chloramphenicol 
• Incubate 8 h at 37°C with vigorous shaking (~ 300 rpm) 
• Overnight culture 
• Add 500 pi of Chloramphenicol stock solution in 500 ml LB medium 
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• Dilute 1 ml of the starter culture in 500 ml selective LB medium 
• Incubate 12 to 16 h at 37°C with vigorous shaking (~ 300 rpm) 
• Harvest the bacterial cells by centrifugation at 6000 x g for 15 min. at 4°C 
• Bacterial lysis 
• Resuspend the bacterial pellet in 20 ml of buffer P1 (+Rnase A, 100 ug/ml) 
• Add 20 ml of buffer P2, mix gently but thoroughly and incubate at room 
temperature for 5 min. 
• Add 20 ml of chilled (4°C) buffer P3, mix immediately and incubate on ice for 10 
min. 
• Centrifuge in a Sorvall Rotor at 9000 rpm for 30 min. at 4°C 
• Remove supernatant (containing BAC/PAC DNA) promptly to a 50 ml Falcon 
tube 
• Filter the lysate through a filter pre-wetted with dH20 
• DNA precipitation 
• Precipitate DNA by adding 0,6 volumes (ca. 36 ml) isopropanol to the lysate, 
shortly mix and centrifuge at 3500 rpm for 60 min. at 4°C 
• Wash DNA pellet with 5 ml 70% Ethanol and centrifuge at 3500 rpm for 30 min. 
• After discard the supernatant, air-dry the pellet and re-dissolve the DNA in 9.5 
ml of buffer EX. 
• Exonuclease digestion 
• Add 200 ul of ATP-dependent exonuclease and 300 pi ATP stock solution to 
the dissolved DNA, mix gently and incubate at 37°C for 60 min. 
• Cleaning the BAC-DNA through a column 
• Equilibrate a QIAGEN®-tip 500 with 10 ml buffer QBT 
• After the genomic DNA digestion with exonuclease, add 10 ml of buffer QS, 
apply the whole sample to the QIAGEN®-tip and allow it to enter the resin by 
gravity flow 
• Wash the QIAGEN®-tip with 2 x 30 ml buffer QC 
• Elute BAC-DNA with 15 ml buffer QF, pre-warmed to 65°C 
• BAC-DNA precipitation 
• Add 10,5 ml (0,7 volumes) isopropanol to the eluted DNA 
• Mix and centrifuge at 3500 rpm for 60 min at 4°C 
• After decanting the supernatant, wash DNA pellet with 5 ml 70% Ethanol and 
centrifuge at 3500 rpm for 30 min. 
• Air-dry the pellet and re-dissolve the DNA in 30 pi TE buffer  
3.4. RNA isolation 
For this purpose the QIAamp® RNA blood mini kit from QIAGEN® was used. 
This kit provides a fast and easy method for the preparation of total cellular 
RNA from human whole blood. In addition, this kit can be used to purify total 
RNA from tissues and cultured cells. 
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3.4.1. From blood 
QIAamp® spin columns technology combines the selective binding properties of 
a silica-gel based membrane with the speed and convenience of microspin 
technology. A high-salt buffering system allows RNAs longer than 200 bases to 
bind to the QIAamp® membrane. During this procedure, the main steps are the 
lysis of erythrocytes followed by the lysis of leukocytes using highly denaturing 
conditions to inactivate RNases, allowing the isolation of intact RNA. RNA is 
then bound to the silica-gel membrane and the contaminations are washed 
away. The RNA is finally eluted from the spin column using RNase-free water. 
• Lysis 
• Mix 1 volume of EDTA-blood with 5 volumes of buffer EL and incubate on ice 
for 15 min. 
• Centrifuge at 1500 rpm for 10 min. at 4CC and discard the supernatant. Wash 2 
or 3 times with buffer EL to obtain a white pellet 
• Add 350 or 600|il buffer RLT (depending on leukocytes number) and vortex or 
pipette to mix 
• Homogenization 
• Pipet lysate into a QIAshredder® spin column and centrifuge for 2 min. at 
! maximum speed to homogenize. 
• Discard QIAshredder® spin column and save homogenized lysate 
• Add 1 volume of 70% ethanol to the lysate and mix by pipetting 
• RNA cleaning (including DNase treatment) 
• Pipet sample, including any precipitate which may have formed, into a Rneasy® 
Mini column 
• Centrifuge for 1 min. at 10000 rpm and transfer the column to a new 2 ml tube 
• Wash with 350jxl buffer RW1 and centrifuge for 1 min. at 10000 rpm 
• Add 10|xl DNase I stock solution to 70|xl buffer RDD and mix by inverting the 
tube 
• Apply the DNase incubation mix to the column and incubate at room 
temperature for 15 min. 
• To wash, pipet 350jxl buffer RW1 and centrifuge for 1 min. at 10000 rpm 
• Pipet 500^1 of buffer RPE into the column and centrifuge for 1 min. at 10000 
rpm 
• To remove residual ethanol, add 500jxl of buffer RPE and centrifuge for 2 min. 
at maximum speed 
• Transfer spin-column to a new 1.5ml tube and elute RNA with 30)il RNase-free 
water. Centrifuge for 1 min. at 10000 rpm 
• Repeat the elution step to a new 1,5ml tube if the expected RNA yield is >30 (ig 
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3.4.2. From cultured cells 
Cell pellets in buffer RLT can be stored at -70°C for several months. To process 
frozen lysates, thaw and incubate at 37°C for 10 min. to ensure that all the salt 
has dissolved. 
• Harvest cells 
• Cells growing in a monolayer can be trypsinized and collected as a cell pellet 
prior to lysis 
• Discard medium, wash cells 2x with PBS, aspirate and add the trypsin solution 
• After cells detach from the flask, add PBS, transfer to a tube and pellet by 
centrifugation at 1200 rpm for 5 min. 
• Disrupt cells by adding 350 or 600p.l buffer RLT (depending on pellet cells 
number), vortex or pipette to mix. No cell clumps should be visible before 
proceeding to the homogenisation steps 
• Homogenization and following steps 
• The protocol used for the following steps is the same as for RNA isolation from 
blood (see above) 
3.5. Genomic DNA Blot experiments 
3.5.1. Sample preparation 
Briefly, the DNA samples were digested with different restriction enzymes, 
restricted DNA fragments separated on agarose gel by electrophoresis and 
transferred to nylon membranes by blotting according to Southern (Southern, 
1975). 
• Samples preparation 
• Prepare 8 ug genomic DNA from each sample. If the sample is too old or to 
viscous incubate at 65°C for 5 min. before pipetting it 
• Precipitate with 1/10 Na Ac and 2V absolute ethanol 
• Incubate at -20°C for 30 min. and centrifuge 30 min. at 4°C 
• Dry pellet and resuspend on appropriate volume with TE buffer (10ul for a 
medium gel; 12.4ul for a big gel) 
• Endonuclease restrictions and pel running 
• Add to the genomic DNA, 1/10 volume spermidine (25 mM), 1x RE buffer and 
50 U RE in a final volume of 20 pi (for plasmidic DNA, no need of spermidine) 
• Incubate O.N. at 37°C (for Taq I incubation at 65°C for 3 h) 
• Add 2 pi of 6x loading buffer, mix and incubate at 65°C for 10 min. 
• Load all volume (20ul) on the gel (0,8% gel with LE-Seakem® agarose) 
• Run gel at 200V for 10-15 min and then 30-75V O.N. or until the orange dye is 
at the end of the gel 
• Stain the gel in Ethidium bromide and take a real size picture  
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3.5.2. Capillary Blot 
For the DNA transfer to a nylon membrane, after the electrophoresis the DNA 
should be depurinated with HCI, denatured with NaOH and neutralised with Tris 
buffer. After the DNA transfer to the nylon membrane, the membrane is UV-
crosslinked (254 nm) and baked to bind DNA permanently to the membrane. 
• Gel treatment: 
• Depurination - 0.25M HCI (freshly prepared) for 15 min. (the orange colour 
should change to grey) 
• Denaturation - 0.5M NaOH / 1.5M NaCI for 2X 45 min. (the blue colour will 
appear again) 
• Neutralisation -1M Tris (pH 7.5) /1.5M NaCI 
• DNA transfer 
• Cut the nylon membrane (Hybond N+) and wet in hot water, followed by 
equilibration step on 2XSSC for 10 min. 
• Mount the blot as shown in figure 1 MM 
• Transfer O.N. in 20X SSC (3M NaCI/ 0.3M Natrium citrat/pH7.0 with HCI) 
• Dismount the blot, UV cross-link the membrane and bake for 2h at 80°C to bind 
permanently the DNA to the membrane 
• Store at R.T. or use to hybridise with a specific probe 
• Stain the gel in EtBr to check if the transfer was complete 
Weight (~500g) 
Glass plate 
Paper towels 
3MM filter paper 
Hybond membrane 
Agarose gel 
3MM filter paper 
Transfer buffer 
Figure 13 - Capillary blots by Southern (according to Southern, 1975). 
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3.5.3. Vacuum-Blot 
The DNA transfer from an agarose gel to a membrane can also be done by 
vacuum with a vacuum blot system from Amersham Pharmacia Biotech. 
Building the vacuum blot 
Cut the nylon membrane and treat as for capillary blot (wet in hot water and 
equilibrate on 2x SSC) and put in the vacuum apparatus 
Cut and adjust a plastic mask to the size of the gel 
Add the agarose gel, after stained with EtBr (seal with Bromophenol blue gel) 
DNA transfer 
Adjust the vacuum to 55 cm3 and treat the gel as follows: 
Depurination ­ 0.25 M HCI for 2 x 15 min. 
Denaturation ­ 0.5 M NaOH/1.5 M NaCI for 1 x 5 min., followed by 2 x 30 min 
Dismount the blot 
Wash the membrane shortly in 2 x SSC 
UV­ crosslink (1.2 J/cm2 for 30 sec.) the membrane and bake for 2h at 80°C to 
bind permanently the DNA to the membrane 
Store at R.T. or use to hybridise with a specific probe 
Stain the gel in EtBr to check if the transfer was complete  
Vacuum 
apparatus 
Y 
Vacuum Pump 
► Agarose gel 
­ Hybond 
membrane 
Figure 14 ­ Vacuum blots scheme. 
3.6. Radioactive hybridisation 
The blots were pre­hybridised for 3 hours in Church buffer at 65°C, followed by 
hybridisation at 65°C overnight with a specific probe. The DNA sequence to be 
used as a probe is labelled with radioactivity (« 32P­dCTP). Blots were washed 
under stringent conditions (2 x SSC / 0 .1% SDS at 65°C). Membranes were 
exposed to auto­radiography at ­70°C with an intensifying screen for 1­3 days. 
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3.6.1. Radioactive labelling by Random Priming 
The complementary strand of DNA is synthesised by a DNA polymerase I 
(Klenow-Fragment) from a template DNA using hexanucleotides mix as a 
random primer. The nucleotide labelled ([32P] dCTP) is incorporated during the 
new strain synthesis. 
• Add 20-100 ng DNA (volume variable) to 4x a Hexamer-Oligonucleotide (80-
400 ng) 
• Complete the volume to 11 |jl with dH20 
• Denature at 95°C for 5 min., centrifuge shortly and cool down on ice 
• On ice, add 2ul 10 x Reaction buffer, 1ul 33 mM dATG mix and 5ul a 32P-dCTP 
(50 uCi) 
• The DNA synthesis starts with the addition of 1pl Klenow-Fragment (2 U/|jl), 
followed by incubation at 37°C for 3 h in a hot block 
3.6.2. Probe cleaning 
In order to have a specific hybridisation and to reduce the background it is 
important to remove the unincorporated radioactive nucleotides. This is 
normally done by using a Sephadex®-G50-column (NICK™ Column, Amersham 
Pharmacia Biotech). The use of these columns is not recommended for 
purification of oligonucleotides shorter than 20bp. 
• Equilibrate the gel from the column with 3 x 3ml dH20 
• Allow the dH20 to completely enter the gel bed 
• Add 80ul dH20 to the labelled probe (20 ul) and load the column with all volume 
(100ul) 
• Add 300 |jl dH20 and allow to enter into the gel bed 
• Discard the first sample collection (400 ul fraction) 
• Elute the purified sample (elution containing the probe) after adding 2x 400 ul 
dH20 
3.6.3. DNA-blot hybridisation 
After labelling and cleaning the probe, but before the hybridisation, the DNA-
probe should be denatured. 
• To avoid non-specific hybridisation, add 200pl Salmon sperm DNA (1 mg/ml) to 
800ul probe preparation in order to block the repetitive DNA 
• Add 31 pi of 10M NaOH solution (final concentration 0,3M) to the cleaned DNA-
probe (1ml) and incubate at room temperature for 10 min. 
• Stop probe denaturation by neutralisation with 31 pi of 10M acetic acid solution 
(final concentration 0,3M) and proceed to the hybridisation 
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The pre- and hybridisation are done at 65°C, in rotating tubes in a hybridisation 
oven. 
I *i* Pre-h ybridisation • Add 10ml Church buffer to the nylon membrane and incubate at 65°C for 3 h 
• Hybridisation 
• Add the denatured DNA-probe to 5 ml Church buffer pre-warmed at 65°C 
• Hybridise the membrane for 8-12h (overnight) at 65°C 
• Post-hybridisation washes (to remove non-specific binding) 
• The membrane washes were done with 2x SSC / 0.1% SDS at 65°C, as 
follows: 
1 x 20 min. in the glass tubes in the hybridisation oven 
2x15 min. at 65 °C in the water bath (with shaking) 
After each washing step, the background is measured with a Geiger counter. 
The washing steps should stop when the background is near zero. If necessary, 
more stringent washing steps should be performed with 1x SSC / 0.1% SDS at 
65 °C, 0.1 x SSC / 0.1 % SDS, etc. 
• Membrane exposition after hybridisation 
• The membrane should be covered by plastic folio and exposed to auto-
radiography at -80°C in a cassette with intensifying screens 
• The exposure time is variable and depending on the type of blot: genomic blot -
at least overnight exposition; plasmidic blot -1 h - 5 h 
The probes used during this work were produced from cDNA transcripts (cDNA 
probes) cloned in different vectors or genomic probes produced by PCR 
amplification and cloned on TOPO® vector. 
3.7. Polymerase Chain Reaction (PCR) 
The Polymerase Chain Reaction (PCR) is an enzymatic method for specific 
exponential amplification of a DNA fragment in vitro (Saiki et al. 1985). 
3.7.1. Standard PCR 
The standard PCR protocol was performed in 25 pi total volume as follows: 
2.5 pi 10 x PCR buffer 
1.25 ul 50 mM MgCI2* 
0.3 pi 25 mM dNTPs 
1.0 Ml 10 MM Primer mix (for/rev) 
0.3 M' 5 U/(jl Taq Polymerase 
1.0 ul 100 na DNAtemDlate 
25.0 Ml final volume with dH2Q 
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* Changes on Magnesium concentration can improve the amplification efficiency 
(Henegariu et al. 1997) 
3.7.2. Standard PCR programme 
The PCRs were performed in a Biometra T1 Personal Cycler or in a Biometra T-
Gradient Cycler. A standard PCR programme (see below) was used, with the 
annealing temperature depending on the primers used and listed on table I: 
PCR standard programme: 
First denaturation 94°C 4 min 
Denaturation 94°C 1 min i 
Annealing variable* 1 min 35 cycles 
Elongation 72°C 1 min J 
Final extension 72°C 4 min 
Primer specific temperature calculated by the formula (Maniatis et al. 2001): 
Annealing temperature [°C] = 4 x (G +C) + 2 x (A+T) 
3.7.3. DAZ SNV/STS analyses 
On table 2MM are described the special PCR conditions used during this work 
for DAZ-SNVs and STS analyses. 
SNV / STS MgCI2 
Annealing 
Temperature 
SNVI 2.0 mM 66,5 °C 
SNV II 2.0 mM 65 °C 
SNV III 2.5 mM 63 °C 
SNV IV 2.5 mM 57 °C 
SNVV 2.0 mM 65 °C 
SNV VI 2.0 mM 64 °C 
Y-RRM3 2.0 mM 66 °C 
SY254 2.0 mM 65 °C 
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TRIPLEX 
STS MgCI2 
Annealing 
Temperature 
Primer mix 
concentration 
sY14 (SRY) 
Y-DAZ3 
SY152 
2,5 mM 66 °C 
5uM 
2 0 | J M 
10 uM 
Table VI - PCR conditions for D/\Z-SNVs/STS. 
On the Triplex PCR, the marker sY14 is an internal positive control for the SRY-
locus and the sY152 is a marker for DAZ1/DAZ4 gene copies (Saxena et al. 
2000). PCR products (10 p.l) were checked on 2% agarose gels. 
3.8. RT-PCR (Reverse Transcription-Polymerase Chain Reaction) 
3.8.1. Reverse Transcription (RT) 
cDNAs were synthesised from varying amounts of purified poly (A)+ or total 
RNA using the Superscript™ First-Strand Synthesis System for RT-PCR 
(Invitrogen). 
The priming method used during this work for cDNA synthesis reaction was the 
use of a gene-specific primer (GSP), containing sequence information of the 
target cDNA. 
Following use of this system, target cDNA can be directly amplified with specific 
primers by PCR but the sensitivity of PCR from cDNA can be increased by 
removal of the RNA template by digestion with RNase H after first-strand 
synthesis. 
• Denature 
• Mix 8 [i\ RNA (2 ng) with 1 jil primer (GSP - 2 |j.M) and 1 JLLI dNTP mix (10mM) 
• Incubate at 65°C for 5 min., and then place on ice for at least 1 min. 
• cDNA synthesis 
• Reaction mix: 2 ^l 10x RT buffer 
4 pi 25 mM MgCI2 
2ul0 .1MDTT 
1 ul RNaseOUT 
| 1 pi Superscript II RT (50 U) 
| » Add 10 pi of reaction mix to each RNA/primer mixture (10 pi)  
52 
Methods 
• Mix gently, shortly centrifuge and incubate at 42°C for 50 min. 
♦ End reaction and remove RNA 
• Terminate the reaction at 70°C for 15 min. Chill on ice 
* Add 1 ul of RNase H to each tube and incubate for 20 min. at 37°C 
3.8.2. Amplification of the target cDNA (PCR) 
PCRs were carried out in 50ul of final solution as protocol described below. 
♦ PCR protocol for targets up to 4 kb 
Reaction mix: 5.0 pi 10 x PCR buffer 
1.5 pi 50mMMgCI2 
1.0 pi 10mMdNTPs 
1.0 Ml 10 MM sense primer (for) 
1.0 Ml 10 MM antisense primer (rev) 
0.4 Ml 5 U/pl Taq DNA Polymerase 
2.0 ul cDNA (from first­strand reaction 
50.0 Ml final volume with dH20 
Cycling conditions were as follows: 
First denaturation 94°C 4 min 
Denaturation 94°C 1 min 1 
Annealing 60°C 1 min 35 cycles 
Elongation 72°C 1 min J 
Final extension 72°C 10 min* 
* The PCR products to be cloned using the TOPO TA cloning kit (see 3.9) 
should have a final 10 minutes extension step. 
The primers were chosen in the DAZ­cDNA, with the GSP (Gene Specific 
Primer) annealing to the 3' UTR region and the PCR primers spanning two 
exons boundaries to ensure the amplification of cDNA only. 
3.9. TOPO® cloning 
TOPO® TA Cloning provides a highly efficient one­step cloning strategy for the 
direct insertion of Taq polymerase­amplified PCR products into a plasmid 
vector. The plasmid vector (pCR®2.1­TOPO®) has a single 3' thymidine (T) 
overhang for TA Cloning and a Topoisomerase I covalently bound to the vector. 
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• PCR products 
• Set up a 50(il PCR reaction using Taq polymerase and be sure to end with a 
final 10 min. elongation step 
• Analyse IOp.1 of the PCR sample by agarose gel electrophoresis 
• If it is not possible to obtain a single band from the PCR, gel-purify the fragment 
with the QIAquick Gel Extraction kit 
• TOPO® cloning reaction 
• For transformation into chemically competent E. coli 
0.5 - 4 pi Fresh PCR product 
1 pi salt solution 
1 pi TOPO® vector 
6 pi final volume with sterile water 
• Mix gently and incubate for 1-30 min. at room temperature. For small PCR 
products (<1kb) the time reaction should be around 15 min. 
• Place tubes on ice 
• One Shof Chemical transformation 
• Thaw One Shot® E. coli on ice 
• Add 2pl of the TOPO® Cloning reaction to a vial of One Shot® E. coli and mix 
• Incubate on ice for 5 min. 
• Heat-shock the cells for 30 sec. at 42°C without shaking 
• Recovery and plating 
• Add 250|j.l of SOC medium and shake the tubes at 37°C for 1 hour 
• Spread 100-150^1 from each transformation onto LB plates containing 50pg/ml 
ampicillin or kanamycin, X-Gal and IPTG ! 
• Incubate at 37°C overnight 
• Pick 10 white or light blue colonies for analysis 
• Analysis of positive clones 
• Culture the 10 colonies in LB medium containing ampicillin or kanamycin, 
isolate plasmid DNA and analyse the plasmids by restriction analysis or by 
sequencing or use PCR to directly analyse positive transformants with M13 
primers. For PCR use 10jn,l template obtained from inoculation of a single 
colony in 100^1 TE buffer  
3.10. Cell culture 
3.10.1. Culture of human cell lines 
Cell lines (NT2, Ep2102, Du-145 and LNCaP) grow as adherent monolayers. 
These cell lines were selected because they derive from testis and prostate 
tumour tissues. They replicate fast and are therefore easy to handle. Routinely, 
cells were maintained at 37°C in a humidified 5% CO2 atmosphere. Under 
optimal conditions (see 2.13.2), all cells double every 24-48h. The cells were 
normally subcultered twice a week. 
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3.10.2. Trypsinisation of human cell cultures 
After sucking off the old medium, cells were washed twice with PBS. 
Subsequently, the appropriate volume of Trypsin-EDTA solution was added to 
flasks and the cells were incubated at room temperature for 5 min.. The 
trypsinisation was stopped and cells were resuspended in complete growth 
media. After centrifugation (1200 rpm for 5 min.) the supernatant was removed, 
the pellet was resuspended in 2-5 ml fresh growth media and cell number 
counted. 
3.10.3. Freezing and thawing of human cell lines 
Cells from a healthy log-phase culture were spun down under sterile conditions 
for 5 min. at 1200 rpm. The cell pellet was maintained on ice, carefully 
resuspended in cold freezing medium (4°C) by pipetting the suspension up and 
down repeatedly (the cell density was at least 2x106 cells/ml). Aliquots of 1 ml 
were quickly dispensed into freezing vials. The cells were frozen slowly, first at 
-20°C for some hours, then overnight at -70°C. On the next day they were 
transferred to liquid nitrogen. 
In order to thaw cells, a freezing vial was removed from liquid nitrogen and 
gently agitated in a 37°C water bath. The surface of the vial was rinsed with 
70% ethanol and the cells were dispensed in 20 ml pre-warmed growth 
medium. The medium was changed once after 12 h to minimise the DMSO 
concentration. 
3.10.4. Methylation studies on human cell lines 
These studies were done to check the methylation status on the DAZ genes 
and its possible interference with its transcriptional activity (Azacytidine). 
3.10.4.1. Azacytidine (AZA) treatment 
Azacytidine is a potent growth inhibitor and cytotoxic agent. It acts as a 
demethylating agent by inhibiting DNA methyltransferase (Broday 1999). DNA 
methylation is an important regulatory mechanism of gene expression, gene 
activation and silencing. 
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The cells were cultivated as described on 3.10.1. After changing the medium, 
5-azacytidine solution in a concentration of 1.2fig/ml was added to 5 different 
flasks, named A1-A5 with the numbers indicating the number of days when the 
cells will be harvest after treated with 5-azacytidine. An additional (A/T) flask 
was treated for 2 days with 5-azacytidine and subsequently treated with 
Trichostatin (see 3.10.4.2.). 
After the azacytidine treatment, the cells were trypsinisated as described below, 
and the pellets were splitted into 3 different tubes and labelled as DNA, RNA 
and Protein. The DNA tubes were used to isolate DNA for D/AZ-SNV/STS 
analyses and methylation specific PCR, the RNA tubes were used to RT-PCR 
protocols and the Protein tubes were stored at -80°C for posterior expression 
studies. 
3.10.4.2. Trichostatin (TCA) treatment 
In order to check if the histones acetylation plays a role on DAZ transcription, 
the cells were treated with a 300nM solution of Trichostatin A, that inhibits 
histone deacetylase at nanomolar concentrations, with the resultant histone 
hyperacetylation leading to chromatin relaxation and modulation of gene 
expression (Yoshida 1995). This mechanism may be involved in cell cycle 
progression of several cell types, inducing cell growth arrest at both G1 and 
G2/M phases. In some cases may induce apoptosis. 
After cells (A/T flask) being treated for 1 day with 5-azacytidine, they were 
subsequently treated with Trichostatin A. 250 \i\ of a 330nM TCA solution was 
added to 25ml specific culture medium and the culture was incubated 7 hours at 
37°C. 
After this treatment, the cells were trypsinisated as described below and the 
pellets were collected into 1 tube labelled as RNA. The isolated RNA was used 
to RT-PCR protocols. 
Trichostatin A is soluble at 1mg/mi in ethanol giving a clear, colourless solution. 
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3.10.4.3. Bisulfite treatment 
DNA is modified by sodium bisulfite treatment converting unmethylated, but not 
methylated, cytosines to timine. Following removal of bisulfite and completion of 
the chemical conversion, this modified DNA is used as a template for PCR. 
• Bisulfite treatment 
• Mix 2.5 \xg DNA (50 JLX! in TE buffer) with 5.5^1 3M NaOH solution and incubate 
at37°Cfor15min. 
• Prepare 2.8M Na-bisulfite and 40 mM Hydroquinone. Working solution: mix 
3.25 ml Na-bisulfite solution, 250p.l hydroquinone and 150JLLI 10M NaOH 
• Denature DNA samples at 95°C for 5 min. and place on ice 
• Add 500jul of working solution to each denatured sample, add mineral oil to (5-6 
drops) and incubate overnight at 55°C, in dark 
• DNA purification 
To purify the DNA after the bisulfite treatment, the Wizard® DNA Clean-Up system 
was used with a vacuum manifold 
• Add 1 ml of Wizard® DNA Clean-Up resin to 500ul treated DNA sample and mix 
by invention 
• Use one Wizard minicolumn for each sample. Attach the syringe barrel to the 
Luer-lok extension of each minicolumn 
• Insert the minicolumn/syringe barrel assembly into the vacuum manifold 
• Pipette the resin/DNA mix into the syringe barrel. Apply a vacuum to draw the 
solution through the column 
• Break the vacuum to the minicolumn and add 2 ml of 80% isopropanol to the 
columns and re-apply the vacuum 
• Dry the resin by continuing to draw a vacuum for 30 sec. after the solution has 
been pulled through the column 
• Transfer the column to a 1.5 ml tube and centrifuge the column at 14000 rpm 
for 2 min. 
• DNA elution 
• Transfer the column to a new 1.5 ml tube and apply 50^1 of pre-warmed (80°C) 
TE buffer to the column 
• Wait 1 min. and centrifuge the column at 14000 rpm for 20 sec. to elute the 
bound DNA 
• Discard the minicolumn and add 5.5ul 3M NaOH 
• Incubate at 37°C for 15 min. and neutralise with 55 pi 6M ammonium acetate 
pH7 
• DNA precipitation with 2 volumes absolut ethanol followed by wash with 70% 
ethanol 
• Air-dry pellet, resuspend in 25JLII TE buffer and store at -20°C or do methylation 
specific PCR (MSP)  
The methylation specific PCR (MSP) is a simple method to determine the 
methylation status of CpG islands and it was performed using a standard PCR 
reaction with specific primers design to the DAZ promoter CpG island (DAZBis 
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for/rev). MSP uses the sequence differences between methylated and 
unmethylated alleles, which occur after sodium bisulfite treatment. 
3.11. DNA sequencing 
DNA sequencing was performed using an ABI PRISM 310 genetic analyser 
from Applied Biosystems. 
• Cleaning PCR products 
• Before sequencing reaction, the PCR products were cleaned with a Microspin™ 
columns S-400HR from Amersham Pharmacia Biotech 
• Vortex and centrifuge the column at 2900 rpm for 1 min. 
• Apply the PCR product (50-100jal) to the column and centrifuge at 2900 rpm for 
2 min. 
• Sequencing with Big-Dye Terminator kit 
• Reaction mix: 2.5 yi Big-Dye-T mix (diluted 1:2 with halfBD) 
LOulDMSO 
1.0 pi primer (2pM for or rev) 
6.0 pi PCR product+water (variable and depending on the PCR) 
• Cycle programme: 94°C 30 sec] 
50°C 15 sec. 25 cycles 
60°C4min. J 
• DNA precipitation 
• Add 80pl dH20 to the sequencing sample 
• Mix DNA with 10pl 3 M Na-Acetate (pH 4.6) and mix gently 
• Add 250fj.l absolute ethanol and incubate at room temperature for 15 min. 
• Centrifuge at 13000 rpm for 20 min. 
• Discard supernatant, wash pellet with 250|il 70% Ethanol and mix by vortexing 
• Centrifuge at 13000 rpm for 10 min. 
• Air-dry pellet and resuspend in 20p.l Hi-Di buffer. Store at -20°C until loading the 
sample  
3.12. Photometric quantification for nuceic acids concentration 
The nucleic acids (DNA and RNA) concentration and purity can be measured in 
a photometer at a wavelength of 260 nm, where the maximum absorvance for 
nucleic acids can be measured. 
1 OD26o corresponds to: 50 ug/ml double strand DNA 
40 ug/ml single strand DNA or RNA 
20 pg/ml Oligonucleotide 
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The DNA concentration [/yg/ml] = OD26o nm x dilution factor x 50 
The RNA concentration [/vg/ml] = OD260nm x dilution factor x 40 
By measuring the OD28o nm, the maximum absorvance for protein, it is possible 
to evaluate the purity of each sample (DNA or RNA) by the coefficient 
OD26o/OD28o- The value should be between 1.8 and 2.0. 
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Results 
4.1. Mapping and structure of 4 DAZ gene copies in the RPCI-11-AZFc 
BAC contig 
Earlier studies suggested that seven DAZ copies were clustered in distal Yq 
(Gláser et al. 1998), but a Genomic sequencing project identified only four 
genes in the AZFc region, arranged in two clusters - DAZMDAZ2 and 
DAZ3/DAZ4 with head to tail arrangement (Saxena etal. 2000). 
The first aim of this work concerning the study of DAZ gene family was to start 
with the identification of each DAZ gene copy and its detailed structure in the 
RPCI-11-BAC sequences, using GenBank, the database of the international 
Human Genome Sequencing project. To identify all DAZ-RPCI-11-BAC clones, 
the GenBank database was screened in silico with the complete DAZ cDNA 
sequence CT351Y (GenBank accession no. AF414184). Other PACs were 
identified as DAZ clones by STS analyses in the Vogt lab (Zeisler PhD) and are 
listed in table IX. 
Seven DAZ-BACs, marked in red on table VII, were gathered in two small 
contigs of the large AZFc contig constructed by a continuous analysis of the 
sequence overlap of 42 RPCI-11 BAC sequences. The AZFc contig starts with 
BAC 400117 containing the STSs sY142 (DYS230, GenBank accession nr. 
G38345, sequence pos. 3068-3268) and sY143 (DYS231, GenBank accession 
no. G38347, sequence pos. 3074-3506). Both STSs have been identified as 
markers of the proximal AZFc border line (Simoni et al. 1999). It ends with the 
BAC 557B9, which contains STS sY167 (DYS248, GenBank accession nr. 
G12008, sequence pos. 98157-98132). This STS is present in the Y 
chromosome of all the 43 patients studied with an AZFc deletion and was 
therefore designated as a marker for the distal AZFc border line. The DAZBAC-
contig with 289L7, 140H23, 263A15 and 70G12 was mapped proximal to the 
DAZ-BAC contig with 290O3, 26D12, 539D10, having a molecular distance of 
approximately 1.47 Mb between them (table VII). 
The proximal DAZ-BAC contig contains two DAZ gene copies (DAZ1 and 
DAZ2) with a 3'-5':: 5'-3' head-to-head orientation, starting with DAZ1 3'end in 
BAC 289L7 and ending with DAZ 2 3'end in BAC 70G12 (fig. 15). DAZ 1 
contains 3 tandem repeats of 10.8 kb, including exon 2 till exon 6, besides a 
tandem repetitive structure of nine variants of exon 7. According to the 
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nomenclature of Yen et al. (1997) they were designated as A, B, C, D, E, F, X, 
Y, Z with the Y variant as the most prominent consensus sequence (fig. 16). 
Eight variants were found in DAZ\ and organised in the order: 5'-B-C-D-E-F-E-
X-Y-Z-3' (fig. 15). Since identical repetitive exon 7 structures linked to a 
triplicate DAZ exon 2-6 domain have been found in testicular DAZ cDNAs 
(Saxena ef al. 2000), it was assumed that the DAZ\ gene is transcribed in 
human testis. 
The DAZ2 gene structure is mapped to three overlapping BAC sequences. 
Typical of DAZ2 is the presence of the A variant and absence of the B variant in 
the repetitive exon 7 structure, besides 7 tandem Y variants (fig. 15). DAZ2 
transcripts with this exon 7 variant structure have been found in testicular DAZ 
cDNA sequences (Yen et al. 1997; Saxena et al. 2000). This indicates that the 
DAZ2 gene is also transcribed in human testis. However, no DAZ2 testis 
transcripts containing a duplicated E-F variant motif were reported, nor an exon 
ID variant flanked proximal by exon 7Xor distal by exon IE, as it was predicted 
by the genomic DAZ2 sequence in BAC263A15 (fig. 15). 
DAZ i DAZ 2 
LI 
fwffiiww / / / / / / i i / / f/////////w /sw/mm 
S H Z V X E F E D C B G G A C D E F K F E X D E X Y Y Y V V V Z I I I / / 1 llll I llll I I III 1 — / / 289L7 140H23 263A15 70G12 
| Exon 1 ■ Eion 6 
I Exon 2 O Eion 7 variants 
I Exon 3 H Eion 8 
I Exon 4 ST1 Exon 9 
I Exnn5 ■ Exon 10 DAZ 3 
I 
/ / 
H Z X E X E X E D C B 
DAZ 4 
mi H,[in i n i B C D E F E X E X Y Y Y Y Y Z II 1 
■it 290O3 26D12 539D10 
Figure 15 - Exon structure of DAZ-BAC contigs. The BAC numbers are indicated above each 
structure. 
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Such DAZ2 transcripts might therefore be rare or do not exist and an artefact of 
the sequence assembly programmes used for the construction of the genomic 
BAC 263A15 sequence has produced this exon 7 variant composition. The 
structure of the D/4Z2-BAC sequence of the CTB library (BAC352E14) also 
contains an A and 7 tandem Y variants in the repetitive exon 7 structure but the 
duplicated E-F motif found in the RPCI-11 BAC263A15 sequence was absent 
(Saxena et al. 2000). 
In the distal region of the AZFc contig (table VII), 1.47 Mb distal to the 3'end of 
DAZ2, the sequence of BAC 290O3 contains the third DAZ gene copy, followed 
by the overlapping BACs 26D12 and 539D10 with the fourth DAZ gene copy 
(fig. 15). Although both have a similar 3'-5':: 5'-3' head-to-head orientation as 
found for DAZ\ and DAZ2 copies, substantial differences were found in their 
repetitive exon structures. 
7Y 
7A 
7B 
7C 
7D 
7E 
7F 
7H 
7 G 
7X 
7Y 
7Z 
GCATTTCCTGCTTATCCAAGTTCACCATTTCAGGTCACCACTGGATATCAGTTGCCTGTATATAATTATCAG 
--T-A-T CA GG T G T  
--T-ACT CA GG T G T  
-A--A A CGA G  
C A TG  
C TG  
A---A A A GG G-G G  
CACA--A--C-C A G--G C-G--T A T  
A G C  
A G--G C-A C C---
Figure 16 - DAZ exon 7 variants. In red the 7Y variant defined as consensus sequence; in 
blue, the 7 variants never found in human testis cDNA. 
Typical for DAZ3 in the RPCI-11-BAC 290O3 sequence is the absence of the Y 
variant and a triplication of the 7 E-X motif in the repetitive exon 7 structure (fig. 
15). The DAZ4 gene structure in the RPCI-11 BAC 539D10 is characterised by 
three copies of a 10.8 kb repeat unit. In the RPCI-1 \-DAZ4 gene, 15 exon 7 
variants were found with the following composition: 5'-B-C-D-E-F-E-X-E-X-Y-Y-
Y-Y-Y-Z-3'. Although testicular DAZ cDNAs with this exon 7 variant typical 
structure (i.e. B variant linked to 5 tandem Y variants) were described by Yen et 
al. (1997), complete D/\Z4-cDNAs with 15 exon 7 copies, linked to a triplicate 
10.8 kb repeat have not yet been isolated. 
Two additional exon 7 variants with normal splicing signals were found in intron 
6 of the first and second 10.8 kb repeat (exon 1G variant) of DAZ 1 and DAZ 4 
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and in the intron 8 sequence (exon 7H variant) on all genomic DAZ copies gene 
structure (fig. 15). Because no DAZ cDNA sequence containing one or both of 
these DAZ exon 7 variants has been found in human testis, DAZ1 transcripts 
spliced with these variants must therefore be rare or do not exist in testis tissue. 
4.2. Establishment of a set of DAZ-SNVs (Single Nucleotide Variants)/ 
STSs (Sequence Tagged Sites) to distinguish each DAZ gene copy 
DAZ gene locus restriction maps and sequence analyses have shown that the 
genomic structures of the 4 DAZ genes present in the AZFc region are more 
than 99% homologous to each other (Saxena et al. 1996, 2000; J. Zeisler, S. 
Fernandes, unpublished results). For the identification of DAZ gene copy 
specific deletion events, the search for DAZ copy specific markers along the 
complete gene sequences was therefore focused on a systematic identification 
of small sequence variants, including a specific restriction site (DAZ-Single 
Nucleotide Variants DAZ-SNVs). Typing the SNVs involves co-amplification of 
two or more similar loci followed by restriction enzyme digestion to reveal the 
absence (A-allele unrestricted) or presence (B-allele restricted) of a given 
restriction site. Beside this I searched for copy-specific DAZ-STSs in the RPCI-
11-DAZ-BAC sequences. 6 DAZ-SNVs (l-VI) spanning the 5'end till the 3'end of 
DAZ gene sequences as well as 2 DAZ gene copy specific STSs (DAZ-RRM3, 
Y-DAZ3) were established (table VIII). 
SNV II was first identified by Agulnik ef al. (1998). SNV III and SNV V were 
identified by Saxena etal. (2000). SNV I is mapped 90 nucleotides upstream of 
the putative transcription initiation site of the DAZ genes with a polymorphic 
Fspl restriction site (B allele) only present in DAZ4. SNV IV was found 1159 
nucleotides downstream of DAZ exon 1H in the intron 8 sequence with a 
polymorphic Alu\ restriction site absent in DAZ2. SNV VI was found 480 
nucleotides downstream of DAZ exon 10, where due to a 4bp deletion (CCTG) 
at the 3'end of DAZ4, an AfHW site was created. An extension of this deletion to 
8 nucleotides (TCCTGTAT) was identified at the 3'end of the DAZ3 gene and 
used for the development of a DAZ3 specific STS (Y-DAZ3). 
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1 5' UTR-exon1 G73167 Fspl 1,2,3 
4 
A 
B 
709 
398+311 
II exon3-exon4 G73166 Mbol 1 
2,3,4 
A 
B 
182 
122+60 
III 
(SY586) 
intron 7A/B G63907 Taql 2 
1,3,4 
A 
B 
301 
184+117 
IV intron 7H G73168 Alu I 2 
1,3,4 
A 
B 
660 
398+262 
V 
(SY587) 
intron 9 G63908 Dral 3,4 
1,2 
A 
B 
195+49 
122+73+49 
VI 3'DAZ G73169 Afl III 1,2,3 
4 
A 
B 
431 
248+183 
DAZ-
RRM3 
DAZ1+4 
intron 6b* 
G73171 BAC140H23 
BAC539D10 
1+4 66 473 
Y-DAZ3 3'DAZ G73170 BAC290O03 3 66 260 
DAZ1+4 
(SY152) 
DAZ1+4 
intron 6a* 
G12039 BAC140H23 
BAC539D10 
1+4 66 125 
SY14 SRY G38356 ~ Control 66 470 
Table VIM - DAZ-SNVs and STSs, with different alleles in DAZ1-DAZ4 gene copies. STS/SNV 
alleles in bold letters and numbers mark their specificity for one DAZ gene copy; * Intron 6a and 
6b are proximal (a) and distal (b) to exon 7G present in 10.8 kb repeat in D>AZ1 and DAZA 
(fig. 15). 
A second STS {DAZ-RRM3) was established in the fused intron 1-intron 6 
structure specific for DAZ1 and DAZ4. This marker is in the same intronic region 
as sY152 declared earlier to be a marker for the DAZ1 and DAZ4 genes 
(Saxena et al. 2000). However, we also found the sY152 primer pair sequences 
in the RPÎÎC\-DAZ2 and -DAZ3 gene sequences (after exon 7A and IB, 
respectively) with only 3 internal mismatches in the forward primer (fig 17). 
Therefore we often obtained false positive amplification products in our PCR 
experiments and developed the DAZ-RRM3 STS as a more stringent alternative 
for the identification of the DAZ1 and DAZ4 gene copies using our PCR 
multiplex conditions. All novel QAZ-SNVs and STSs including the optimal PCR 
conditions were deposited in the GenBank under the accession numbers given 
in table VIII. 
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SY152 in BAC 539D10 (DAZ4) 
2581 cttttaaact agtgaactgt acctaaaatt taagaaaaca cttagaatta gtgtaatgaa 
2641 gacctctgta gtatgtagaa gtgatgaaat aatattttg^caggagggta :tragcaj|a 
2701 acttttctgc agaacagttt ctgagatttg gtgttcctgt cttggtttca gcatgaattt 
2761 tgttatcttt gctgtcaaag agcj ■ : ' Jtcgtga attttgtaga 
2821 gatacagagt gaaataaaag ctttacccaa ttcttagagc gcagaattcc aattgtgttt 
SY152 in BAC 140H23 (DAZ2) 
94141 gaaatcactt agaattagtg taatgaggac ctctgtttta tttagaagtg atgaaataag 
94201 attttgjr.i- gagggcactt ^J|aact tttccgtaga acaatttctg agatttggtg 
94261 ttcccttctt tgtttcagca tgtattttgt tatctttgct gtcaaagagc |gaaacatec 
94321 |gactgact| tcctgaatct tgtagagata cagagtgaaa taaaagcttt accgaattct 
94381 tagagcacag aatttcagtt gtatttttat tttagcttgc tgcttcatga tagcagttct 
Figure 17 - sY152 primers (in pink) in DAZA copy showing 100% homology and in DAZ2 copy 
showing 3 internal mismatches (in green) in the forward primer and 1 mismatch in reverse 
primer. 
4.2.1. DAZ SNV/STS analysis in DAZ-PACs and DAZ-BACs 
The establishment of the novel D^Z-SNVs and STSs was firstly used for the 
identification of the DAZ gene copies present in the DAZ-PACs and BACs 
isolated before. The results are summarised on table IX with allele A meaning 
non-digested, allele B digested and A+B non-digested and digested. 
PAC/cosmids SNVI SNVII SNVIII SNV IV SNVV SNVVI SY152 RRM3 DAZ 3 DAZ gene 
G19633C - A B B B A - - - 1 without RRM 
G19660C A+B B B B A A + - - DA24 
K07760F A A B B B A + ++ - Q4Z1 
D061100C A A B B A A - + - not defined 
O131180D A A B B B A + + + D4Z1 
K07760E A A B B B A + + - DAZ\ 
cos63C9 - A B B B A - - - DAZIpart 
BAC clones SNVI SNVII SNV III SNV IV SNVV SNVVI SY152 RRM3 DAZ 3 DAZ gene 
290O3 A+B B B B A A - - + DAZ3/4part 
140H23 A A A+B B B A + + - DAZM2 
539D10 A B B B A B + ++ +w DAZA 
226N11 A B A A B A - - ' - DAZ2 
26D12 A+B B B B A A+B + + + DAZ3IA 
263A15 A A+B A A B A + + - DAZ2I1 
148114 A A B B B A + + - DAZ\ 
CTB352E14 A B A A B A - +w - DAZ2 
CTA132B16 A B B B A A - - + DAZ3 
CTB546E5 A A B B A A + ++ - DAZ4 
K1020B A A B B B A + + - DAZ\ 
Table IX - DAZ SNV/STS analyses in DAZ-PACs and DAZ-BACs. 
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Based on these set of SNVs and STSs, specific DAZ deletion haplotypes {DAZ-
del-hap) were established, each one indicative for the deletion of a specific set 
of DAZ gene copies (table X). The identification of one of them would predict 
the deletion of the related DAZ gene copy. Partial DAZ gene deletions would be 
indicated by the occurrence of different DAZ deletion haplotypes. 
DAZ gene deletions | SNV 1 J SNV 1. j SNV III J SNV IV | SNV V | SNV VI | M* J ^ | DAZ del | 
DAZ1 A+B B A+B A+B A+B A+B + + 1 
DAZ2 A+B A+B B B A+B A+B + + 2 
DAZ3 A+B A+B A+B A+B A+B A+B + - 3 
DAZ4 A A+B A+B A+B A+B A + + 4 
DAZ1+ DAZ2 A+B B B B A A+B + + L 5 
DAZ1+DAZ3 A+B B A+B A+B A+B A+B + - 6 
DAZ1+DAZA A B A+B A+B A+B A - + 7 
DAZ2+ DAZ3 A+B A+B B B A+B A+B + - 8 
DAZ2+DAZ4 A A+B B B A+B A + + 9 
DAZ3+DAZ4 A A+B A+B A+B B A + - 10 
DAZ1+ DAZ2+ DAZ3 B B B B A B + - 11 
DAZ1+ DAZ2+ DAZ4 A B B B A A - + 12 
DAZ2+ DAZ3+ DAZ4 A A B B B A + - 13 
Table X - DAZ deletion haplotypes (DAZ-del-hap). 
4.2.2. DAZ SNV/STS analysis in fertile men (FM) 
On the Y chromosome of men with normal fertility, the presence of 4 DAZ gene 
copies would be indicated by the presence of A and B alleles of each of the 6 
DyAZ-SNVs and the presence of the STSs DAZ-RRM3 and Y-DAZ3. The 
deletion of a specific DAZ gene copy is recognised by the absence of specific 
SNVs A or B alleles associated with this DAZ gene copy (table X) and the 
deletion pattern of the DAZ-RRM3 and Y-DAZ3 STSs. Absence of all DAZ 
markers would indicate the absence of the complete DAZ gene family on the Y 
chromosome. 
One hundred and seven fertile men (FM samples) were used as a control 
population and the results obtained are shown on table XI. 
Surprisingly, 3 DAZ-del-hap could be found in this control group, indicating the 
existence of some DAZ partial deletions even in fertile men. 
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SNVI SNVII SNV III SNV IV SNVV SNV VI DAZ-RRM3 Y-DAZ3 FM samples 
A+B A+B A+B A+B A+B A+B + + 50 
DAZ-del-hap 2 and derivatives 
A+B A+B B B A+B A + + 25 
- 1 
A+B A+B B A+B A+B A+B + + 1 
A+B A+B B A+B A+B A + + 4 
A+B A+B A+B B A+B A+B + + 1 
A+B A+B A+B B A+B A + + 5 
- 3 
DAZ-del-hap 4 and derivatives 
A A+B A+B A+B A+B A + - 2 
A A+B A+B A+B A+B A+B + + 6 
A+B A+B A+B A+B A+B A + + 3 
DAZ-del-hap 9 and derivatives 
A A+B B B A+B A + + 2 
- 1 
A A+B B A+B A+B A + + 1 
A A+B A+B B A+B A + + 1 
- 1 
Table XI - DAZ-del-hap analyses in 107 men with proven fertility. 
DAZ-del-hap 2, indicative for a deletion of DAZ 2 was found in 26 FM samples 
and is associated with the absence of the B allele for SNV VI, suggesting an 
additional deletion in the distal part of DAZA. Derivatives of D/\Z-del-hap 2 
(absence of only the A allele of SNV III or SNV IV) were also identified in this 
control group. Similar pattern was also observed for DAZ-de\ hap 4 (indicative 
for deletion of DAZA) and DAZ-del hap 9 (indicative for deletion of DAZ2 and 
DAZA). 
The results suggest that these DAZ deletions are not associated with an 
oligozoospermic phenotype and could be seen like familial variants, inherited 
from father to son. 
4.2.3. DAZ SNV/STS analysis in oligozoospermic patients (OZ) 
We selected for the analysis of DAZ gene copy specific deletions 63 infertile 
men with a clinical diagnosis of idiopathic oligozoospermia. These men had a 
normal karyotype and no Yq11 microdeletions. 
DAZ-del-hap 2 and derivatives were found in 20 OZ samples; derivatives of 
DAZ-del-hap 4 were found in 5 samples and 1 sample showed the DAZ-de\-hap 
9. Beside these 3 DAZ-de\ haplogroups, found already in fertile men group, we 
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found in 5 OZ samples DAZ-de\ hap 5, indicative for a deletion of DAZ1 and 
DAZ2. 
SNVI SNVII SNV III SNV IV SNVV SNV VI DAZ-RRM3 Y-DAZ3 OZ samples 
A+B A+B A+B A+B A+B A+B + + 32 
DAZ-del-hap 2 and derivatives 
A+B A+B B B A+B A + + 8 
A+B A+B B A+B A+B A + + 2 
A+B A+B A+B B A+B A+B + + 1 
A+B A+B A+B B A+B A + + 4 
- 5 
D/AZ-del-hap 4 and derivatives 
A A+B A+B A+B A+B A+B + + 2 
A+B A+B A+B A+B A+B A + + 3 
D/\Z-del-hap 9 and derivatives 
A A+B B A+B | A+B | A | + + 1 
DAZ-del-hap 5 and derivatives 
A+B B B B A A+B + + 2 
A+B B B B A A+B - + 1 
B B B B A A + + 2 
Letters in bold indicate the presence of deletions 
Table XII - DAZ-del-hap analyses in 63 oligozoospermic men. 
Two of them showed also absence of the A allele for SNV I and of the B allele 
for SNV VI (fig. 18), indicating additional partial deletion on the 5'region of the 
DAZ3 and in the 3'region of the DAZ4 gene, respectively. 
SNVI SNVII SNV HI 
SNV IV SNVV SNV VI 
Figure 18 - DAZ-SNVs analysis of DNA samples with D/4Z-del-hap 5. 
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Some results obtained for DAZ-SNVs from DNA samples with DAZ-del-hap 5 
(defined on table X) are shown in figure 18. On table XII are summarised the 
results obtained for the studied oligozoospermic population. 
The DAZ-SNV/STS analyses suggests that the B alleles of SNV I and VI in 
DAZA are polymorphic. The derivatives of DAZ-del-hap 2, 4 and 9 were found in 
FM and OZ samples. We conclude that most probably, familial gene conversion 
events occurred between the DAZ different copies, especially within the DAZ2 
and DAZA genes. Because gene conversion events prevent the identification of 
a specific DAZcopy deletion by only SNV/STS analyses, an additional analysis 
by DYS1 blot experiments was developed. 
4.3. DNA blot analysis of DYS1 locus 
The Y chromosome specific p49f ITaq I polymorphism of the DYS1 locus was 
the first one described (Ngo 1986) and is now known to be part of the DAZ 
locus (fig 7). 
The p49f probe was sub-cloned from cosmid 49 (Bishop et al. 1984). It is an 
EcoR I fragment of 2.847 bp, starting in intron 3 of the third DAZ1 RRM domain 
(BAC140H23 sequence pos.: 34027) and ending in DAZ1 intron 7B 
(BAC140H23 sequence pos.: 31181; GenBank accession no. AF414183). After 
Taq I digestions, 18 restriction fragments could be detected (table XIII) and after 
EcoRV digestions, 5 restriction fragments cross-hybridised with the p49f probe 
in fertile men population (table XIII). 
After the establishment of the DAZ sequence structure in AZFc on a BAC contig 
(fig. 15), we were able to map the different genomic DYS1 fragments to each 
DAZ gene copy (table XIII). There are identically sized fragments arising from 
more than one copy but some of them (marked in red on table XIII) could be 
identified to be associated with a specific DAZ gene copy. 
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TaqI DAZ1 | DAZ2 DAZ3 DAZ4 
A4 19612 81 
A3 
A2 14853 <80% 
Al 10100 81 
B 10094 <80% 
CO 
Dl 7152 81 
D2 
E 5854/7 5857(2) 97/83 
Fl 5008 83 
G 4782 4781 4783 81 
H 4020 4020 4021 83 
I 3112 99/81 
J 2975 2976 2975 2975 83 
K (DAZL) 83 
L (DAZL) 86 
M 2076 2076 2075 2075 81 
N 1992(3) 1992 1992 1992(3) 99/97 
0 1877 1876 1876 99 
P 1419(3) 1419(2) 80 
Q 1237 1236 1236 81 
R 966 966 966(2) 80 
Haranw» m\jx*m m>T.v*m ■»J.VA« m\jy/.m wammEmm 20321 20320 20321 20323 99/86 
10843/5 99/98 
7325/7 97/83 
5169 5170 5169 5169 83 
2385­91 2382­96 2390 2385­90 81 
Table XIII ­ Taq I and EcoR V restriction fragments (in kb) co­hybridising with p49f 
probe. 
Two DYS1­EcoRV fragments, 10845 and 10843 bp, could be associated with 
OAZ1 and two DYS1­EcoRV fragments, 7327 and 7325 bp with DATA. 
Similarly, the 3112 bp DYSI­Taq I fragment could be associated with DAZ2 and 
the 19612 bp DYS1 -Taq I fragment with DAZ3. Therefore it should be possible 
to identify the deletion of a single DAZ gene copy by deletion of the associated 
DYS1­£coRV and Taq I fragments. This prediction was controlled with DNA 
blots from gels of DAZ-BACs after restrictions with Taq I and EcoR V. The 
results are shown on figure 19. 
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BACs/Taql BACs/EcoRV 
Figure 19 - Taq I and EcoR V restrictions using BACs DNA as template and p49f probe for 
hybridisation. 
Due to the low quality of the hybridisation results obtained, the226N11, 539D10 
and 148114 BACs were excluded from this analysis. The results obtained (fig. 
19) confirmed some of the predictions for the DAZ content, described on table 
II: the presence of the 10.8 kb EcoR V fragment in BACs 140H23 and 
CTB546E5 indicative for DAZ1 copy; the presence of the 3.1 kb Taq I fragment 
for BACs 140H23, 263A15 and CTB352E14 indicative of DAZ2; the presence of 
the 7.3 kb EcoR V fragment in BAC 26D12 indicative of DAZ4 gene copy; the 
19.6 kb Taq I fragment indicative for DAZ3 is not visible on BAC 290O3, 
probably due to the weakness of this sample. In BAC CTB546E5 the EcoR V 
fragment indicative of DAZ4 gene copy has a higher size, probably indicative of 
the different DAZ structure on Y chromosome from the male donor of the CTB 
library. 
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Although the BAC-blots experiments did not allow the identification of single 
DAZ gene copies, it also does not contradict the DAZ SNVs/STSs analyses. 
So, this system was used in cases where enough amount of DNA (~20ug) was 
available. 
Some results from samples with DAZ-del-hap 5 are shown in figure 20. The 
deletion of the DAZ\ and DAZ2 genes in the samples with DAZ-del-hap 5 was 
confirmed by absence of the DAZ1 10.8 kb-EcoR V and DAZ2 3.1 kb-Taq I 
fragments of the DYS1 locus group. OZ-5 and his father displayed a familial 
deletion of DAZA, detected through the absence of the DAZA specific 7.3 kb 
EcoR V fragment in both DNA samples. 
23 
9.6 
6.7 
* 
4.4 
2.0 
kb EcoEV 
2.0 
kb 
.':■'■'- ' ..Sip:: . , J: : 
Taql 
Figure 20 - Taq I and EcoR V restrictions using genomic DNA (DAZ-del-hap 5 samples) as 
template and p49f probe for hybridisation. Absence of 10.8kb-EcoR V fragment on OZ20 and 
OZ5, indicative for deletion of DAZ1 copy; absence of 3.1 kb-Taq I fragment on OZ5, indicative 
for DAZ2 deletion; absence of 7.3kb-EcoR V fragment on OZ5 and his father, indicative of a 
familial deletion of DAZ4. Pictures used with permission of Vogt & Hirschmann. 
However, we could confirm that the DAZ1/DAZ2 gene deletion in the OZ-5 
family is restricted to the patient OZ-5, i.e., is a de novo deletion. 
Deletions of the DAZ3 and DAZA genes in the Y chromosomes of OZ-74 (data 
not shown) and OZ-75 (DAZ-del-hap 10) were confirmed by absence of the 
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DAZ3 19.6 kb-Tag I fragment and DAZA 7.3 kb-EcoR V fragment (Fig. 21). The 
variable length of the A band is explained on table XIII with DAZ3 being 
responsible for 19.6 kb fragment, DAZ4 for 14.8 kb and DAZ2 for 10.1 kb Taq I 
fragment. The prediction that the DAZ3 and DAZA gene deletions in OZ-74 and 
OZ-75 are not associated with their testicular pathology was also confirmed 
because the fertile father of OZ-5 has the same DAZ deletion (Fig. 20). A DNA 
sample from father of OZ-74 was not available. 
M1 M2 75 75F M1 75 75F 
Taq I EcoRV 
Figure 21 - Taq I and EcoR V restrictions using genomic DNA (DAZ-del-hap 10 samples) as 
template and p49f probe for hybridisation. Absence of 19.6kb-Tag I fragment and absence of 
7.3kb-EcoR V fragment on sample 75 and his father indicative, respectively, for a DAZ3 and 
DAZA familial deletion. Pictures used with permission of Vogt & Hirschmann. 
4.3.2. Mlu I blots 
A Mlu\ restriction map, specific for each DAZ gene copy, was reported by 
Saxena era/. (2000). By in silico analyses a specific Mlu I fragment of 13kb was 
found for DAZ\ and DAZ4, 21 kb for DAZ2 and >75kb for DAZ3, with a 633bp 
fragment present in all DAZ copies serving as a positive control for the Mlu I 
restriction digest. On figure 22 (left) are presented some examples of the 
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experiments performed with DAZ-BACs. The 13 kb fragment present in BACs 
CTA148I14, 140H23 and CTB546E5 is indicative of DAZ1 copy for the first two 
and of DAZ4 copy for the last one and the 21 kb fragment is indicative of DAZ2 
copy. However, in none of the genomic samples (fig. 22 right) these fragments 
were detected, indicating no Mlu I restriction. It was assumed that this fact is 
related with the methylated state of these DNAs, presenting most of the Mlu I 
sites methylated and, therefore, not available for Mlu I restriction activity. 
1 2 3 4 5 6 7 M1 8 9 10 11 12 13 14 15 M2 
BACs / Mlu I Genomic / Mlu I 
Figure 22 - BACs (non-methylated DNA) and genomic DNA blots after Mlu I restriction using 
DAZ1.1 as genomic probe. The samples are as following: 1-148114; 2-CTB352E14; 3-
CTB546E5; 4-CTA132B16; 5-290O3; 6-140H23; 7-K1020; 8,9-fertile male control; 10-OZ5; 11-
OZ5 father; 12-OZ5 AZA1w; 13-OZ5 father AZA1w; 14-OZ5 AZA2w; 15-OZ5 father AZA2w; M1-
WHindlll; M2-1kb ladder. 
Samples 12 to 15 were treated with 5-azacytidine (1 and 2 weeks) in order to 
demethylate the genomic DNA but no relevant differences were observed. 
Therefore, it was not possible to check the methylation state of these samples 
after this treatment. 
4.4. SNVs analysis of AZFc genes and amplicons 
During the DAZ gene copy analysis was developed, the complete AZFc 
sequence has been published by Kuroda-Kawaguchi et al. (2001). 
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This structure is composed of large repeated sequence blocks called 
amplicons. There are six distinct families of amplicons in AZFc region (fig. 23). 
The amplicon unit range in length from 115kb (grey amplicon) to 678kb (yellow). 
The turquoise, grey and yellow amplicons occur twice, whereas the green 
amplicon occurs three times and the blue and red amplicons occur four times 
each. Together the six amplicon families account for 93% of the 4.5Mb 
sequence defined as AZFc. This palindromic complex (fig. 23) contains 11 
families of transcription units, most of them with exclusive testis expression: 15 
genes representing 5 families previously reported to have protein coding 
potential ­ RBMYÎ, PRY, BPY2, DAZ and CDY1; six new families of 
transcription units ­ CSPG4LY, GOLGA2LY, TTY3, TTYA, TTY5 and 7TY6 with 
the last four presenting non coding transcripts. 
ul bl t l t2 b2 u3 gl r l r2 b3 P1.2 g2 r3 r4 g3 P l . l b4 
DAZ1/2 
•4 ► 
DAZ3/4 
■4 ► 
GENES 
R B M V T ^ 
BPY2 
DAZ 
CDY1 
PRY 
4 ► 
♦ 
4 
► 4 
CSPGILY 
Q0LGA2LY 
TTY3 
TIY4 
TIYS 
TTY6 
4-
I ' ■ 
I 
4 ► 4 
Figure 23 ­ AZFc palindromic structure and listed below, the AZFc genes with a functional 
transcription unit. Their 5'­3' polarities correspond to the arrows directions, coloured according 
to their corresponding amplicons. 
It was therefore possible to investigate the variation in all gene families in the 
AZFc region, outside the DAZ genes. The sequence data of Kuroda­Kawaguchi 
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et al. (2001) was used and single nucleotide variants were searched, as have 
been found in the DAZ gene locus, within exonic and intronic structure of other 
six gene families: BPY2 (Basic Protein Y2), CDY1 (Chromo-Domain Y1), 
CSPG4LY (Chondroitin sulfate proteoglycan 4-like Y), GOLGA2LY (Golgi 
antigen 2-like Y), TTY3 (Testis transcript Y 3) and TTY4 (Testis transcript Y 4). 
SNVs were found for BPY2 and TTY4 mapped in the green amplicons (g1, g2, 
g3) and GOLGA2LY in the yellow amplicons (P1.1, P1.2). It was not possible to 
find suitable variants in the CDY1, CSPG4LY and TTY3 genes located in the 
yellow amplicons (fig. 23). Therefore, an AZFc-Yellow marker located outside 
the genes but able to distinguish the yellow P1.1 amplicon from the P1.2 was 
developed. The summary of this AZFc SNV set is shown on table XIV and 
presented graphically on figure 24. 
| S N V S ." | A ? F C S i ^ T a 5 e ï s b n nr f l U l | a r ^ c o n | aTeîeXagmíntsfbp) 
Yellow 
SNVI 
P1.1/P1.2 G73351 Dde I P1.1 
P1.2 
A 
B 
467 
284+183 
GOLY 
SNVI 
GOLGA2LY 
genes 
(2 copies) 
BV012731 Hhal P1.1 
P1.2 
A 
B 
531 
289+242 
BPY2 
SNVI 
BPY2 genes 
(3 copies) 
BV012732 EcoRV g2,g3 
gi 
A 
B 
470 
289+181 
TTY4 
SNVI 
TTY4 genes 
(3 copies) 
BV012733 Hae III g3 
g i .g2 
A 
B 
541 
323+218 
J STSs | AZFc site | ^ n e B a n ^ | ^BAC^ | BACseq. jTanneal PCR product 
SY1192 u3 G67166 BAC 5C5 
AC010080 
52109-
52362 
64 255 
Table XIV - AZFc SNVs and STS with different alleles in palindromes and gene copies. 
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Figure 24 - AZFc palindromic structure and the localisation of the AZFc-SNVs developed. 
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Thirty one samples from fertile men (In1-ln31), with variable DAZ-SNVs were 
analysed with this AZFc marker set (table XIV). Variations in SNVs that do not 
affect fertility, due to deletion, gene conversion or other causes, will behave like 
neutral markers and can be placed on the phylogeny to reveal the number of 
such events and some information about their likely time and place of origin. 
These samples were also typed by S. Paracchini, with a large set of Y-
chromosomal binary markers, defining 116 haplogroups, to establish their 
location in the phylogeny, according to Underhill et al. (2000) and Paracchini et 
al. (2002). Only 10 of the 116 haplogroups were present in these samples, as 
would be expected from their predominant origin in Europe (table XV). From 
these results, thirteen different "AZFc haplotypes" could be defined in these 
samples, 12 of which were associated with the loss of one or a small number of 
variants in DAZ- and AZFc-SNVs set (fig. 25). Among these, five belonging to a 
common haplogroup (haplogroup N), lacked SNVs from a large segment of the 
distal part of the AZFc containing the DAZ3 and DAZA genes. 
Yellow-SNV GOLY-SNV 
BPY2-SNV TTY4-SNV 
Figure 25 - AZFc-SNVs analysis of DNA samples from different Y-haplogroups. 
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In] A+B A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 1 104 RI* 
In2 A+B A+B A+B A+B A+B A+B + + + A+B A A+B B 2 108 Rial* 
In3 A+B A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 1 104 RI* 
In4 A+B A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 1 104 RI* 
In5 A+B A+B A+B A+B A+B A+B + + + A+B A A+B B 2 108 Rial* 
In6 A+B A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 1 104 RI* 
In7 A+B A+B B B A+B A + + + A+B A A+B B 3 52 I* 
In8 A+B A+B B B A+B A + + + A+B A A+B B 3 52 I* 
In9 A+B A+B B B A+B A + + + A+B A A+B B 3 52 I* 
InlO A+B A+B B A+B A+B A + + + A+B A+B B B 4 58 J2* 
Inll A+B A+B B A+B A+B A + + + A+B A A+B B 5 35 E3bl* 
Inl2 A+B A+B B A+B A+B A + + + A+B A+B A+B B 6 56 J2P 
Inl3 A+B A+B B B A+B A + + + A A A+B B 7 58 L J2* 
Inl4 A+B A+B B A+B A+B A + + + A+B A A+B B 5 32 E3b3a* 
Inl5 A+B A+B A+B B A+B A - + + A+B A A+B B 8 52 I* 
Inl6 A+B A+B A+B B A+B A - + + A+B A A+B B 8 35 E3bl* 
Inl7 A+B A+B A+B B A+B A - + + A+B A A+B B 8 32 E3b3a* 
Inl8 A+B A+B A+B B A+B A - + + A+B A A+B B 8 35 E3bl* 
Inl9 A+B A+B A+B B A+B A - + + A+B A A+B B 8 35 E3bl* 
In20 A A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 9 104 RI* 
In21 A A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 9 104 RI* 
In22 A+B A+B A+B A+B A+B A + + + A+B A+B A+B B 10 115 Q3* 
In23 A A+B A+B A+B A+B A+B + + + A+B A+B A+B B 11 108 R i a l * 
In24 A A+B A+B A+B A+B A - - - B B A B 12 92 N3* 
In25 A A+B A+B A+B A+B A - - - B B A B 12 92 N3* 
In26 A A+B A+B B A+B A + + + A+B A+B A+B B 13 76 0 3 * 
In27 A A+B A+B B A+B A + + + A+B A A+B B 14 52 I* 
In28 A A+B B A+B A+B A + + + A+B A+B A B 15 58 J2* 
In29 A A+B A+B A+B B A - - - B B A B 16 92 N3* 
In30 A A+B A+B A+B B A - - - B B A B 16 92 N3* 
In31 A A+B A+B A+B B A - ­ - B B A B 16 92 N3* 
*Th eY­ha plotypir ig was perforr ned by S. P araci :hini and C. " ryler­S mith. 
Table XV ­ Summary 
samples. 
of AZFc­SNVs/STSs analyses and Y­haplogroup typing in 31 DNA 
To confirm the relationship between the DAZ3/DAZ4 deletion and the observed 
phytogeny, 15 individuals known to belong to the Y­haplogroup N (In32­ln46) 
were analysed for their "DAZ and AZFc haplotype". The results are summarised 
on table XVI. Beside small variations in D/AZ­SNVs II and IV (2 samples) and 
one sample with sY1192 positive, all samples lost u3 and g2-DAZ3-DAZ4-g3-
P1.1 markers. It was, therefore, identified a common Y lineage, haplogroup N, 
related with a large deletion in this part of the AZFc region. 
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In32 A A+B A+B A+B B A ­ + B B A B 16 87 N*(xN3) 
In33 A A+B A+B A+B B A ­ ­ B B A B 16 87 N*(xN3) 
In34 A A+B A+B A+B B A ­ ­ B B A B 16 87 N*(xN3) 
In35 A A+B A+B A+B B A ­ ­ B B A B 16 87 N*(xN3) 
In36 A A+B A+B A+B B A . . B B A B 16 87 N*(xN3) 
In37 A A+B A+B A+B B A . ­ B B A B 16 92 N3* 
In38 A A+B A+B A+B B A ­ ­ B B A B 16 92 N3* 
In39 A A+B A+B A+B B A ­ ­ B B A B 16 92 N3* 
In40 A A+B A+B A+B B A ­ ­ B B A B 16 92 N3* 
In41 A A+B A+B A+B B A ­ ­ B B A B 16 87 N*(xN3) 
In42 A A+B A+B A+B B A . ■ B B A B 16 87 N*(xN3) 
*T he Y ­haplot yping v vas per forme d by S. P aracc :hini andC. Tyler­Smith. 
Table XVI ­ Summary of AZFc­SNVs/STSs analyses in 15 DNA samples from Y­haplogroup N. 
4.5. DAZ promoter structure 
The first approach to understand the regulatory mechanism controlling testis­
specific DAZ genes expression was the molecular analysis of the DAZ 
upstream region for putative promoter elements. For this purpose, several in 
silico analyses were performed using different promoter prediction programmes, 
listed on table XVII. The promoter is usually defined in terms of the sequences 
that react with RNA polymerase as well as a unique set of transcription factors 
which probably influence the transcription initiation. 
Promoter programmes Internet addresses Reference 
Promoter Inspector httpVgenomatix.gsf.de Quandtefa/. 1995 
ProScan http:/bimas.dcrt.nih.gov/cgi­
bin/molbio/proscan 
Prestridge 1995 
Promoter 2.0 www.cbs.dtu.dk/services/ 
promoter 
Knudser1999 
FunSiteP http:/transfac.gbf.de Kondrakhin etal. 1995 
Promoter Predictions www.fruitfly.org/cgi­
bin/seq_tools/promoter 
Fickett1997 
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Promoter databases Internet addresses Reference 
Eukaryotic Promotor Database http://www.epd.isb-sib.ch Périerefa/. 1998 
Transcription Regulatory 
Regions Database 
http://www.bionet.nsc.ru/trrd IC&GSBRAS1997 
Table XVII - Promoter prediction programmes and databases. 
The results for DAZ\ intron 1 are schematically shown on figure 26 and the 
most informative data obtained is summarised on table XVIII. The results 
pointed for a DAZ gene promoter domain at DAZ region from exon 1 to exon 2 
(intron 1). 
f & 
\ 
Promotorlnspector 
ProScan 
Promotor 2.0 Prediction 
FunSiteP 
Promotor Prediction 
I Exon 1 
| Exon2 
1Kb 
Figure 26 - Schematic representation of DAZ\ promoter predictions in BAC140H23, using 
different in silico tools. 
DAZ gene BAC pos. Prom. 
Inspector 
Pro Scan Prom2.0 FunSite 
P 
Prom 
prediction 
DAZ1 140H23 
(56000-
63420) 
62689-
62912 
62340-
62680 
Score>1 
62500 
62600-
62700 
62968-
63018 
DAZ2 140H23 
(84061-
908501 
84334-
84557 
84568-
84808 
Score>1 
88461 
84562-
84619 -
DAZ3 290O3 
(70971-
76990) 
76260-
76483 
76000-
76250 - - -
DAZA 290O3 
(97381-
103356) 
97902-
98129 
98138-
98388 - - -
Table XVIII - DAZ promoter predictions with the exact positions found in each DAZ-BAC. 
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In eukaryotes, DNA methylation affects cytosine residues and it is specific for 
CpG sequences. The CpG island found in the DAZ genes, located upstream to 
the translation initiation site (ATG), are shown on figure 27. 
DAZ promotor 
CTCCCATCCAACCCCTTATATCTCAAACTTGACAGAAAGGAGTCCAAGTTTCTJI JTGTTGATGTCTCC 
CTCBITTTTCCACAGACTTBTACTATTTATTTCTHAGGTACTTTAAAAGATTTTGGGGTGGGTGTGAI 
BTAACAGTGATTGTdTAAACCTGTBATTcB|GAAj[|CATTTTGAAACTACAj JAGACACATTATC 
ATTTTTTAAAACTATACCATATATTTCAGTATB^TACTTATTTCAAGGGTGTTTTGGAGBIGGTJICTI 
|CTGGAACCCAGMACTGB|CAMACACA|||HCA|| FATACCCTHJTACTCTA^BACCCACAJETGG 
GGGAH JTCATB | A | |TCCACCCTCCAB- ■ ■ MTGTMT^BACCCATTBBTCAI 
BATACCAJ ' HATAJ : - BACAGGAJUACCTCCCAGAH : BAGTCCATHT C A G TB 
| T | | T C C T C A H T B BTTCTACCT(BAGGGTT| ' |TTGGTTTTCCT|ACACCTTA| 
BTTTMTCCTTTGACCACTMAA> JACA^BTGTTCCAB BACTTCACCABAGACCCAGAAGT 
GGTGGGTGAAACACTMTCTGTTCCTCCTTGAMTGTM ■ ||MlliTIPT^BTM^r-r-ACC[MCT(:;A 
GTTGAAGGAAAGACCTGAGGGGCAAGGCCTGTGGGGTCTTCACCGGTGGGTGAAACCAGGCTCCGCCTTA 
TCCTCGGTTTTCCTGTTTCGGGGCCACCCCGCTGAATGCATTAGGAGCCGTGGCCCGCAGGGTGGGGTGA 
Figure 27 - CpG island in DAZ promoter region found with CpG island searcher programme 
(http://ccnt.hsc.usc.edu/cpgisl). Legend: Exon 1,BC boxJ|, | T § | a s the start codon. 
4.6. Transcriptional regulation of the DAZ locus by methylation? 
The results obtained from the Mlu I blots with the genomic DNA samples (fig 22) 
are indicative for a methylation of the DAZ gene locus. It has been therefore 
analysed whether this methylation is also influencing the transcriptional activity 
of the DAZ genes. 
To study the effects of methylation in DAZ gene expression in vitro, 2 testicular 
and 2 prostate cell lines (table XIX) were used, taking the advantage of the 
testicular origin of 2 of them and the data of Lau & Zhang (2000) showing 
expression in prostate. They will also provide large amount of material to be 
studied (DNA and RNA) and allow treatments with chemicals to induce 
demethylation and acetylation of the nuclear chromatin. 
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4.6.1. Cell lines characterisation 
The cell lines characterisation studies started with cytogenetic analysis in order 
to check their karyotypes and their Y-chromosome integrity. The karyotypes 
(table XIX) were quite complex and to clarify the results, M-FISH studies were 
done in all cell lines. These results are presented on Appendix A. 
Testicular cancer cell lines Sex chromosome 
constitution 
NT2 62XY 
Ep2102 53XXY 
Prostate cell lines 
Du-145 61XY,t(Y ;20) 
LNCaP 74XYY 
Table XIX - Sex chromosome constitution from 2 testicular and 2 prostate cell lines. 
The Y chromosome had complete structure in both testicular cancer cell lines. 
Du-145 cell line presents a translocation between Y chromosome and 
chromosome 20 (t(Y;20)) and LNCaP had a Y-chromosomal duplication. 
D/AZ-SNV and AZF-SNS/ analyses were then performed to analyse the DAZ 
locus and AZFc structural integrity in all cell lines. The results obtained for DAZ-
SNV are shown on figure 28 and for AZFc-SNV on figure 29. The /4ZF-SNV 
pattern obtained for LNCap suggests that this cell line belongs to the AZFc 
deletion haplotype 8, as it presents the same AZFc-SNVs pattern found for 
samples In15 to In19 (see table XV). 
Du LN Ep Nt Du LN Ep Nt Du LN Ep Nt 
Figure 28 - D/AZ-SNVs analysis on cell lines. Absence of SNV VI B allele and Y-DAZ3 
STS in LNCaP. 
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Figure 29 - AZFc-SNVs analysis on cell lines. Absence of Yellow-SNV A allele and B allele of 
BPY2-SNV in LNCaP. 
The results obtained with both SNV analyses were indicative of some molecular 
rearrangements on AZFc of Y chromosome in LNCaP cell line, not only on the 
DAZ locus but specially on the AZFc region. In order to clarify this point, 
Southern blot analysis was done with the same system previously used for 
BACs and genomic samples (EcoR V blot). The results, shown on figure 30, 
demonstrated the DAZ locus molecular integrity of the four cell lines as they 
show the same pattern obtained for the male control. 
NT Ep LN Du M 
Figure 30 - EcoRV restrictions using cell lines DNA as template and p49f probe for 
hybridisation. NT - NT2; Ep - Ep2102; LN - LNCaP; Du - Du-145; M - Male control. 
87 
Results 
4.6.2. DAZtranscription studies 
4.6.2.1. RT-PCR on cell lines 
In order to study transcription of the DAZ genes in each cell line, specific 
primers were designed. The reverse transcription (RT) step was always 
performed with a gene specific primer covering part of the DAZ exons 9 and 10 
(cDNADAZ primer, table I). The primers used in the RT-PCR experiences and 
their specificity are displayed on figure 31. The blue coloured ones, named 
DAZ-short (table I), indicate a general positive DAZ transcription and do not 
distinguish among the different DAZ gene copies. The lilac coloured ones, 
named long (DAZ1/4, table I), identify specific transcription of DAZ1 and DAZA 
copies; the orange coloured ones, named 7A (table I), identify specific DAZ2 
transcripts. DAZL specific primers (355ex2-3for and 355ex8-9rev, table I), 
covering the exon 2/3 boundary till exon 8/9 boundary and DBX primers 
covering the cDNA from exon 3/4 till exon 6/7 were used as positive controls for 
all RT-PCR experiments. 
DAZ 1 DAZ 2 
II 
/ / 
H Z Y X E F E D C i 1 I I Hil A C D E F E F E X D E X Y Y Y V Y Y Z H JO II 
— / / 
short 
< 
long 
DAZ 3 
7A 
DAZ 4 
short 
> 
H Z X E X E X E D C B 
111 
/A  
iniiiKi 111 llll III llll 
C D E F E X E X Y Y Y Y Y Z H 
I l l l l : : I I 
— / / 
short 
long 
Exon 1 
Exon 2 
Exon 3 
Exon 4 
Exon 5 
Exon 6 
Exon 7 variants 
Exon 8 
Exon 9 
Exon 10 
Figure 31 - Localisation of DAZ primers used for transcription studies. Because testis DAZ 
transcripts containing exons 7G and 7H were never found, they are crossed. 
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The RT-PCR results are displayed on figure 32. Although long transcripts, 
indicative of DAZ1 and DAZA transcription, were not found in NT2 and Du-145 
cell lines, two transcripts with different lengths (1.2 and 1.6 kb) were obtained 
for LNCaP. As shown on fig. 31 (lilac primers) they correspond to transcripts 
containing one or two RRM domains, respectively. Short transcripts indicative 
for transcription of all DAZ genes were not found on Du-145 cell line. The 
transcript estimated length is 254bp. The existence of 2 transcripts for NT2 and 
Ep2102 could only be explain by the existence of different transcripts containing 
small exons, already described as pseudoexons (y8) (Saxena et al. 1996, fig. 
5). Female and male controls do not display any transcription showing the 
primers specificity for cDNA. On human testis sample the DBX transcription was 
very weak. 
Transcripts 
T NT2 Ep Du LN M F 1kb 
T F M NT2 Ep Du LN - 100bp 
T F M NT2 Ep Du LN - 100bp 
Figure 32 - DAZ transcripts on cell lines. T- human testis; F - female control; 
M - Male control; 100bp ladder used as a molecular weight marker. 
Specific primers were also designed to check the existence of testis transcripts 
containing the exons (7G and 7H). The primers used were selected for 
annealing to exon 6 and exon 2 boundaries (primer 6-2), exon 6 and exon 7G 
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(primer 6-G) and exon 7G and exon 2 (primer G-2). They could produce RT-
PCR products only from transcription of DAZ copies containing more than 1 
RRM domain {e.g. DAZ\ and DAZ4). The results obtained are shown on figure 
33. The Ep2102 cell line displayed two transcripts with 412 and 907bp 
corresponding to both RRM domains, indicating that the DAZ copies transcripts 
had 2 RRM domains. 
NT Ep Du LN T M NT Ep Du LN T M NT Ep Du LN T 
6-2 6-G G-2 
Figure 33 - DAZ transcripts on cell lines. NT - NT2; Ep - Ep2102; LN - LNCaP; Du - Du-145; T-
human testis; M - 100bp ladder; No results were obtained when using primers to check the 
transcription of exon 7H. 
The different DAZ transcripts obtained (fig. 32 and 33) were extracted from the 
agarose gel, cloned and sequenced in order to identify their origin for a distinct 
DAZ gene copy, by analyses of the number of RRM domains present in each 
transcript and by the presence of different 7 exon variants composition. 
Because repetitive sequences, like the ones from the 7 exon variants are quite 
difficult to get, good sequences could be only obtained from the testis 
transcripts. On table XX are shown the different compositions of 7 exon variants 
found in different transcripts. 
Clone name , Long transcripts DAZ gene 
Testisl .4 Ex6-2,3,4,5,6...Ex7y,7y,7y,7z,8,9 DAZ4 
Testisl .5 Ex6-2,3,4,5,6,7b,7c..Ex7x,7e,7y,7y,7y,7y,7z,8,9 DAZA 
Testisl .6 Ex6-2,3,4,5,6,7b,7c,7d..Ex7e,7x,7y,7z,8,9 DAZ\ 
Clone name Short transcripts 
Testis 7A1 Ex7a,7c,7d...Ex8,9,10 DAZ2 
Testis2.4 Ex7a,7c,7d,7e,7f,7e DAZ2 
Testis2.1 ...Ex7e,7x,7e,7x,7z,8,9 DAZ3 
Testisl .2 ...Ex7d,7e,7f,7e,7x,7y,7z,8,9 DAZ\ 
Table XX - Sequencing results from cDNA DAZ clones. 
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The analysis of all sequences obtained for each transcript confirmed the 
transcription of all DAZ gene copies, at least in testis. Among long transcripts, 
DAZ4 ones could be distinguish from those from DAZ\ by the number of 7Y 
variants present (DAZ1 was described as containing only one 7Y while DAZA 
should contain 6 of the exon 7Y variant). DAZ2 transcripts were found quite 
often, suggesting that these transcripts should be produced earlier than the 
others. In all clones sequenced, it was not possible to find the 7H variant, 
between exon 8 and exon 9, as predicted by in silico analysis. This suggests 
that the transcripts containing this variant do not exist or are only produced in a 
low level. Extrapolation from the results obtained to the testis to the cell lines 
transcripts has been allowed as they presented the same size on the gel. 
4.6.3. DAZ gene transcription after demethylation of genomic DNA 
The transcriptional activity of the DAZ genes in the 4 cell lines was analysed, 
after treatment with 5-azacytidine for different time points (1 to 5 days).The 
results are shown on figures 34-37. 
The DAZ7B forward primer differs from 7A (shown on fig. 31) only in the first 
nucleotide and it was designed in this way to be specific for the exon 7B variant, 
present in all but DAZ2 copy. 
Additionally the Trichostatin A treatment was used to check if the histones 
acetylation plays a role on DAZ transcription. The results are shown on the right 
side of each picture, on figures 34-37, being referred as A/T, as the cell lines 
were treated firstly (2 days) with 5-azacytidine and then with Trichostatin A. 
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NT2 
Long 
Short 
NT A1 A2 A3 A4 A5 A/T T 1kb 
NT A1 A2 A3 A4 A5 A/T 100bc 
DAZ7B 
DAZL 
NT A1 A2 A3 A4 A5 A/T 1kb 
NT A1 A2 A3 A4 A5 A/T 100bp 
Figure 34 - DAZ transcripts on NT2 cell line after azacytidine treatments. NT - Testicular 
cancer cell line NT2; A1-A5 - Azacytidine treatments from 1 to 5 days; A/T - Azacytidine (day 2) 
+ Trichostatin ; 1kb ladder or 100bp ladder used as a molecular weight marker. 
Long 
Short 
DAZ7B 
DAZL 
Ep2102 
Ep A1 A2 A3 A4 A5 T F 1 kb 
Ep A1 A2 A3 A4 A5 T F - 100bp 
Ep A1 A2 A3 A4 A5 A/T 1Kb 
Ep A1 A2 A3 A4 A5 T M F 100bp 
Figure 35 - DAZ transcripts on Ep2102 cell line after azacytidine treatments. Ep - Testicular 
cancer cell line Ep2102; A1-A5 - Azacytidine treatments from 1 to 5 days; A/T - Azacytidine 
(day 2) + Trichostatin ; 1 kb ladder or 10Obp ladder used as a molecular weight marker. 
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Long 
Short 
DAZ7B 
Du-145 
Du A1 A2 A3 A4 A5 A/T 1 kb 
Du A1 A2 A3 A4 A5 A/T 100bp 
1kb Du A1 A2 A3 A4 A5 A/T T 
Du A1 A2 A3 A4 A5 A/T 100bp 
DAZL 
Figure 36 - DAZ transcripts on Du-145 cell line after azacytidine treatments. Du - Prostate cell 
line Du-145; A1-A5 - Azacytidine treatments from 1 to 5 days; A/T - Azacytidine (day 2) + 
Trichostatin ; 1kb ladder or 100bp ladder used as a molecular weight marker. 
LNCaP 
Long 
LN A1 A2 A3 A4 A5 A/T T 1kb 
Short 
DAZ7B 
LN A1 A2 A3 A4 A5 A/T T 100bf 
LN A1 A2 A3 A4 A5 A/T 1kb 
DAZL 
LN A1 A2 A3 A4 A5 ATT T 
Figure 37 - DAZ transcripts on LNCap cell line after azacytidine treatments. LN - Prostate cell 
line LNCap; A1-A5 - Azacytidine treatments from 1 to 5 days; A/T - Azacytidine (day 2) + 
Trichostatin ; 1kb ladder or 100bp ladder used as a molecular weight marker. 
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The NT2 studies revealed that only after the third day of treatment it was 
possible to obtain long transcripts (only present on DAZ1 and DAZ4) as well as 
7B transcripts (DAZ1, 3, 4). Short transcripts were detected after second day of 
treatment and this could be explained because all DAZ copies will produce this 
transcript. DAZL transcription activity seem to be methylation independent. 
The Ep2102 cell line seem to be demethylated because the transcriptional 
activity of DAZ genes is independent of the treatment. 
The DAZ transcriptional activity of Du-145 and LNCap cell lines presents a 
similar pattern to the one obtained with NT2 cell line, with the increase of 
transcription from the third for the fourth day being clearer. 
The different cell lines displayed similar increase of transcriptional DAZ activity 
after on going demethylation. It was therefore possible to demonstrate that the 
transcriptional activity of DAZ genes is controlled by methylation and can be 
activated after a progressive loss of DNA methylation in each round of cell 
division (A1 to A5). 
After the Trichostatin A (TCA) treatment, there was a decrease on the 
transcriptional activity in NT2, Du-145 and LNCaP. This can be indicative that 
histone hyperacetylation could modulate the gene expression, as referred by 
Yoshida (1995), although the TCA toxicity is also a factor that should be 
considered. 
4.7. Bisulfite treatment 
The methylation status of each CpG of CpG islands can be checked after a 
DNA treatment with bisulfite, whereas the non-methylated C are converted in T. 
Methylation specific PCR (MSP) uses the sequence differences between 
methylated and unmethylated alleles, which occur after sodium bisulfite 
treatment. 
However, the bissulfite treatment performed in the four cell lines DNA did not 
produce conclusive results. This fact happens after several attempts to get a 
good sequence of the PCR product after bisulfite treatment. In the future, other 
experiments need to be developed in order to check if and which CpG doublet 
in the DAZ promoter CpG island are, indeed, methylated. 
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4.8. Transcriptional analyses of DAZ-L1 element 
A complete LINE element was mapped in each DAZ copy between the 7X/7Y 
repeat in DAZ 1, 2 and 4 copies and in DAZ 3 between the 7X/7Z repeat (fig. 
15). The sequence used to map the Line element on DAZ genes was the 
Human transposon L1.2 (GenBank ac. nr. M80343, Santos et al. 2000). L1.2 
has 2 ORFs (Open Reading Frames) with the first one (ORF1) coding for a 40 
kDa RNA binding protein and the second one (ORF2) coding for a protein 
containing an endonuclease and a reverse transcriptase domains. In DAZ-LINE, 
the sequence of ORF1 shows nucleotides changes that leads to two stop 
codons, in positions 330 and 390 of the ORF1 translated sequence. 
Different promoter prediction programmes were used and a promoter region 
was found in DAZ-LINE element. In each DAZ copy gene the promoter and the 
ORFs have an inverted orientation in relation to the DAZ gene promoter. 
The attempt to find specific DAZ-Line primers in order to check a putative 
transcriptional activity of this element within the DAZ gene was, however, not 
successful. This fact was due to the high homologies present on almost all the 
LINE sequences spread all over the genome. 
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Discussion 
AZFc deletions are the most common known genetic cause of human male 
infertility and are found in different human populations with a rate of about 10"4 
(Vogt 1996). In spite of this, it is not yet known whether the Y gene families 
mapped to this chromosomal region (fig. 4) and exclusively expressed in 
testicular tissue (Lahn & Page 1997, Vogt 1998, Kuroda-Kawaguchi et al. 2001) 
are indeed essential for human spermatogenesis. Gene specific deletions or 
point mutations have not been reported for any of the proposed AZFc candidate 
genes. Therefore it has been proposed that the observed AZFc testicular 
pathology might only probably be caused by deletion of the entire AZFc gene 
content of the human Y chromosome (Vogt 1998). 
5.1. AZFc structure 
The AZFc region is now covered with a contig of 44 BAC sequences and a 
molecular extension of about 4.94 Mb. A similar BAC contig of the AZFc region 
was recently published by Kuroda-Kawaguchi et al. (2001). Their data confirm 
the correct assembly of our AZFc-BAC contig shown on table VII. The same 
group extended this analysis by additional interactive alignment processes that 
revealed a unique repetitive and palindromic AZFc sequence structure along 
93% of its length (Kuroda-Kawaguchi etal. 2001). 
As the main conclusion for the first part of this work, strong experimental 
evidence was found showing that not only AZFc deletion but also partial AZFc 
deletions including the DAZMDAZ2 will cause the same pathology. It was found 
that in 5 of 63 oligozoospermic individuals (OZ), deletions of the DAZ1/DAZ2 
gene doublet are associated with a oligozoospermic phenotype similar to that 
observed after deletion of the entire AZFc region. These results are a major 
step towards the solution of the frequently discussed enigma on the function of 
the different DAZgene copies in human spermatogenesis. 
5.2. DAZMDAZ2 deletions associated with severe oligozoospermia 
The number and structure of the DAZ genes on the human Y chromosome has 
been assumed to be variable, in a range between 3 and 7 gene copies (Yen et 
al. 1997, Glãser etal. 1998, Saxena et al. 2000). In the RPCI-11 BAC library, it 
was not found more than 4 DAZ gene copies nor the presence of truncated DAZ 
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pseudogenes. These 4 DAZ gene copies were mapped as DAZMDAZ2 and 
DAZ3/DAZ4 doublets in the middle of the 4.94 Mb long AZFc BAC contig with a 
distance of 1.47 Mb between them (Fig. 15). This genomic structure was first 
proposed in the AZFc duplication model by Kirsch et al. (1996). The presence of 
four DAZ genes with the same doublet structure was first found in the Y 
chromosomes of 8 men by Saxena et al. (2000), although with different 
repetitive exon 7 domains in DAZ2, DAZ3 and DAZ4. The four copy gene 
structure found on the Y chromosome of the RPCI-11 donor was also found in 
50 out of 107 fertile control individuals and in 32 out of 63 OZ samples (48%) of 
the samples analysed. Therefore, it has been proposed that the 4 DAZ gene 
pattern, found in the RPCI-11 DAZ-BACs, represents the most common DAZ 
gene structure in Caucasian male populations. 
However, the QAZ-deletion analyses suggest that in some individuals (fertile 
men and oligozoospermic patients), the DAZ copy number is reduced to three 
by deletion of the DAZ2 or DAZ4 gene copy. The presence of only 3 DAZ gene 
copies on the Y chromosome of some fertile men was first proposed by Yen et 
al. (1997). 
In DNA samples where the deletion of DAZ2 or DAZ4 could not be confirmed by 
appropriate DYS1-blot experiments, familial gene conversion events between 
the highly homologous DAZ gene copies (<99%) should have occurred. Gene 
conversion events, especially within the DAZ2 and DAZ4 gene structures, 
would easily explain the complex pattern of derivatives obtained for DAZ-de\-
hap 2, 4, and 9 in D/\Z-SNV analyses. Similar conclusions were drawn recently 
for other human gene loci, based on unexpected linkage disequilibrium (LD) 
between closely spaced SNP markers (Ardlie et al. 2001). Obviously, gene 
conversion events prevent the identification of a specific DAZ copy deletion by 
only SNV/STS analyses and the additional analysis by DYS1-blot experiments 
is required. 
A possible link of a specific D/\Z-deletion haplotype specific to the occurrence of 
the patients' oligozoospermic phenotype was found only for the oligozoospermic 
samples with D/\Z-del-hap 5 (5 of 63), pointing to a deletion of the DAZ\ and 
DAZ2 gene copies. These results could be confirmed by the DYS1-DNA blot 
analysis. D/\Z-del-hap 5 was not found in any of the 107 fertile men samples. It 
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is, then, assumed that the DAZ1IDAZ2 deletions are most likely de novo 
mutation events, restricted to the DAZ locus of each patient. 
The analyses of DAZ gene copy specific restriction fragments in the RPCI-11 
D/AZ-BAC contigs were only successful for the repetitive DYS1-D/4Z gene 
regions. The exact molecular extensions of the DAZMDAZ2 gene deletions 
could not be estimated. However, absence of the DAZ1 specific DYS1-EcoRV 
fragments in all D/\Z-del-hap 5 patients includes a deletion of at least two of the 
DAZ\ RNA binding domains (RRM) in exon 2-5 (Fig. 38). A distortion of the 
putative D/\Z1 germ line specific RNA binding function is then expected. 
Figure 38 - DAZ genes with the 3 RRM domains on D/4Z1 and DAZA copies. Below each copy, 
the position of DYS1-EcoRV and Taq\ specific fragments. 
5.3. DAZ3IDAZ4 deletions in fertile men 
The highly repeated nature of the sequences within AZFc required the 
establishment of assays for specific variants within the DAZ regions that 
allowed to distinguish among similar sequences. These markers were extended 
to other regions in the AZFc region, providing an assay for 8 loci spread over 
3Mb in this region. 
It was shown that Y chromosomes carrying a large AZFc deletion that removes 
the DAZ3 and DAZA genes, are common in the European population. It was 
shown here that haplogroup N chromosomes carry this deletion. This 
haplogroup is common throughout Northern Europe and Asia, making up to 
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12% of Y-chromosomes in one world-wide survey (Zerjal et al. 1997). It is an 
ancient and successful lineage where the lack of DAZ3 and DAZA has no 
detrimental effect. This deletion has existed for a long time in normal males, so 
it was possible to conclude that DAZ3 and DAZA gene copies are not essential 
for spermatogenesis, at least in these men. 
5.4. Putative molecular mechanisms for the DAZ genes deletion 
The comparison between the DAZ gene structures of the RPCI-11 donor and 
that of the CTA/CTB donors described by Saxena et al. (2000) reflects a 
dynamic structure of the DAZ2, DAZ3 and DAZA gene copies but not of the 
DAZ\ gene copy. The DAZ gene doublets DAZ1/DAZ2 and DAZ3/DAZA are 
located in two palindromic sequence domains, separated by a distance of 1.47 
Mb (figure 23). The observed dynamic rearrangements, which distinguished the 
DAZ2, DAZ3 and DAZA gene copies of the CTA/CTB and the RPCI-11 donors, 
as well as gene conversion events (Ardlie et al. 2001) might be caused by the 
structural specific organisation in the genomic region of both DAZ gene 
doublets and could be extended to the entire AZFc sequence, composed by 
massive palindromes in 93% of its length (Kuroda-Kawaguchi et al. 2001). 
Palindromes and inverted repeat structures in the genome are generally known 
to induce local instabilities which depend on their lengths and repetitive 
sequence contents. Local rearrangements increasing their asymmetry could 
stabilise them (Zhou et al. 2001). In the DAZ1/DAZ2 and DAZ3/DAZA 
palindromes, this could explain the amplification of RRM domains in only DAZ\ 
and DAZA and the variable structure of the repetitive exon 7 in DAZ2, DAZ3 and 
DAZA. 
An important prerequisite for a recombination event is the existence of repetitive 
sequence blocks, presenting the same polarity. On figure 39 are presented the 
potential intrachromosomal recombination in AZFc locus between amplicons 
presenting >99.9% homology (arrows with the same colour) and the same 
polarity (same arrow direction). 
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Figure 39 - Potential deletions in the AZFc locus due to intrachromosomal recombinations of 
four different amplicons present in AZFc with the same polarity (Vogt & Fernandes, 2003). 
Table XXI shows the number of functional AZFc gene copies affected by each 
potential recombination event leading to the respective AZFc internal deletion. 
b2/b4 gl/g2 r l /r3 r2/r4 
BPY2 0 2 2 2 
DAZ 0 2 2 2 
TTY4 0 1 1 1 
Table XXI - Number of functional AZFc gene copies present after recombinations and internal 
AZFc deletions. (According to Yen 2001). 
After analysing the palindromic structure of AZFc region and each recombinant 
event, the gene content of this region can be reduced to zero, when a complete 
AZFc deletion happen (b2/b4), but it will be only partially reduced when other 
recombination mechanism occur (g1/g2, r1/r3 or r2/r4). These findings, together 
with the fact that the Y chromosome sequence is now totally known, enable, in 
a near future, to characterize the breakpoints and to identify the exact genes 
deleted in each oligozoospermic patient presenting partial AZFc microdeletions. 
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5.4.1. Mechanism for DAZMDAZ2 genes deletion 
Because deletions of the DAZ\ gene alone were not found but only in 
combination with the DAZZ gene, it was possible to assume that molecular 
mechanisms inducing the observed DAZ1/DAZ2 gene deletion events are most 
likely based on the recombination of homologous repetitive sequence blocks 
flanking the DAZ1/DAZ2 gene doublet (Chen etal. 1997). 
Intrachromosomal recombination events of two repetitive 10 kb sequence 
blocks in proximal Yq11 were also found as causative agents for the occurrence 
of most AZFa deletions (Kamp et al. 2000; Sun et al. 2000). Long homologous 
repetitive sequence blocks were also found around the DAZgenes. 
Analysis of the AZFc palindromic structure shows the existence of two long 
repetitive blocks in the same polarity (g1 and g2 amplicons) and with a high 
sequence homology, extending to the 3'ends of the DAZ\ and DAZ3 gene 
respectively. Intrachromosomal recombination events between these two green 
amplicons would delete not only the DAZ\ gene but also the entire DAZ2 gene. 
A deletion of the complete DAZ\/DAZ2. gene doublet could be caused by 
intrachromosomal recombination events between the b1 and b3 amplicons or, 
as a second possibility, between the AZFc amplicons g1 and g2. 
The exclusion of a b1/b3 recombination event as causative agent for the 
complete deletion of the DAZ1/DAZ2 gene doublet in the samples with DAZ-del-
hap 5 was assumed by the presence of two STSs, namely DYS227/sY139 
(GenBank ac. no. G12002), mapped to AZFc-u2 and sY1192 (GenBank 
accession no. G67166), mapped to AZFc-u3. 
A DAZMDAZ2 deletion caused by g1/g2 recombination event is then the most 
probable mechanism for the occurrence of the oligozoospermic phenotype in 
samples with the DAZ-del-hap 5. This putative molecular mechanism is shown 
in figure 40. 
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Figure 40 ­ Putative molecular recombinant mechanism responsible for deletion of DAZMDAZ2 
doublet. 
5.4.2. DAZ3IDAZ4 genes deletion 
Complete AZFc deletions were described as a intrachromosomal recombination 
event between the b2 and b4 amplicons (Kuroda­Kawaguchi et al. 2001) and 
deletions of the DAZMDAZ2 gene doublet occurring through recombination 
events between the g1 and g2 amplicons (Fernandes et al. 2002). From the 
/4ZFc­SNVs analyses combined with the Y­haplogroup studies performed with 
fertile men samples, it was possible to associate a deletion of the complete 
DAZ3/DAZ4 gene doublet in samples belonging to Y­haplogroup N with the 
absence of the sY1192 and 50f2/C markers, located in AZFc-u3. 
There are no obvious candidates for directly repeated amplicons flanking the 
two deleted regions, so recombination between long homologous flanking 
sequences cannot provide an explanation for the DAZ3/DAZ4 deletions in the N 
lineage Y chromosomes. This deletion includes two AZFc regions that are non­
contiguous in the GenBank sequence (Fig. 24) and so cannot readily be 
explained in a simple way. Two more complex mechanisms could be proposed: 
(1) two independent deletions could have occurred, one removing u3 and other 
the g2­DAZ3­DAZ4­g3­P1.1 region; alternatively (2) the deletion substrate could 
differ from the GenBank AZFc sequence and be rearranged in the Y 
chromosomes of the pre­N lineage, carrying u3 adjacent to the g2­DAZ3­DAZ4­
g3­P1.1 region. In that case, a single deletion event would remove all of the 
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sequence missing in the N lineage by a similar intrachromosomal recombination 
event to that seen for DAZ1/DAZ2 and complete AZFc deletions (fig. 39). 
While it is possible that short regions of sequence identity, not apparent in the 
gross AZFc amplicon structure, might be involved in the DAZ3/DAZ4 deletions, 
it has been explored the alternative possibility that evolutionary earlier 
rearrangements in the AZFc amplicons could have produced a structure that 
differs from the GenBank sequence and provides a substrate for a single 
deletion event. 
Such rearrangements in the GenBank AZFc structure could place u3 adjacent 
to the g2-DAZ3-DAZ4-g3-P1.1 region: Inversion between the b2 and b3 
amplicons followed by inversion between the P1.1 and P1.2 or b2 and b4 
amplicons or vice versa leading to the same end product where then, a single 
g1/g2 recombination would delete all the sequences absent from lineage N 
chromosomes in a single step (Fig. 41). In such AZFc amplicon structure, 
typical for N lineage Y chromosomes, the putative mechanism responsible for 
the complete deletion of AZFc region will involve an intrachromosomal 
mechanism event between the b3 and b4 amplicons. 
b 2 i u 3 i g l i r l r2> i b 3 : PL2 i H 2 ( r 3 1 fl3, P11 ^ 
Figure 41 - Putative molecular recombinant mechanism responsible for deletion of 
DAZ3IDAZ4 doublet. 
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5.5. DAZ promoter 
DAZ promoter studies were not conclusive and other tests need to be 
performed in order to check if the predicted sequences obtained by in silico 
analysis have indeed a promoter activity. This functional analysis could be done 
by subcloning the intronic region between exon 1 and exon 2 from each DAZ 
gene copy in an expression vector suitable for the analyses of functional 
promoter elements, like pGL3-Luciferase® system from Promega. 
5.6. DAZ transcriptional regulation 
The methylation studies performed in this work led to the assumption that DAZ 
gene present a transcriptional activity regulated by methylation. The results 
obtained by using testicular and prostate cell lines indicated that the first gene 
to be transcribed is DAZ2, at least in 2 cell lines, and that only 3 DAZ gene 
copies are transcribed in all cell lines, excepting LNCaP. These findings and the 
fact that different AZFc composition associates with different Y-haplogroups, 
suggest that LNCaP should belong to a different Y-haplogroup, where all 4 DAZ 
copies are present and transcribed. However, further research projects need to 
be developed in order to check this hypothesis. Real-time PCR technology is 
now available and could be used to quantify, separately, the transcription of 
each DAZ gene, clarifying whether all DAZ genes became activated 
simultaneously or at different times. 
5.7. Conclusion 
Molecular biology has revealed that microdeletions of the Y chromosome 
represent an important cause of male infertility and the most frequent genetic 
aetiology of severe impairment of spermatogenesis. Such findings are 
fundamental for a careful diagnosis of male infertility and its treatment. The Y 
chromosome deletion screening is now a reality in the majority of infertility 
centres. The detection of a deletion in an infertile man provides a proper 
diagnosis of the disease, avoiding unnecessary and often expensive treatments 
to improve fertility (e.g. hormonal treatments), and has important ethical 
consequences if the patient is a candidate for assisted reproduction techniques. 
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The identification of the actual role played by the AZFc candidate genes in 
spermatogenesis will provide significant advances to a better understanding of 
the biology of spermatogenesis and the analysis of Y-chromosomal genes with 
a potential role in male germ cell development. 
With the establishment of a set of DAZ-SNVs/STSs is now possible to 
distinguish each DAZ gene copy and to detect, for the first time, partial DAZ 
gene deletions in a systematic way. Because gene conversion events exist, an 
additional analysis by DYS1 blot experiments was developed to confirm the 
identification of a specific DAZ copy deletion achieved by SNV/STS analyses. 
The establishment of a AZFc-SNVs set extended this analysis to entire AZFc 
region, and revealed to be essential for a better understanding of recombinant 
mechanisms responsible for AZFc partial deletions 
There are also some clinical implications from this work. After the detailed 
description of the genes responsible for some cases of infertility, the basis for 
molecular deletion diagnosis of each AZFc gene copy is now provided. This 
increases the possibilities of genetic counselling, giving clues about the father-
to-son transmission and increasing the preimplantation genetic diagnosis 
(PIGD) possibilities. 
An understanding of the structure and function of the AZFc genes, in future 
research projects, and the knowledge of their interactions will facilitate the 
development of potential therapies. The development of drugs able to restore 
the normal proceed of spermatogenesis will be only possible after 
understanding the function and the pathways where these genes are involved. 
The Y chromosome is unique under many aspects. It is always in the haploid 
state, is full of repeated sequences but is responsible for important biological 
roles such as male sex determination and male fertility. 
For all these reasons the Y chromosome is an important component of the 
human genome, at least for about 50% of all individuals in all populations - the 
so called men. 
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Abstract 
Men with non-obstructive azoospermia exhibit different histopathologic syndromes in the testicle biopsy, varying from aplasia, 
Sertoli cell only syndrome, maturation arrest and hypoplasia. The genetic basis of these syndromes is discussed. We present the 
diagnostic testicle biopsies performed on 160 consecutive non-obstructive azoospermic patients, and these results were correlated 
with the findings after multiple bilateral treatment testicle biopsy. Each syndrome had to be reevaluated as for the presence of at 
least one focus of spermatogenesis up to the primary spermatocyte, round spermatid, elongating spermatid, elongated spermatid, 
or spermatozoa stages. The clinical outcome using donor sperm-IVF, spermatid or sperm intracytoplasmic injection is thereafter 
presented. A new prognosis based on the findings of this large clinical series coupled to results obtained with Y chromosome 
molecular screening is offered. Alternative treatments to donor sperm for men without spermatids are discussed. © 2000 Elsevier 
Science Ireland Ltd. All rights reserved. 
Keywords: Azoospermia; Intracytoplasmic injection; Human; Spermatids; Testicle biopsy; Y chromosome 
1. Intracytoplasmic injection with sperm from semen, 
epididymus and testicle 
Intracytoplasmic sperm injection was successfully in-
troduced into clinical practice (Palermo et al., 1992; 
Van Steirteghem et al., 1993a,b) after several unsuccess-
ful trials in humans (reviewed in Palermo et al., 1996). 
This technique enabled to solve the majority of cases of 
male infertility due to abnormal concentration, mor-
phology and/or motility of spermatozoa in the ejaculate 
(Nagy et al., 1995a). The technique could also be 
successful applied in cases of male immunological infer-
tility (Nagy et al, 1995b), total sperm immotility (Bar-
ros et al., 1997a,b), patients with chromosome 
aberrations (Montag et al., 1997), and anejaculation 
due to spinal-cord injuries (Barros et al, 1998). 
This was later further complemented by sperm ex-
traction from the epididymus in cases of obstructive 
azoospermia (Tournaye et al., 1994; Silber et al., 
1995a), and by sperm extraction from the testicle 
* Corresponding author. Tel: +351-22-2062217; fax: + 351-22-
20662232. 
E-mail address: msousa@icbas.up.pt (M. Sousa). 
(TESE) in cases of non-obstructive azoospermic pa-
tients (Devroey et al., 1994; Silber et al., 1995a; De-
vroey et al., 1996; Silber et al., 1996; Nagy et al., 1998). 
However, some of those azoospermic patients did not 
present sperm in the testicle tissue, and for these cases 
no treatment could be found. 
2. Intracytoplasmic spermatid injection 
Spermatid conception was proposed and clearly an-
ticipated by Edwards et al. (1994), and first successfully 
achieved by using microinjection of round spermatids 
(ROSI) retrieved from the semen (three successful cases: 
Tesarik et al., 1995; Tesarik and Mendoza, 1996; 
Tesarik et al, 1996; Barak et al., 1998) or testicle (five 
successful cases: Antinori et al, 1997a,b; Vanderzwal-
men et al., 1997; Kaharaman et al., 1998), and of 
elongating and elongated spermatids (ELSI) recovered 
from the testicle (27 successful cases: Fishel et al, 1995, 
1996; Amer et al., 1997; Antinori et al., 1997a; Araki et 
al., 1997; Vanderzwalmen et al., 1997; Bernabeu et al., 
1998; Kaharaman et al., 1998; Sofikitis et al., 1998; 
Sousa et al., 1999). 
0303-7207/00/$ - see front matter © 2000 Elsevier Science Ireland Ltd. AU rights reserved. 
PII: S0303-7207(00)00295-l 
38 M. Sousa et al. /Molecular and Cellular Endocrinology 166 (2000) 37-43 
However, large series demonstrated that the use of 
round spermatids was associated with a very bad prog-
nosis, with pregnancies having been achieved only in 
cases where the patients had presented mature sperm in 
previous ejaculates or testicle diagnostic biopsies, thus 
suggesting that no major genetic causes were present 
and responsible for the azoospermia situation (Sousa et 
al., 1998; Tesarik et al., 1998a; Sousa et al., 1999). A 
bad prognosis has also been found with ELSI using 
elongating spermatids (Bernabeu et a l , 1998; Sousa et 
al., 1999). Thus, so far, spermatid microinjection works 
finely only when spermatids appear at the elongated 
stage and present normally developed flagella. The fail-
ure of treatments using the more immature spermatid 
forms has been attributed to germ cell unrecognized 
apoptosis, presence of more than one single male germ 
cell centriole (the normal situation in spermatids), and/ 
or deficiency in sperm-oocyte activating substance 
(Sousa et al., 1996, 1998; Tesarik et a l , 1998a; Sousa et 
al., 1999). In all these unsuccessful cases, a strong 
correlation has also been noticed with predominance of 
unipronuclear development, a finding which suggests 
that instead of syngamy a single pronucleus may in fact 
represent parthenogenetic activation (Sousa et al., 
1999). 
3. Interstitial microdeletions in Yqll 
About 11% of idiopatic infertile men present a nor-
mal caryotype with microdeletions in Yql l , showing 
severe oligozoospermia or non-obstructive azoospermia 
(Vogt, 1996; Vogt et al., 1997; Kostiner et al., 1998; 
Vogt, 1998). 
Comparative molecular screening programs of these 
patients showed that Yqll could be resolved in at least 
25 subintervals, D1-D25. Patients were then further 
classified in relation to their specific histopathological 
testicle syndromes into three main groups: with Sertoli 
cell only syndrome (microdeletions in D3-D6, locus 
AZFa, 1Mb length), with maturation arrest up to the 
primary spermatocyte stage (microdeletions in D 1 3 -
D16, locus AZFb, 1.5Mb length), and with hyposper-
matogenesis/severe oligozoospermia (microdeletions in 
D20-D22, locus AZFc, 3 Mb length; Vogt, 1996; Vogt 
et a l , 1997; Kostiner et a l , 1998; Vogt, 1998). Yql l 
microdeletions appear more frequent in AZFc, and are 
due to errors occurring during spermatocyte meiosis of 
the patients' fathers (hereditary microdeletions), and/or 
to de novo microdeletions occurring during early em-
bryogenesis (in the majority of the patients). Brakes in 
the Y chromosome that are responsible for these mi-
crodeletions appear to be caused by the presence of 
repetitive sequences which generate genetic instability at 
the transition of the three AZF regions, being more 
numerous in AZFc (Edwards and Bishop, 1997). 
Several genes have already been described in all three 
AZF regions (AZFa, AZFb, AZFc), but their function 
has not yet been ascribed to any of the testicle syn-
dromes (Vogt, 1996; Vogt et a l , 1997; Kostiner et al., 
1998; Vogt, 1998). 
3.1. Genes in AZFa 
In AZFa have been localized the genes DBY (heli-
cases of RNAs metabolism), DFFRY (ubiquitin 
protease), and UTY (male antigen of the minor histo-
compatibility H-Y: HYD), with all presenting X homo-
logues (DBX, DFFRX, UTX). Their function remains 
unknown, and it is supposed that none of them is 
responsible for the Sertoli cell only syndrome. Due to 
the homologies with the X chromosome, the AZFa 
region pairs with the X homologue region during meio-
sis, which could facilitate microdeletions in this region. 
3.2. Genes in AZFb 
In AZFb exist several copies of the gene families 
RBM (D16, D18), and the genes SMCY (D13-D14), 
TSPY, and E1F1AY. 
The locus RBM (RNA Binding Motif) is a gene 
family whose products are RNA binding proteins. They 
are testicle specific and do not present X homologues. 
Only the gene RBM1 (D16) is specifically transcribed in 
the testicle and appears related to spermatogenesis. The 
gene RBM1 has at least seven different sequence 
classes, each class with multiple copies in Yq (with the 
majority at AZFb) and Yp (associated with copies of 
the gene TSPY). Patients may present partial or total 
microdeletions of only one of these classes of the RBM 
gene family. The gene RBM2 localizes outside of the 
AZFb region at D18, and is not expressed in the 
testicle. Genes RBM1/A and RBM1/F are in D15 
(AZFb), but it remains unknown if they are functional. 
Proteins RBM1 have been isolated from the testicle and 
immunolocalized to the nuclei of spermatogonia, sper-
matocytes, and round spermatids, but not in elongating 
or elongated spermatids or in spermatozoa. 
Another candidate is gene SMCY (D13-D14 in 
AZFb). This region also includes the locus Spy, which 
is related to spermatogenesis, and a family of genes 
which express the minor histocompatibility antigen H-
Y (HLA-B7) and the male antigen SDMA. The gene 
SMCY has homology with the gene SMCX of the short 
arm of the X chromosome (Xpll.l-Xpll.2), and both 
are believed to control sexual differentiation during 
embryogenesis, with a double dose of Smcx causing 
female differentiation, and a single dose of each Smcx 
and Smcy favoring male evolution. Because patients 
with microdeletions in AZFb and maturation arrest 
also show deletions in SMCY, in these patients the 
microdeletion has to have only attained the SMCY 
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gene after expression of this gene in early embryogene­
sis, once the male differentiation has not been affected. 
The locus HY is also supposed to be involved in male 
differentiation during embryogenesis, before gonadoge­
nesis and spermatogenesis, and is also supposed to be 
related with locus GBY, present in Yp and Yql 1 and 
responsible for gonadoblastoma. The locus GBY is 
expressed before spermatogenesis, causing about 30% 
of the cases of gonadoblastomas in XY gonad dysgene­
sis (XY females because of SRY deletion in Yp). This 
can be explained by expression of gene GBY during 
embryogenesis causing an abnormal growth of female 
gonadic cells. Expression of gene GBY is also responsi­
ble for 55% of gonadoblastoma cases with positive HY 
antigen, thus suggesting a relationship between the 
levels of expression of the HY antigen and the tumor 
developmental potential of gonad remnants. 
The gene TSPY is also a family of genes whose 
majority of copies appear in Yp associated with copies 
of the RBM gene family, although other copies can also 
be found in AZFb associated with RBM copies. These 
genes code for proteins involved in spermatogonia pro­
liferation. The gene El F1 AY was also located to 
AZFb. It codes for proteins that initiate translation of 
mRNAs and has an homologue in the X chromosome 
(E1F1AX). 
3.3. Genes in AZFc 
Microdeletions in AZFc are associated with 
azoospermia (with hypospermatogenesis) and severe 
oligozoospermia. It remains unknown if these two dis­
tinct syndromes are due to deletions of different genes 
or if they represent the natural evolution of a same 
mutation (oligozoospermia followed by hypospermato­
genesis). 
The locus DAZ/SPGY belongs to the region AZFc, 
and contains multiple copies of genes DAZ1 (ex­DAZ) 
and DAZ2 (ex­SPGY). These genes code for RNA 
binding proteins, are testicle specific, and have no X 
chromosome homologues. Their deletion causes severe 
oligozoospermia and/or non­obstructive azoospermia 
with hypospermatogenesis. They appear important for 
the optimal function of the later stages of spermiogene­
sis but are not involved in the terminal sperm differenti­
ation process itself. This suggests that deletion of these 
genes do not cause azoospermia but oligozoospermia, 
which then can evolve with time to azoospermia. The 
DAZ genes have an homologue in chromosome 3 
(DAZL1), which is expressed only in the male germinal 
tissue. DAZ proteins have been isolated from the testi­
cle, and were immunolocalized to the cytoplasm of 
elongated spermatids and along the flagellum of mature 
sperm. This suggests that they transport or store spe­
cific mRNAs whose translation appears inhibited up to 
more advanced stages of the spermiogenetic process. 
Several other genes have been found in AZFc (BPY2, 
PRY, RBM, TTY1, TTY2), each one with multiple 
copies in that interval. These genes also have copies in 
the proximal Yp region, but their function in spermato­
genesis remains unknown. 
3.4. Other genes in Yqll 
Several other genes with a potential role in spermato­
genesis (BPY1, CDY, TTY1, XKRY, TB4Y) have been 
identified to Yql l but outside the ÁZF regions. They 
also present copies in Yp. Gene TB4Y has an.homo­
logue in the X chromosome; it is not testicle specific, its 
deletion does not cause infertility, and its function is 
still to be determined. .,,:.■...■..■■:.■ 
3.5. DNA repetitive regions in Yqll 
Region AZFc exhibit two polymorphic loci, DYS1 
(D22) and DYS2 (D20), which enables the possibility of 
different patients showing distinct deletions of the same 
gene. DYS1 has seven sequence variations, and encases 
DAZ. DYS2 has five sequence variations, with se­
quence DYS1/C being the most frequently mutated. In 
some patients with extensive microdeletions, it includes 
region RBM and DAZ1 of AZFc. 
4. Prognostic factors for successful testicle spermatid 
recover 
It is now clear that the histopathological diagnosis 
after single testicle biopsy, even when performed bilat­
erally, the testis volume, and the male hormonal profile 
does not entirely correlate to the findings from multiple 
bilateral treatment testicle biopsy (Silber et al., 1995b; 
Tournaye et al., 1996; Silber et al., 1997; Tournaye et 
al., 1997; Sousa et al., 1999). 
We here present a review of our consecutive 160 
cycles of multiple bilateral treatment testicle biopsy and 
Y chromosome molecular screening in patients with 
male factor infertility due to non­obstructive azoosper­
mia. This is the larger published clinical series, and may 
enable teams to offer to their patients a prognosis and 
correctly schedule the treatment approach. 
Of the 160 patients analyzed, the diagnostic testicle 
biopsy have shown three major syndromes, maturation 
arrest at the primary spermatocyte stage (n = 70; 44%), 
Sertoli cell only syndrome (« = 55; 34%), and hypo­
plasia (H = 35; 22%). After multiple bilateral treatment 
testicle biopsy, about 69% of the maturation arrest 
cases, about 16% of the Sertoli cell only syndrome 
cases, and 100% of the hypoplasia cases, showed at 
least one focus of complete spermatogenesis up to the 
elongated spermatid or sperm stages, whose cells 
proved to have full fertilizing potential (Figs. 1­3). 
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Diagnostic testicle Biopsy Treatment Testicle Biopsy 
N=160 
Cell found 
Effected treatment: 
Clinical pregnancy rate /cycle: 
Fig. 1. More mature cells found: Sa, round spermatids; Sc, Sertoli 
cells; Sd, elongated spermatids; Sz, spermatozoa. Treatments: ELSI, 
intracytoplasmic elongated spermatid injection; ICSI, intracytoplas­
mic sperm injection; IVF­D, in vitro fertilization with donor sperm; 
ROSI, intracytoplasmic round spermatid injection. Pregnancy results: 
NB, newborns; OG, ongoing pregnancies. 
Diagnostic Testicle Biopsy Treatment Testicle Biopsy 
N=160 
15.7% 
(n=11) 
Cell found: 
Effected treatment: 
Clinical pregnancy rate /cycle: 
68.6% 
(n=48) 
SCI Sa Sd/Sz 
(28/20) 
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| IVF­D ROSI ELSI/ICSI 
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4 0G 
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Fig. 2. More mature cells found: Sa, round spermatids; SCI, primary 
spermatocytes; Sd, elongated spermatids; Sz, spermatozoa. Treat­
ments: ELSI, intracytoplasmic elongated spermatid injection; ICSI, 
intracytoplasmic sperm injection; IVF­D, in vitro fertilization with 
donor sperm; ROSI, intracytoplasmic round spermatid injection. 
Pregnancy results: NB, newborns; OG, ongoing pregnancies. 
This shows that the majority of non­obstructive 
azoospermic patients can be successfully treated despite 
the bad initial prognosis. These figures are now offered 
as a general prognosis to patients before initiating the 
treatment biopsy. In patients with hypoplasia, TESE is 
performed always after oocyte pick­up; for cases of 
maturation arrest and Sertoli cell only syndrome, we 
schedule the treatment biopsy for the day of oocyte 
pick­up only if patients accept donor sperm­IVF. If 
patients refuse this approach or donor semen, we prefer 
to perform the multiple bilateral treatment testicle 
biopsy without simultaneous female partner controled 
ovarian hyperstirnulation. If a focus of elongated sper­
matids or spermatozoa is found, the sample is frozen 
after 2 days of culture to optimize the maturation 
process (in IVF medium, at 30­32°C, 5% C0 2 in air); if 
one focus of spermatogenesis up to the spermatid elon­
gating phase is found, the tissue is cultured up to 
flagella and elongated spermatid forms are found (in 
IVF medium + rFSH to stimulate spermatogenesis + 
testosterone to stimulate Sertoli cells and avoid acceler­
ated in vitro cell apoptosis; at 30­32°C, 5% C0 2 in air; 
Tesarik et al., 1998b,c,d Cremades et al., 1999). In our 
experience this takes about 2­3 days to attain success­
ful results, with about 16% of the cells evolving to more 
developed stages in about 42% of the clinical cases. If 
one focus of spermatogenesis up to the spermatocyte or 
round spermatid stages is found, we also perform cul­
ture of the tissue in the same conditions. However, in 
these more difficult cases this takes about 7­12 days to 
attain successful results, with about 6­8% of the cells 
evolving to elongated spermatids and spermatozoa in 
about 25% of the clinical cases. 
In an effort to improve our prognostic figures, all our 
studied non­obstructive azoospermic patients were 
screened for Yqll microdeletions (Vogt, 1998). Results 
showed no microdeletions in patients with abnormal 
caryotypes and hypoplasia, and about 34% of mi­
crodeletions in the other cases. 
We then correlated Y microdeletions with findings 
obtained after diagnostic testicle biopsy and the de­
tailed findings obtained with multiple bilateral treat­
ment testicle biopsies. Results suggest that the presence 
of microdeletions in AZFc can improve the prognosis 
of our patients, once this deletion was associated with 
successful recover of elongated spermatids during 
TESE. However, the improved prognosis appears to be 
useful only for Sertoli cell only syndrome cases. This is 
so, because 67% of the patients simultaneously with a 
Sertoli cell only syndrome diagnosis and deletion in 
AZFc will have a focus of complete spermatogenesis in 
TESE, whereas only 40% of the patients simultaneously 
with a maturation arrest diagnosis and deletion in 
AZFc will have a focus of complete spermatogenesis in 
TESE (in opposition to the 69% of success rate given by 
histopathology). Thus, for Sertoli cell only patients, 
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Diagnostic Testicle Biopsy Treatment Testicle Biopsy 
N=160 
100% 
(n=35) 
Cell found: 
Effected treatment: 
Sz 
T 
ICSI 
Clinical pregnancy rate /cycle: 
Fig. 3. More mature cells found: Sz, spermatozoa. Treatments: ICSI, 
intracytoplasmic sperm injection. Pregnancy results: NB, newborns; 
OG, ongoing pregnancies. 
instead of offering a good prognosis of 16% based on 
histopathology, we can now offer a much better prog-
nosis of 67% if they also present an AZFc mutation. 
5. Conclusions and future directions 
The large clinical series here presented enables to 
offer to non-obstructive azoospermic patients a progno-
sis for successful recover of fertilizing spermatids/sper-
matozoa during TESE. Patients now program their 
preferential treatment. In our experience, all patients 
with hypoplasia, most of the patients with maturation 
arrest, and all patients with Sertoli cell only syndrome 
and an AZFc mutation prefer to perform TESE at the 
time of oocyte recover. Most of our cases with a worse 
prognosis also prefer the same strategy because they 
accept to use donor sperm-IVF. On the contrary, pa-
tients with a worse prognosis prefer TESE in advance 
of female partner stimulation when donor sperm is an 
unacceptable procedure for the couple. Although we 
offer to all patients tissue culture, the elongated sper-
matids and spermatozoa produced in vitro are still not 
used by our team in clinical treatments until our genetic 
research program is finished. Preliminary results suggest 
that the normal (2PN, 2PB) fertilization rate (49%), the 
blastocyst formation rate (22%), and the chromosomal 
constitution of embryos produced with those in vitro 
matured cells are still far away from the desirable 
objectives. 
In conclusion, despite these advances, about 43% of 
the secretory azoospermic population remain without a 
solution. Although testicle tissue cultures appear 
promising for about 54% of these cases, it remains 
urgent to find a new strategy for those men with pure 
Sertoli cell only syndromes as also for those male 
patients that have one focus of spermatogenesis up to 
the spermatocyte stage but whose cells do not mature 
during in vitro culture. 
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Deletions of the DAZ gene family in distal Yqll are always associated with deletions of the azoospermia factor c 
(AZFc) region, which we now estimate extends to 4.94 Mb. Because more Y gene families are located in this 
chromosomal region, and are expressed like the DAZ gene family only in the male germ line, the testicular pathology 
associated with complete AZFc deletions cannot predict the functional contribution of the DAZ gene family to 
human spermatogenesis. We therefore established a DAZ gene copy specific deletion analysis based on the DAZ-
BAC sequences in GenBank. It includes the deletion analysis of eight ZMZ-DNA PCR markers [six DAZ-single 
nucleotide varients (SNVs) and two DAZ-sequence tag sites (STS)] selected from the 5' to the 3'end of each DAZ 
gene and a deletion analysis of the gene copy specific EcoKV and Taql restriction fragments identified in the internal 
repetitive DAZ gene regions (DYS1 locus). With these diagnostic tools, 63 DNA samples from men with idiopathic 
oligozoospermia and 107 DNA samples from men with proven fertility were analysed for the presence of the 
complete DAZ gene locus, encompassing the four DAZ gene copies. In five oligozoospermic patients, we found a 
DAZ-SNV/STS and DYSl/EcoRV and Taql fragment deletion pattern indicative for deletion of the DAZ1 and DAZ2 
gene copies; one of these deletions could be identified as a 'de-novo' deletion because it was absent in the DAZ 
locus of the patient's father. The same DAZ deletions were not found in any of the 107 fertile control samples. We 
therefore conclude that the deletion of the DAZ1/DAZ2 gene doublet in five out of our 63 oligozoospermic patients 
(8%) is responsible for the patients' reduced sperm numbers. It is most likely caused by intrachromosomal 
recombination events between two long repetitive sequence blocks (AZFc-Repl) flanking the DAZ gene structures. 
Key words: AZFc/DAZ deletions/DAZ-SNVs/male infertility/oligoazoospermia 
Introduction 
The Deleted in Azoospermia (DAZ) gene family is located in 
the distal euchiomatic part of the long arm of the human Y 
chromosome (Yq 11.23) in the so-called azoospermia factor c 
(AZFc) region (Vogt, 1998; Saxena et ai, 2000). It has been 
transposed to the Y chromosome during primate evolution 
after the divergence of the New World and Old World monkeys, 
i.e. 35X106 years ago (Shan et ai, 1996; Seboun et ai, 1997). 
The ancestor gene DAZ-Like 1 (DAZL1) is located on the short 
arm of chromosome 3 (3p25). DAZ and DAZL1 are transcribed 
exclusively in the germ line and encode RNA binding proteins 
of the highly conserved RNA-recognition motif (RRM) class 
(Burd et al, 1996). 
The DAZL1 gene is an essential master gene for the pre-
meiotic development of male and female germ cells (Ruggiu 
et al, 1997; Houston et al, 1998). The function of the DAZ 
genes in germ cells is not yet known. Human DAZ proteins 
have been found in late spermatids and in sperm tails 
(Habermann et al, 1998), and in spermatogonia and spermato-
cytes (Reijo et al, 2000), and a DAZ transgene can partially 
rescue the pathological phenotype of a DAZL1 knock-out 
mutant in the mouse (Slee et al, 1999). This suggests that 
the DAZ genes are functional at different phases of human 
spermatogenesis and might have evolved to improve or extend 
specifically the male germ line function of DAZL1 in Old 
World monkeys. However, deletion of the complete DAZ gene 
family in humans is compatible with the formation of mature 
spermatozoa, although only in small numbers; severe oligozoo-
286 © European Society of Human Reproduction and Embryology 
spermia is the primary phenotype (Vogt, 1998) and rare cases 
exist where complete DAZ deletions have been transmitted 
from father to son (Vogt et al, 1996; Kleiman et al, 1999). 
Comparative nucleotide mutation rates in DAZ exon and intron 
sequences have also led to the assumption that the Y-located 
DAZ gene family plays only a limited role in human spermato-
genesis (Agulnik et al, 1998). 
An association between specific DAZ gene mutations and a 
particular testicular pathology is still lacking, because all AZFc 
deletions described so far remove not only all of the DAZ 
genes, but also all other Y gene families which have been 
mapped to the AZFc interval (Lahn and Page, 1997; Vogt, 
1998). Like the DAZ gene family, all these genes are expressed 
in testicular tissue only and therefore are also AZFc candid-
ate genes. 
The number and structure of the DAZ gene copies on the 
human Y chromosome is assumed to be variable in different 
men, ranging between three and seven gene copies (Yen et al, 
1997; Gláser et al., 1998; Saxena et al, 2000) and the structures 
of the DAZ genes in the GenBank BAC sequences (Tilford 
et al., 2001) have been proposed to be similar to those present 
in the DAZ-BACs isolated by Saxena et al. (Saxena et ai, 
2000). However, their detailed structures are not yet described. 
We assumed that these structures may be different because the 
BACs from GenBank were cloned from a different male donor 
(RPCI-11-donor) (Osoegawa et al., 1998) than the one used 
to clone the BACs isolated by Saxena et al. (CTA/CTB-donor) 
(Saxena et al, 2000; Shizuya et ai, 1992). We therefore 
assembled a contig of 44 RPCI-11-BAC sequences from the 
GenBank data base, covering the complete AZFc region 
(4.94Mb, AZFc-BAC contig) and analysed the structures of 
the DAZ genes in this contig in detail. Only the DAZ1 gene 
structure was found to be identical to that proposed by Saxena 
et al. in the CTA/CTB BAC sequences (Saxena et al, 2000). 
Substantial differences were found in the repetitive exon 
regions of the DAZ2, DAZ3 and DAZ4 genes structures. In the 
AZFc RPCI-11-BAC contig, the molecular distance between 
the two identified DAZ gene doublets was estimated to be 
1.47 Mb. 
Based on the DAZ gene sequences of the RPCI-11-ZX4Z-
BACs, we established a gene copy specific marker analysis 
with six ZMZ-single nucleotide variants (SNVs) and two DAZ-
sequence tagged sites (STSs). Presence or absence of a specific 
DAZ gene copy could be correlated with the presence or 
absence of a specific set of SNV alleles and/or STS markers 
{DAZ deletion haplotype). This SNV/STS deletion analysis 
was confirmed by a deletion analysis of DAZ gene copy 
specific £coRV and Taql restriction fragments of the DYS1 
locus (Ngo et al, 1986) in DNA blot experiments. The DYS1 
DNA locus includes the repetitive DAZ exon 7 regions (Vogt 
et al, 1997). 
We used this analysis to investigate the presence of putative 
DAZ gene deletions in the Y chromosomes of 63 infertile men 
with idiopathic oligozoospermia and of 107 men with normal 
fertility. In five oligozoospermic patients, we found DAZ-
SNV/STS and DYSl-£coRV/7açI fragment deletion patterns 
indicative for deletion of the DAZ1 and DAZ2 gene copies, 
one of which could be identified as a 'de-novo' deletion event 
DAZ1/DAZ2 gene deletions and severe oligozoospermia 
because it was absent in the DAZ locus of the patient's father. 
Since the same DAZ deletion haplotype was not found in any 
of the 107 fertile control samples, we assume that the deletions 
of the DAZ1IDAZ2 gene doublet in five of our 63 oligozoo-
spermic patients (8%) is the causative agent for the patients' 
reduced sperm numbers. 
Materials and methods 
Selection of oligozoospermic patients and the fertile men group 
We first selected 77 infertile patients with a clinical diagnosis of 
idiopathic oligozoospermia, i.e. gonadal epididymal and prostatic 
abnormalities and testis tumours were excluded in all patients. Their 
sperm numbers ranged between 0.1 and 10X106 per ml of seminal 
fluid. Sperm motility and morphology were found to be below the 
World Health Organization reference values (World Health Organiza-
tion, 1999) for spermatozoa with normal fertilization capacity. All 
patients were also analysed for the presence of a normal karyotype, 
46XY, and for the absence of Yqll microdeletions using the STS 
marker set which we established previously for the detection of 
complete AZFa, AZFb and AZFc deletions (Vogt et al, 1996). Using 
gene-specific STSs we also analysed each patient for a possible 
deletion of other AZFc candidate genes. According to these criteria, 
63 of the 77 patients were found to be 'normal'. Only these individuals 
were included in our DAZ gene copy specific deletion analysis 
(OZ samples). 
The fertility status of 107 fertile men (designated as 'FM samples') 
was proven by the fact that they had fathered one or more children. 
In addition, the normal reproductive status of 51 Danish FM controls 
(italic numbers in Table III) was confirmed by a normal sperm count 
(>20X 106 per ml semen fluid), normal motility and morphology and 
normal levels of inhibin B, testosterone, LH and FSH according to 
the guidelines of the World Health Organization. 
SNVs/STSs PCR assays for partial DAZ deletions 
Of the six Z)AZ-SNVs and two DAZ-STS listed in Table I, three 
SNVs (I, IV, VI) and the two STSs specific for the detection of the 
DAZ1 and DATA genes (DAZ-RRM3) and the DAZ3 gene (Y-DAZ3) 
were novel. Their primer sequences and respective PCR conditions 
were deposited in Genbank (accession numbers: Table I). The PCR 
reactions were performed in a 25 ul reaction volume with IX PCR 
buffer (Gibco-BRL, Life Technologies GmbH, Karlsruhe, Germany), 
2.5 mmol/1 MgCl2 (SNV III, IV, Y-DAZ 3) or 2.0 mmol/1 MgCl2 
(SNV I, II, V, VI, DAZ-RRM3), 0.2 mmol/1 dNTPs, 1 IU Taq DNA 
polymerase (Gibco) and 100 ng of genomic DNA. For the STS 
analyses, we developed multiplex PCR assays, containing two internal 
positive controls, one for the SRY locus (sY14) and one to confirm 
the proposed DAZ1/DAZ4 deletions (sY152), analysed also by DAZ-
RRM3 STS. Genomic DNA samples from a fertile male and a female 
were used as positive and negative controls respectively in each PCR 
experiment. The DNA sample from the fertile man controls the 
sensitivity and specificity of each performed PCR assay, whilst the 
female DNA sample controls the Y specificity of the used primer 
pairs. In addition, a water sample containing all components except 
genomic DNA was run with each set of primers in order to detect 
any possible reagent contamination. 
The PCR reaction profile (for Biometra T-Gradient Personal Cycler) 
was as follows: 35 PCR cycles with a pre-soak for 3 min at 94°C, 
denaturation for 1 min at 94°C, annealing for 1 min at the annealing 
temperature specific for each primer pair, with a subsequent polymeriz-
ation step of 1 min at 72°C and, at the end, a final extension step of 
3 min at 72°C. The PCR products (5 Ul aliquots for SNVs and 15 ul 
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Table I. DÂZ-SNVs and STSs, with different alleles in DAZ1-DAZ4 gene copies 
DAZ-SNVs DAZ gene GenBank SNV restriction DAZ gene SNV Restricted 
region accession no. enzyme copy" allele3 fragments (bp) 
I 5' UTR-exonl G73167 Fspl 1,2,3 
4 
A 
B 
709 
398+311 
n exon 3-exon 4 G73163 Mbol 1 2,3,4 
A 
B 
182 
122+60 
IH (sY586) intron 7A/B G63907 Taql 2 
1,3,4 
A 
B 
301 
184+117 
IV intron 7H G73168 Alul 2 
1,3,4 
A 
B 
630 
398+262 
V (sY587) intron 9 G63908 Dm I 3,4 
1,2 
A 
B 
195+49 
122+73+49 
VI 3' DAZ G73169 Afim 1,2,3 
4 
A 
B 
431 
248 + 183 
DAZ locus DAZ gene GenBank BAC clone(s) in Presence in Anneal. PCR product 
STSs region accession no. DAZ locus contig DAZ copy temp. (°C) (bp) 
DAZ-RRM3 DAZ1+4 
intron 6bb 
G73171 BAC140H23; AC053490 
BAC539D10; AC006338 
1+4 66 473 
Y-DAZ3 3' DAZ G73170 BAC290O03; ACO10089 3 66 260 
DAZ1+A DAZ1+4 G12002 BAC140H23; AC053490 1+4 66 125 
(sY152) intron 6ab BAC539D10; AC006338 
sY14 SRY G38356 - Control 66 470 
"STS/SNV alleles 
bIntron 6a and 6b 
in bold letters and numbers mark their specificity for one DAZ gene copy. 
are proximal (a) and distal (b) to exon 7G only present in 10.8 kb repeat in DAZ1 and DAZ4 (Figure IB). 
aliquots for STSs) were analysed on agarose gels stained with 
ethidium bromide. GeneRuler™ 100 bp DNA ladder-plus (Gibco) 
was used as molecular size marker. A positive result for STS markers 
was indicated by the presence of the respective fragment on the gel. 
For the subsequent SNVs analyses, the restriction digestions with the 
enzymes listed on Table I were performed in a 25 u.1 reaction volume 
with the appropriate IX buffer (MBI-Fermentas GmbH, St Leon-
Rot, Germany for SNV II, III, IV, V and New England Biolabs 
GmbH, Frankfurt, Germany for SNV I and VI), 10 units of each 
enzyme and 20 u.1 of the PCR solution. Incubations were for 2 h at 
37°C, except for Taql digestion which was performed at 65°C. The 
digests (25 (J.1 aliquots) were analysed on agarose gels (2 or 3% 
depending on the fragment size obtained for each SNV; Table I) and 
stained with ethidium bromide (see Figure 2). 
Southern blot analysis 
A total of 8 u.g of purified genomic DNA were digested with 
2.5 IU/(i.g of the restriction enzyme £coRV or Taql (MBI). The 
fragments were separated by electrophoresis on 0.8% agarose gels 
(LE-SeaKem; FMC® Bioproducts, Rockland, Maine, USA) and 
transferred to nylon membranes (Hybond-N+; Amersham Pharmacia, 
Freiburg, Germany) by vacuum or capillary blot. Filters were UV-
cross-linked (1200 J) and baked at 80°C for 2 h. These were 
pre-hybridized for 2 h and hybridized overnight at 65°C in Church 
buffer [7% sodium dodecyl suphate (SDS), 0.5 mol/1 NaHP04, 
1 mmol/1 EDTA, pH7.2] in roller bottles. The probe used was the 
2.8 kb EcoRl fragment of plasmid p49f, gel-purified and labelled 
with 32P dCTP by random priming. After overnight hybridization, 
filters were washed for 30 min at 65°C in 2Xstandard saline citrate/ 
0.1% SDS and exposed for 1-6 days at -70°C with Kodak XAR 
films and intensifying screens (REGO) for visualization of the 49f 
cross-hybridizing genomic DNA fragments by autoradiography. 
Sequence analysis 
For sequence homology analysis in the National Center for 
Biotechnology Information (NCBI) and GenBank databases, restric-
tion mapping and multiple alignment analysis, we used the HUSAR 
software package of die German Cancer Research Centre, Heidelberg 
(http://genome.dkfz-heidelberg.de/biounit). Database searches with 
the BLAST programs of the NCBI (http://www.ncbi.nlm.nih.gov) for 
the identification of the exon-intron structures of each DAZ gene 
copy were performed with a complete cDNA sequence of the DAZ2 
gene (CT351Y, Genbank AF414184) using the universal splicing 
rules. The AZFc BAC contig was established by identifying first the 
BAC clones containing the AZFc border STSs: sY142 (BAC400I17) 
and sY167 (BAC557B9). Then inspection of the overlap data provided 
by GenBank were used to collect the internal 41 AZFc RPCI-11 
BACs and assemble them in the unique order shown in Figure 1A. 
Only BACs with certified sequences (i.e. all regions were covered 
by sequences from more than one subclone and the assembly was 
confirmed by restriction digest) were selected. The sequence assembly 
of the RPCI-11-DAZ BAC contigs shown in Figure IB was used to 
construct the restriction maps of EcoRV, Taql and Mlul in the genomic 
DAZ gene structures. 
Results 
Mapping and structure of four DAZ gene copies in the 
RPCI-11-AZFc BAC conûg 
For the development of a DAZ gene copy specific deletion 
analysis, the knowledge of the detailed structure of each DAZ 
gene copy in the RPCI-11-BAC sequences was an essential 
prerequisite. We therefore screened the GenBank database 
with the complete DAZ cDNA sequence CT351Y (GenBank 
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accession no. AF414184) to identify all DAZ-RPCI-11-BAC 
clones. Seven DAZ-BACs were identified: 26D12 (163948 
bp; GenBank accession no. AC006982); 70G12 (180345 bp 
GenBank accession no. AC006983); 140H23 (103432 bp 
GenBank accession no. AC053490). 263A15 (168639 bp 
GenBank accession no. AC007039); 289L7 (199458 bp 
GenBank accession no. AC010088); 290O3 (103356 bp 
GenBank accession no. AC010089) and 539D10 (186838 bp 
GenBank accession no. AC006338). They were assembled in 
two small contigs of the large AZFc contig which we con-
structed by a successive analysis of the GenBank sequence 
overlap data of 44 RPCI-11 BAC sequences (i.e. 4.94 Mb; 
Figure 1A). The AZFc contig starts with the BAC400I17 
sequence, containing the STSs sY142 (DYS230, GenBank 
accession no. G38345; sequence position: 3068-3268) and 
sY143 (DYS231; GenBank accession no. G38347; sequence 
position: 3074-3506). Both STSs have been identified as 
markers of the proximal AZFc border line (Simoni et al., 
1999). The contig ends with the BAC557B9 sequence, which 
contains STS sY167 (DYS248; GenBank accession no. 
G12008; sequence position: 98016-98132). This STS is present 
in the Y chromosome of all our patients with an AZFc deletion 
(43 individuals) and therefore was designated as a marker for 
the distal AZFc border line (S.Fernandes and K.Huellen, 
unpublished results). Within this AZFc sequence, 1.39 Mb 
distal to sY142, the DAZ-contig containing BACs 289L7, 
140H23, 263A15 and 70G12 was mapped proximal to the 
DAZ-contig including BACs 290O3, 26D12, 539D10 with a 
molecular distance of -1.47 Mb between them (Figure 1A). 
The proximal DAZ-BAC contig contains two DAZ gene 
copies with a 3'-5':: 5 ' -3 ' head-to-head orientation, a similar 
structure as found earlier in one of the DAZ-BAC contigs 
extracted from the CTA/CTB BAC libraries (Saxena et ai, 
2000). We therefore used the same nomenclature and desig-
nated them as DAZ1 starting with its 3' end in BAC289L7 
and DAZ2 ending with its 3' end in BAC70G12 (Figure IB). 
DAZ7 contains three tandem repeats of 10.8 kb, including 
exons 2-6 and a tandem repetitive structure of nine exon 7 
copies. Nine sequence variants of exon 7 have been found in 
testicular DAZ cDNAs (Vogt et ai, 1997; Yen et ai, 1997). 
According to the nomenclature of Yen et al. we named them 
A, 5, C, D, E. F, X, K Z with the Y variant as the most 
prominent consensus sequence (Yen et ai, 1997). Eight variants 
are found in DAZ1 and organised in the order: 5' -B-C-D-E-F-
E-X-Y-Z-3' (Figure IB). Since identical repetitive exon 7 
structures linked to a triplicated DAZ exon 2-6 domain have 
been found in testicular DAZ cDNAs (Saxena et al, 2000), 
we can assume that the DAZ1 gene is transcribed in human 
testis. Two additional exon 7 sequence variants with normal 
splicing signals were found in intron 6 of the first and second 
10.8 kb repeat (exon 1G variant; in DAZ7: BAC140H23 
sequence position: 39936-40007 and 50781-50852) and one in 
the intron 8 sequence (exon 1H variant; in DAZ1: BAC140H23 
sequence position: 2563-2634) of the genomic DAZ gene 
structures (Figure IB). However, no DAZ cDNA sequence 
from human testis tissue has yet been found to include one or 
both of these DAZ exon 7 variants. DAZ7 transcripts spliced 
with these variants must therefore be rare or not found in 
testis tissue. 
The DAZ2 gene structure maps to three overlapping BAC 
sequences. Typical for DAZ2 is the presence of the A variant 
and absence of the B variant in the repetitive exon 7 structure 
next to six tandem Y variants (Figure IB). DAZ2 transcripts 
with this exon 7 variant structure have been found in testicular 
DAZ cDNA sequences (Yen et al, 1997; Saxena et al., 2000), 
our cDNA screening probe CT351Y being one example 
(GenBank accession no. AF414184). This indicates that the 
DAZ2 gene is also transcribed in human testis tissue. However, 
there have been no reports of DAZ2 testis transcripts containing 
a duplicated E-F variant motif and an exon ID variant flanked 
proximal by exon IX or distal by exon IE, as would be 
predicted by the genomic DAZ2 sequence in BAC263A15 
(Figure IB). Such DAZ2 transcripts might therefore be rare or 
do not exist. Alternatively, an artifact of the sequence assembly 
programmes used for the construction of the genomic 
BAC263A15 sequence might have produced this exon 7 variant 
composition. The structure of the DAZ2-BAC sequence from 
the CTB library (BAC352E14) contains an A and seven tandem 
Y variants in the repetitive exon 7 structure, but the duplicated 
E-F motif found in the RPCI-11 BAC263A15 sequence was 
absent (Saxena et ai, 2000). 
In the distal region of the AZFc contig (Figure 1A), 1.47 Mb 
distal to the 3'end of DAZ2, the sequence of BAC290O3 
contains the third DAZ gene copy, followed by the overlapping 
BACs 26D12 and 539D10 with the fourth DAZ gene copy 
(Figure IB). Both have a similiar 3'-5':: 5 '-3 ' head-to-head 
Figure 1. (A) Schematic view of the AZFc RPCI-11 BAC contig between the STS loci sY142 and sY167 (i.e. 4.94 Mb). Their continuous 
overlap was guaranteed by GenBank data and our own BLAST2 alignments of the proposed overlapping end fragments. BAC428D10, 
including the DYZ1 border of the Yql2 heterochromatin, overlapped with the distal AZFc border sequence in BAC557B9 (shown at the 
right). The GenBank accession number of each BAC sequence (blue colour) is given above the corresponding BAC clone (red colour). The 
location of the two DAZ gene doublets and the underlying BAC clones are marked in green. A long repetitive sequence block (AZFc-Repl. 
grey arrow) with the same polarity was identified proximal to DAZ] and DAZ3. The molecular distances between the STSs sY142 and 
sY 167 and the DAZ1/DAZ2 and DAZ3/DAZ4 gene doublets were estimated by summarizing the length of all BACs spanning the gap and 
subtraction of their overlaps. (B) Detailed view of the two DAZ-BAC contigs for inspection of their different exon structures described in 
detail in the text. The numbers above each exon (see colour code on the right) correspond to their extension in the underlying BAC 
sequence. For clarity, these numbers were omitted for the densely spaced exon 3-5 regions. The letters above the exon 7 variants 
correspond to the nomenclature given by Yen et al. (Yen et al., 1997) with the exception of the G and H variants. These exons were not 
found in testicular DAZ transcripts. The locations and extensions of the DYS1 EcoRV and Taq\ fragments identified as specific for one DAZ 
gene copy (see text) are drawn in red and blue respectively, below each contig. The contigs are drawn to scale with a 20 kb gap in the DAZ 
promoter regions. The locations of STSs, sY152 and (ZMZ)-RRM3 in DAZ] and DAZ4. Y-DAZ3 in DAZ3, and the A and B alleles of the 
six DAZ- SNVs (I-Vl a/b) in each DAZ copy are marked with orange arrows. 
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orientation as found for the DAZ3 and DAZ4 gene structures 
extracted from the CTB-BAC library (Saxena et al, 2000). 
However, substantial differences were found in their repetitive 
exon structures. 
Typical for DAZ3 in the CTB-BAC132B16 sequence was 
the absence of the Y variants and a triplication of the E-X 
motif in the repetitive exon 7 structure (Saxena et al., 2000). 
This was also found in the DAZ3 gene of the RPCI-11-
BAC290O3 sequence (Figure IB). However, two additional 
exon 7 variants (E and F) in the CTB-DAZ? gene were not 
present in DAZ3 of the RPCI-11-BAC. Since testicular DAZ 
cDNA sequences with both exon 7 variant compositions have 
been found (Yen et ah, 1997), we can assume that the repetitive 
sequence region of the DAZ3 gene structure can be variable 
on different Y chromosomes, as marked here by the presence 
or absence of the exon 7 E-F motif. 
The DAZ4 gene structure in the RPCI-11 BAC539D10 
sequence is substantially different from that of DAZ4 in the 
CTB-BAC546E5 sequence. Both DAZ4 genes were recognised 
by their 10.8 kb repeat unit; however, three copies of this 
large repeat unit were found in the RPCI-11-DAZ4 gene and 
only two 10.8 kb repeats were found in the CTB-DAZ4 gene 
(Saxena et ai, 2000). The number and composition of the 
exon 7 variants in both DAZ4 genes was also different. We 
found 15 exon 7 copies with the composition 5'-B-C-D-E-F-
E-X-E-X-Y-Y-Y-Y-Y-Z-3' in the RPCI-11-DAZ4 gene, whereas 
only nine exon 7 repeats with the composition 5'-B-C-D-E-F-
E-X-Y-Z-3' were identified in the DAZ4 gene of the CTB-
BACs (Saxena et al., 2000). Testicular DAZ cDNAs with an 
exon 7 variant structure typical for the RPCI-11-DAZ4 structure 
(i.e. B variant linked to five tandem Y variants) have been 
described by Yen et al. (Yen et ai, 1997), although complete 
DAZ4-cDNAs with 15 exon 7 copies, linked to a triplicated 
10.8 repeat, have not yet been isolated. 
Establishment of a DAZ gene copy specific deletion analysis 
DAZ gene copy specific sequence variants (SNVs) and STSs 
DAZ gene locus restriction maps and sequence analyses have 
shown that the genomic structures of the four DAZ genes 
present in the AZFc region are more than 99% homologous 
to each other (Saxena et al, 1996, 2000; J.Zeisler and 
S.Fernandes, unpublished results). For the identification of 
DAZ gene copy specific deletion events, our search for DAZ 
copy specific markers along the complete gene sequences 
therefore first focused on a systematic identification of small 
sequence variants, including specific restriction sites (DAZ-
SNVs) and copy-specific DAZ-STSs in the RPCI-11-DAZ-BAC 
sequences. We established six DAZ-SNVs (I-VI) spanning the 
5' to the 3' end of these DAZ gene sequences and two DAZ 
gene copy-specific STSs (DAZ-RRM3, Y-DAZ3; Table I). We 
would like to acknowledge the work of our colleagues who 
first identified the SNV in intron 3 of the DAZ1 gene (Agulnik 
et al, 1998) and in intron 7A of the DAZ2 gene (sY586) 
(Saxena et al, 2000). Because both were also found in the 
RPCI-11-DAZ-BAC sequences, we included them in our SNV 
marker set as DAZ-SNV II and DAZ-SNV III respectively. We 
also included the sY587 marker of Saxena et al as DAZ-SNV 
V for analysis of the Dral restriction site in the DAZ1 and 
DAZ2 genes (Saxena et al, 2000). 
Additionally, we established three novel DAZ-SNVs (SNV 
I, SNV IV, SNV VI). SNV I was identified 90 nucleotides 
upstream of the putative transcription initiation site of the DAZ 
genes with a polymorphic Fspl restriction site only present in 
DAZ4. SNV IV was found 1159 nucleotides downstream of 
DAZ exon IE with a polymorphic AM restriction site absent 
in DAZ2. SNV VI was found 480 nucleotides downstream of 
DAZ exon 10, where due to a 4 bp deletion (CCTG) at the 
3'end of DAZ4, an AflJll site was created. An extension of 
this deletion to eight nucleotides (TCCTGTAT) was identified 
at the 3' end of the DAZ3 gene and used for the development 
of a DAZ3 specific STS (Y-DAZ3). A second STS (DAZ-
RRM3) was established in the repeated intron 1-intron 6 
structure specific for DAZ1 and DAZ4. This marker is in the 
same intronic region as sY152 (Figure IB) declared earlier to 
be a marker for the DAZ1 and DAZ4 genes (Saxena et al, 
2000). However, we found the same sY152 primer pair 
sequences in the RPCI-11 DAZ2 and DAZ3 gene sequences 
(3' to exon 7A and IB respectively) with only three internal 
mismatches in the forward primer. Therefore, we often obtained 
false positive amplification products in our PCR experiments 
and developed the DAZ-RRM3 STS as a more stringent 
alternative for the identification of the DAZ1 and DAZ4 gene 
copies using our PCR multiplex conditions. All novel DAZ-
SNVs and STSs including the optimal PCR conditions were 
deposited in GenBank (accession numbers in Table I). 
On the Y chromosome of men with normal fertility, we 
expect the presence of four DAZ gene copies to be indicated 
by the presence of A and B alleles for each of the six DAZ-
SNVs as well as the presence of the STSs DAZ-RRM3 and 
Y-DAZ3, as shown in Figure IB. Absence of all DAZ markers 
would indicate the absence of the complete DAZ gene family 
on the Y chromosome. The deletion of a specific DAZ gene 
copy would then be recognized by the absence of specific 
SNV A or B alleles associated with a particular DAZ gene 
copy and the deletion pattern of the DAZ-RRM3 and Y-DAZ3 
STSs (Figure IB), i.e. by a specific DAZ deletion haplotype. 
In this way, we propose 13 specific DAZ deletion haplotypes 
(DAZ-del-haps), each one indicative for the deletion of a 
specific set of DAZ gene copies (Table II). 
DAZ gene deletions in men with severe oligozoospermia and 
in men with proven fertility 
We analysed the presence of each of the 13 DAZ-del-haps in 
the genomic DNA samples of 63 men with severe oligozoo-
spermia (OZ samples) and of 107 men with proven fertility 
(FM samples). All OZ samples had a normal karyotype, 46XY, 
and Yqll microdeletions analysed with the STS marker set 
established previously for the detection of complete AZFa, 
AZFb and AZFc deletions (Vogt et al., 1996) were not 
detectable. Four DAZ-del-haps (#2, 4, 5, 9) could be identified. 
Surprisingly, most of them were found in both groups (i.e. 
fertile and infertile men) with similar frequencies (Tables III 
and IV). DAZ-del-hap 2, indicative for a deletion of DAZ2, 
was found in 26 FM samples (Table III) and in eight OZ 
samples (Table IV) and is associated with the absence of the 
B allele for SNV VI, which would suggest an additional 
deletion in the distal part of DAZ4 including the SNV VI Afllll 
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Table II. Thirteen ZMZ-deletion haplotypes are specified by eight DAZ SNV/STS markers 
DAZ gene deletions SNVI SNVII SNvni SNVIV SNV V SNV VI DAZ-RRM3 Y-DAZ3 DAZ del. haplotype 
DAZ1 A+B B A+B A+B A+B A+B + + 1 
DAZ2 A+B A+B B B A+B A+B + + 2 
DAZ3 A+B A+B A+B A+B A+B A+B + - 3 
DAZ4 A A+B A+B A+B A+B A + + 4 
DAZ1+DAZ2 A+B B B B A A+B + + 5 
DAZ1+DAZ3 A+B B A+B A+B A+B A+B + - 6 
DAZ1+DAZ4 A B A+B A+B A+B A - + 7 
DAZ2+DAZ3 A+B A+B B B A+B A+B + - ;-; 
DAZ2+DAZ4 A A+B B B A+B A + + 9 
DAZ3+DAZ4 A A+B A+B A+B B A + - 10 
DAZ1+DAZ2+DAZ3 B B B B A B + - 11 
DAZ1+DAZ2+DAZ4 A B B B A A - + 12 
DAZ2+DAZ3+DAZ4 A A B B B A + 13 
Letters marked in bold indicate the presence of deletions. 
Table III. DAZ-del-hap analyses in DNA samples of 107 men with proven fertility 
SNV I SNV II SNV III SNV IV SNV V SNV VI DAZ-RRM3 Y-DAZ3 FM samples 
A+B A+B A+I A+B A+B A+B 
DAZ-del-hap 2 and derivatives 
A+B A+B 
A+B A+B 
A+B A+B 
A+B A+B 
A+B ** A+B 
B 
B 
B 
A+B 
A+B 
A+B 
A+B 
B 
B 
A+B 
A+B 
A+B 
A+B 
A+B 
A+B 
A 
A+B 
A 
DAZ-del-hap 4 and derivatives 
A A+B 
A A+B 
A+B A+B 
A+B 
A+B 
A+B 
A+B 
A+B 
A+B 
A+B 
A+B 
A+B 
A 
A+B 
A 
DAZ-del-hap 9 and derivatives 
A 
A 
A+B 
A+B 
A+B 
B 
B 
A+B 
A+B 
B 
A+B 
A+B 
A+B 
+ 
+ 
A 
A 
39,40 
ll,13,25,27,37,2i 
2,15,26 
16,S 
25 
30 
14 
3 
'Italic numbers indicate the 51 Danish controls who had confirmation of a normal sperm parameter. 
Letters marked in bold indicate the presence of deletions. 
N 
1,4,5,6,7,10,17,20,23,28,31,33,34,38,41,4248,49,50,54, 50 
55,56,57,58,4,5,6,9,11,13,14,15,16,17,18,19,28,29,30,31, 
32,33,34,37,42,43,44,45,46,47l 
+ 9,12,18,19,29,36,46,47,53,60,i,2,7,i0,i2,20,22,24,2c5,5J> 25 
36,38,40,48,50 
52 1 
+ 8 1 
+ 22,32,59,27 4 
+ 51 1 
+ 3,24,44,61,23 5 
43, 45, 51 3 
restriction site (Figure IB). Derivatives of DAZ-del hap 2, i.e. 
absence of only the A allele of SNV III, or only the A allele 
of SNV IV (with or without absence of the B allele of SNV 
VI and absence of the Y-DAZ3 STS marker), were also 
identified in both groups of men (Tables III and IV). A similar 
pattern of SNV and STS deletion events was also observed in 
both sample groups for DAZ-del hap 4 (indicative for deletion 
of DAZ4) and DAZ-del-hap 9 (indicative for deletion of DAZ2 
and DATA) (Tables III and IV). It strongly suggests that these 
DAZ deletions are not associated with the occurrence of the 
oligozoospermic phenotype in the OZ individuals, but are most 
likely familial variants, inherited from father to son. We were 
able to confirm this by also finding DAZ-del-hap 2 in the 
fathers of FM 46 and FM 53 and DAZ-del-hap 4 in the father 
of FM 39. 
Contrasting with these results, we found a deletion of the 
DAZ1 gene linked to a deletion of the DAZ2 gene (i.e. 
DAZ-del-hap 5; Table II) in only five DNA samples of the 
oligozoospermic men (OZ 5, 20, 35, 65 and 73; Table IV; 
Figure 2). Two of them (OZ 20, 35) additionally displayed 
absence of the A allele for SNV I and of the B allele for SNV 
VI (Figure 2). This would indicate additionally partial deletions 
in the 5' region of the DAZ3 gene and in the 3' region of the 
DAZ4 gene. In OZ 5, we also found a deletion of the DAZ-
RRM3 marker (Table IV), which would suggest that the 
internal part of the repetitive DAZ4 RRM region (location of 
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Figure 2. ZMZ­SNV analyses of genomic DNA samples with ZMZ­del­hap 5 (OZ 5, OZ ­20, OZ ­35, OZ ­65 and OZ ­73). The A allele 
was defined as not restricted and the B allele as restricted (two fragments). The C fragment in SNV V (49 bp) was constant in all samples 
analysed. The fragment lengths for each SNV are given in bp on the right side of the pictures. The father of OZ 5 has both alleles for all 
SNVs tested, as did the male control sample. For further details see text. 
Table IV. DAZ­del­hap analyses in genomic DNA samples of 63 oligozoospermic men 
SNVI SNVII SNV HI SNV IV SNVV SNV VI DAZ­RRM3 Y­DAZ3 OZ samples N 
A+B A+B A+B A+B A+B H A+B + + 
DAZ­del­hap 2 and derivatives 
2,3,4,9,11,14,18,22,26,29,30,32,33,34,36,38,40, 
41,43,45,46,48,49,50,51,55,56,59,61,68,69,71 
32 
A+B A+B B B A+B A + 
A+B A+B B A+B A+B A + 
A+B A+B A+B B A+B A+B + 
A+B A+B A+B B A+B A + 
DAZ­del­hap 4 and derivatives 
+ 1,15,23,42,52,57,63,77 
+ 17,21 
+ 66 
+ 13,44,47,53 
24,27,54,62,64 
+ 39,67 
+ 25,37,58 
A A+B A+B A+B A+B A+B + 
A+B A+B A+B A+B A+B A + 
DAZ­del­hap 9 and derivatives 
A A+B B A+B 
DAZ­del­hap 5 and derivatives 
A+B 60 
+B B B B A A+B + + 65,73 
+B B B B A A+B ­ + 5 
B B B A A + + 20,35 
Letters marked in bold indicate the presence of deletions. 
the DAZ-RRM3 marker; Figure IB) is absent in this patient 
in addition to the deletion of the DAZ1 and DAZ2 genes 
(Table IV). DAZ­del­hap 5 occurred in five of our 63 OZ 
samples (8%). It could be shown as a 'de­novo' mutation 
event in the family of OZ 5 as the father of OZ 5 displayed 
the same complete DAZ­SNV pattern as our fertile male 
control (Figure 2). Our request for a genomic DNA sample 
from the fathers of OZ 20, 35, 65 and 73 was unsuccessful 
because they were deceased or did not want to collaborate. 
The alternative use of DNA samples from fertile brothers was 
not possible either, because no brothers were present in 
these families. 
Specific DYSl-EcoRV and -Taql DNA blot patterns in men 
with DAZ gene deletions 
We found that the deletion of single DAZ gene copies could 
also be identified by DYS1­DNA blot experiments after 
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restriction digest of genomic DNA samples with EcoRV and 
Taql. A detailed DAZ gene copy specific restriction analysis 
on the sequences of the RPCI-11 -DAZ BAC contigs revealed 
that EcoRV restriction fragments specific for DAZ1 and DAZ4 
and Taql restriction fragments specific for DAZ2 and DAZ3 
were present in the repetitive DAZ gene regions (Figure IB). 
They are part of the well-known DYS1 locus (Ngo et al, 
1986) because they cross-hybridize with the DYS1 cognate 
fragment 49f (subclone from cosmid 49) (Bishop et al, 1984). 
Our sequence analysis identified 49f as an EcoRl fragment of 
the DAZ1 gene, starting 5' in intron 3 of the third DAZ1 RRM 
domain (BAC140H23 sequence position: 34027) and ending 
3' in DAZ1 intron 7B (BAC140H23 sequence position: 31181; 
Figure IB; GenBank accession no. AF414183). 
From these findings, we expect a deletion of the DYS1-
EcoRV fragments 10845 and 10843 bp to be associated with 
a deletion of the DAZ1 gene, and a deletion of the 7327 bp 
DYSl-£coRV fragments to be associated with a deletion of 
the DAZ4 gene (Figure IB). Similarly, a deletion of the DYS1-
Taql fragment of 3112 bp should be associated with a deletion 
of the DAZ2 gene, and a deletion of the DYSl-Taql fragment 
of 19612 bp should be associated with a deletion of the DAZ3 
gene. The MM restriction patterns identified as specific for 
each DAZ gene copy by Saxena et al (Saxena et al, 2000) 
could not be used for genomic DAZ gene deletion analysis, 
because the methylation of most MM sites in the genomic DAZ 
DNA inhibited restriction (S.Fernandes, unpublished results). 
Examples with relevant DNA blot experiments using gen-
omic DNA samples of patients with DAZ-del-hap 5 are shown 
in Figure 3A. A deletion of the DAZ1 and DAZ2 genes was 
confirmed in all DAZ-del-hap 5 samples by absence of the 
DAZ1 -specific 10.8 kb-£coRV and the DAZ2-specific 3.1 kb-
Taql fragments of the DYS1 locus. Interestingly, both OZ 5 
and his father displayed additionally a familial deletion of 
DAZ4, detected through the absence of the DAZ4-specific 
7.3 kb EcoRV fragment in both DNA samples (Figure 3A). 
This familial DAZ4 deletion includes most likely the entire 
repetitive DAZ4 gene structure, as the signal intensities of the 
5 and 2.4 kb EcoRV fragments are weak in comparison with 
the normal male control (Figure 3A). These two DYSl-£coRV 
fragments are not gene copy-specific but span the repetitive 
DAZ exon 7 structure in each DAZ gene. The presence of the 
DAZ4-specific B alleles of SNV I and SNV VI in OZ 5 and 
his father (Figure 2), marking the 5' and 3' end of the DAZ4 
gene, suggests that the DAZ4 deletion in this family is partial. 
We also performed a DYS1 blot analysis for some DNA 
samples of men with DAZ-del-hap 2 (FM 18, OZ 1 and 15; 
DYSl-Taql) and DAZ-del-hap 9 (FM 16, OZ -60; DYSl-Taql 
and EcoRV). We confirmed a deletion of DAZ2 through 
absence of the DAZ2-specific 3.1 kb Taql fragment in all of 
them (Figure 3B), but we could not identify a deletion of the 
DAZ4-specific 7.3 EcoRV fragment in FM 16 and OZ 60. 
Discussion 
Thanks to the Human Genome Sequencing project, it was 
possible to cover the genomic Y sequence of the AZFc region 
with a contig of 44 BAC sequences and to estimate its 
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molecular extension to be 4.94 Mb (Figure 1A). This starts at 
STS sY142 and ends at STS sY167 in distal Yqll.23. sY167 
was mapped not >100 kb proximal to the DYZ1 border of 
the Yql2 heterochromatin, found in BAC428D10 (Figure 1A). 
A similar BAC contig of the AZFc region was recently 
published by Kuroda-Kawaguchi et al (Kuroda-Kawaguchi 
et al, 2001). Their data completely confirm the correct 
assembly of our AZFc-B AC contig in Figure 1. They extended 
this analysis by additional iterative alignment processes and 
revealed a unique repetitive and palindromic AZFc sequence 
structure along 93% of its length. 
AZFc deletions are the most common known genetic cause 
of human male infertility and are found in different human 
populations with a rate of -10^ (Vogt, 1998). In spite of this, 
it is not yet known whether the Y gene families mapped to 
this chromosomal region, and which are expressed exclusively 
in testicular tissue (Lahn and Page, 1997; Vogt, 1998; Kuroda-
Kawaguchi et al, 2001) are indeed essential for human 
spermatogenesis. Gene-specific deletions or point mutations 
have not been reported in any of the proposed AZFc candidate 
genes. Therefore it has been proposed that the observed AZFc 
testicular pathology might only be caused by deletion of the 
entire AZFc gene content of the human Y chromosome 
(Vogt, 1998). 
In this paper, we present strong experimental evidence that 
this might not be the case since we found that, in five of 63 
OZ individuals, deletions of the DAZ1/DAZ2 gene doublet are 
most likely associated with an oligozoospermic phenotype 
similar to that observed after deletion of the entire AZFc 
region. Our results are a major step towards the solution of 
the frequently discussed enigma on the function of the different 
DAZ gene copies in human spermatogenesis. 
Variable numbers of DAZ gene copies in the AZFc region 
of men with proven fertility? 
The number and structure of the DAZ genes on the human Y 
chromosome has been assumed to be variable, in a range 
between three and seven gene copies (Yen et al, 1997; Glãser 
et al, 1998; Saxena et al, 2000). We did not find more than 
four DAZ gene copies in the RPCI-11 BAC library, nor the 
presence of truncated DAZ pseudogenes. The Y chromosome 
of the RPCI-11 BAC-library donor should therefore contain 
four DAZ gene copies. They were mapped as DAZ1IDAZ2 and 
DAZ3IDAZ4 doublets in the middle of the 4.94 Mb AZFc 
BAC contig with a distance of 1.47 Mb between them (Figure 
1A). This genomic AZFc structure was first proposed in the 
AZFc duplication model by Kirsch et al. (Kirsch et al, 1996). 
The presence of four DAZ genes in AZFc with the same 
doublet structure was first found by Saxena et al., although 
with different repetitive exon 7 domains in DAZ2, DAZ3 and 
DAZ4 (Saxena et al, 2000). We also found the four copy gene 
structure found on the Y chromosome of the RPCI-11 donor 
in 50 of our 107 fertile control individuals and in 32 of our 
63 OZ samples, i.e. in 48% of the samples analysed. That is 
indicated by the same DAZ-SNV and STS patterns (Tables III 
and IV). Therefore, we predict that the 4-DAZ-gene pattern 
found in the RPCI-11-DAZ-BACs represents the most common 
DAZ gene structure in Caucasian male populations. 
DAZ1/DAZ2 gene deletions and severe oligozoospermia 
DAZ-del-hap 5 ZMZ-del-hap 2 
J 
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Figure 3. DYSl­£coRV and -Taql DNA blot DAZ deletion analyses with the DYS1 cognate probe 49f. (A) Example of an EcoRW DNA 
blot from oligozoospermic men identified with DAZ­del­hap 5 (OZ ­20, OZ 5). DAZ1 deletion is indicated by absence of the DAZ7­specific 
10.8 kb EcoRY fragment (see also Figure IB). The same DYSl­£coRV deletion pattern was observed in OZ ­35, OZ ­65 and OZ ­73. A 
familial DAZ4 gene deletion in OZ 5 and his father was identified by the additional deletion of the 7.3 kb EcoRY fragment in both DNA 
samples. The DYSl­ra^I blot of OZ 5 and his father shows the de­novo deletion of DAZ2 in OZ 5, indicated by absence of the 3.1 kb Taql 
fragment only in the OZ 5 DNA sample. The same DYSl-Taql deletion pattern was found for all other OZ samples with DAZ­del­hap 5. 
(B) DYSl-Taql blot deletion pattern of OZ 1 (DAZ­del­hap 2) and FM 16 (DAZ­del­hap 9). A deletion of DAZ2 is indicated by absence of 
the 3.1 kb DYSl-Taql fragment. The same DYSl-Taql deletion pattern was found for FM 18 and OZ 15 (DAZ­del­hap 2) and OZ 60 (DAZ-
del­hap 9). In the lanes of OZ 1 and FM 16, different intensities of the autoradiographic signal are due to different DNA amounts. 
Molecular lengths of the X-HindJll marker that was used are given on the left. : , 
In addition, our DAZ­deletion analyses suggest that at least 
in some individuals with DAZ­del­hap 2, two of our two 
sample groups (FM and OZ ), the DAZ copy number is reduced 
to three by deletion of the DAZ2 gene copy (Figure 3B). The 
presence of only three DAZ gene copies on the Y chromosome 
of some fertile men was first proposed by Yen et al. (Yen et al, 
1997). We could not perform a Taql-DYS1 blot experiment with 
all DNA samples carrying the DAZ­del­hap 2 listed in Tables 
III and IV, because the DNA amount was insufficient and a 
request for a second genomic DNA sample was not possible; 
for ethical reasons most fertile male samples had to be collected 
anonymously, since these individuals had no health problem. 
We were unable to confirm the additional deletion of DAZ4 
in FM 16 and OZ ­60 with DAZ­del­hap 9, since the DAZ4-
specific 7.3 kb EcoRV fragment of the DYS1 locus was present 
in both DNA samples. DNA samples with DAZ­del­hap 4, 
indicative for deletion of only DAZ4, were found in the fertile 
men exclusively (Table III). For the practical reasons given 
above, DYS1 blot experiments were not possible for these 
individuals. However, the D AZA deletion in the father of OZ 
5 (Figure 3A) and in the father of FM 39 strongly suggests 
that DAZ4 deletions are common variants in the normal fertile 
male population and are not associated with the occurrence of 
male infertility. 
Our DAZ­SNV/STS analyses also suggest that the B alleles 
of SNV I and VI in DAZ4 are polymorphic. Although they 
are present in the DAZ4 gene of the RPCI­11­donor and of 88 
individuals in our two sample groups (Tables III and IV), 
absence of the B allele of SNV VI was found, independently 
from absence of the B allele of SNV I, in all DNA samples 
with DAZ-del-hap 2 and in three FM ­DNA samples with 
DAZ­del­hap 4 (FM 2, 15, 26). Absence of the B allele for 
SNV I was found, independently from absence of the B allele 
of SNV VI in six FM and two OZ samples of DAZ­del­hap 4 
(Tables III and IV). Similar derivatives of DAZ­del­hap 2 (i.e. 
absence of the A allele of only SNV III, or of only SNV IV) 
were found in FM and OZ samples as well (Tables III and 
IV). We therefore conclude that in DNA samples where the 
deletion of DAZ2 or DATA could not be confirmed by appro­
priate DYS1 blot experiments, most probably familial gene 
conversion events occurred between the highly homologous 
DAZ gene copies (<99%) in the DAZ locus of the Y chromo­
some in these families. Gene conversion events, especially 
within the DAZ2 and DAZ4 gene structures, would easily 
explain the complex pattern of derivatives which we observed 
for DAZ­del­hap 2, 4 and 9 in both groups of men. Similar 
conclusions were drawn recently for other human gene loci, 
based on an unexpected linkage disequilibrium between closely 
spaced SNP markers (Ardlie et al., 2001). Obviously, gene 
conversion events prevent the identification of a specific DAZ 
copy deletion by only SNV/STS analyses and the additional 
analysis by DYS1 blot experiments is required. 
We do not think that our findings would be improved 
by additional fibre­fluorescence in­situ hybridization (FISH) 
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experiments, because FISH probes including the repetitive 
DAZ gene regions can also result in an over-estimation of the 
number of DAZ gene copies (Saxena et ai, 2000) and FISH 
probes specific for each DAZ gene copy cannot be created 
because of their high sequence homology (<99%). Moreover, 
irrespective of whether real DAZ deletions or simple SNV/ 
STS polymorphisms due to gene conversion events had led to 
the derivatives of the DAZ-del-hap 2, 4, 9 classification in a 
portion of our FM and OZ samples, both molecular events 
would not interfere with the men's fertility, as they were found 
in both sample groups. 
Only DAZ1/DAZ2 deletions were associated with severe 
oligozoospermia 
A possible link of a specific DAZ-deletion haplotype specific 
to the occurrence of the patients' oligozoospermic phenotype 
was found only for the OZ samples with DAZ-del-hap 5, 
pointing to a deletion of the DAZ1 and DAZ2 gene copies in 
the Y chromosome of these men. These were confirmed by 
the DYS1-DNA blot analysis (Figure 3A). DAZ-del-hap 5 was 
not found in the DNA samples of 107 fertile men nor in the 
father of OZ 5 (Figure 2, 3A). We therefore assume that not 
only in OZ 5, but in all OZ samples with DAZ-del-hap 5, the 
DAZ1IDAZ2 deletions are most likely 'de-novo' mutation 
events, i.e. restricted to the DAZ locus of the patient. A 
spermatogenic influence of the DAZ4 deletion in the OZ 5 
family can be excluded because the father of OZ 5 was 
reported to have normal fertility (J.Gonçalves, personal com-
munication). No other AZFc STS deletions nor the deletion 
of any other AZFc candidate genes were identified in the Y 
chromosome of the DAZ-del-hap 5 patients, although small 
deletions or point mutations in the other AZFc candidate genes 
cannot yet be excluded. 
Our extensive analyses of DAZ gene copy specific restriction 
fragments in the RPCI-11 DAZ-BAC contigs (Figure IB) were 
only successful for the repetitive DYS1-DAZ gene regions. 
The exact molecular extensions of the indicated DAZ1IDAZ2 
gene deletions could therefore not be estimated. However, 
absence of the DAZi-specific DYSl-EcoRV fragments in all 
DAZ-del-hap 5 patients includes a deletion of at least two of 
the DAZ1 RNA binding domains (RRM) in exons 2-5 (Figure 
IB). A distortion of the putative DAZ1 germ line-specific 
RNA binding function is therefore expected. The most probable 
explanation for the occurrence of the oligozoospermic pheno-
type in OZ 5, 20, 35, 65 and 73 is therefore the deletion of 
the entire DAZ1IDAZ2 gene doublet in all of them. 
Putative molecular mechanisms for the DAZ gene deletions 
in the AZFc region 
Our comparison of the DAZ gene structures, of the RPCI-11 
donor with that of the CTA/CTB donors described by Saxena 
et al. reflects a dynamic structure, especially of the DAZ2, 
DAZ3 and DAZ4 gene copies, but not of the DAZ1 gene copy 
(Saxena et al, 2000). We found that the DAZ gene doublets 
DAZ1IDAZ2 and DAZ3IDAZ4 are located in two palindromic 
sequence domains, separated by a distance of 1.47 Mb (Figure 
1A). The observed dynamic rearrangements which distingu-
ished the DAZ2, DAZ3 and DATA gene copies of the CTA7 
CTB- and the RPCI-11 donors, as well as the proposed gene 
conversion events discussed above, might therefore be caused 
by the structural-specific organization in the genomic region 
of both DAZ gene doublets and/or of the entire AZFc sequence, 
now shown to be composed of massive palindromes in 93% 
of its length (Kuroda-Kawaguchi et al., 2001). Palindromes 
and inverted repeat structures in the genome are generally 
known to induce local instabilities which depend on their 
lengths and repetitive sequence contents. Local rearrangements 
increasing their asymmetry could stabilize them (Zhou et al., 
2001). In the DAZ1/DAZ2 and DAZ3/DAZ4 palindromes, this 
could explain the amplification of RRM domains in only DAZ1 
and DAZ4 and the variable structure of the repetitive exon 7 
in DAZ2, DAZ3 and DAZ4. 
Deletions of the DAZ7 gene alone were found neither in 
our fertile men nor in our infertile men, but only in combination 
with the DAZ2 gene. We therefore assume that molecular 
mechanisms inducing the observed DAZ1/DAZ2 gene deletion 
events are most likely based on the nature of their unique 
palindromic sequence structure or on the recombination of 
homologous repetitive sequence blocks flanking the DAZ1/ 
DAZ2 gene doublet (Chen et ai, 1997). Intrachromosomal 
recombination events of two repetitive 10 kb sequence blocks 
in proximal Yqll were recently found to be causative agents 
for the occurrence of most AZFa deletions (Kamp et al, 2000; 
Sun et al., 2000). Long homologous repetitive sequence blocks 
were also found around the DAZ genes. Two long repetitive 
blocks (AZFc-Repl, Figure 1) in the same polarity and with 
a surprisingly high sequence homology (<99%), starting in 
BACSCS^and BAC160O2 (respectively positions 134890 and 
50000) and extending to the 3'ends of the DAZ1 and DAZ3 
gene respectively, were easily identified by BLAST alignment 
(Figure 1A). Their molecular lengths were estimated from the 
AZFc-BAC contig sequence to be 368 (DAZI-AZFc-Repl) 
and 320 kb (DAZ3-AZFc-Repl). Different amplifications of 
the human (3-sateUite 68 bp repeat unit (Waye et al, 1989) 
explain their length differences. Intrachromosomal recombina-
tion events between these two AZFc-Repl blocks would delete 
not only the DAZI gene, but also the entire DAZ2 gene, as 
demonstrated in our five OZ samples with DAZ-del-hap 5. 
We also found a considerable extension of the palindromic 
inverted repeats wherein the DAZ1/DAZ2 and DAZ3/DAZ4 
gene doublets were embedded. These structures would certainly 
also promote a deletion of the complete gene doublets (Zhou 
et al, 2001). 
The presence of the long repetitive AZFc-Repl sequence 
block with the same polarity upstream of the DAZ1/DAZ2 and 
DAZ3/DAZ4 gene doublets respectively was confirmed by the 
work of Kuroda-Kawaguchi et al. (Kuroda-Kawaguchi et ai, 
2001). In their paper, the AZFc-Repl blocks are the green 
AZFc amplicons, gl and g2. A third homologous amplicon, 
g3, but with an opposite polarity, was found 3' downstream 
of the DAZ3/DAZ4 gene doublet .(Kuroda-Kawaguchi et al., 
2001; Figure 1 in that paper). Based on this palindromic AZFc 
sequence structure, we indeed expect that a deletion of the 
complete DAZ1/DAZ2 gene doublet can be caused by intrachro-
mosomal recombination events between the AZFc-Repl blocks 
as shown in Figure 1, or, as a second possibility, between the 
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AZFc amplicons bl and b3 (Kuroda-Kawagucbi et al., 2001). 
DAZ1/DAZ2 deletions caused by bl/b3 recombination events 
would be indicated by the absence of two AZFc-STSs: 
DYS227/sY139 (GenBank accession no. G12002) mapped 
to AZFc-u2 (S.Fernandes, unpublished results) and sY1192 
(GenBank accession no. G67166) mapped to AZFc-u3 
(Kuroda-Kawaguchi et al, 2001). DAZ1/DAZ2 deletions 
caused by AZFc-Repl (or gl/g2) recombination events would 
be indicated by absence of the PI.2 amplicon of the AZFc-
yellow-palindrome (Kuroda-Kawaguchi et ai, 2001). There-
fore, for the analysis of AZFc-Repl recombination events we 
established a novel SNV in the AZFc-Pl.l/P1.2 amplicons 
(AZFc-yellow-palindrome-SNV I; GenBank accession no. 
G73351). Only AZFc-P1.2 located between gl/g2 has the A 
allele and AZFc-Pl.l has the B allele (Ddel restriction site; 
S.Fernandes, unpublished results). 
We exclude a bl/b3 recombination event as a causative 
agent for the proposed complete deletion of the DAZ1/DAZ2 
gene doublet in the OZ samples with DAZ-del-hap 5 (OZ 5, 
.20, 35, 65 and 73) because STS sY139 and sY1192 were 
found to be present in all these DNA samples. However, 
absence of the A- allele for SNV I of the AZFc-yellow-
palindrome was noted in OZ 5 and OZ 65, indicating deletion 
of AZFc-Pl.2. This confirms our assumption of a AZFc-Repl 
recombination event as the causative agent for a complete 
deletion of the DAZ1/DAZ2 gene doublet in these OZ samples. 
Interestingly, the three other OZ samples with DAZ-del-hap 5 
(OZ 20, 35 and 73) displayed a deletion of the SNV I B allele 
of the AZFc-yellow-palindrome, suggesting a deletion of the 
Pl. l amplicon in these samples. Although not yet proven, we 
speculate that in the Y chromosome of these three OZ families 
both AZFc-yellow amplicons (Pl.l and P1.2) have an inverted 
orientation when compared with that in the AZFc sequence of 
the Y chromosome of the RPCI-11 donor (Kuroda-Kawaguchi 
et ai, 2001). If this holds true, we can suggest that a general 
reference for the AZFc sequence as proposed by Kuroda-
Kawaguchi et al. might not exist (Kuroda-Kawaguchi et al, 
2001) and that in the OZ 20,35 and 73 samples, a recombination 
event between the AZFc-Repl blocks has caused a complete 
deletion of the DAZ1/DAZ2 gene doublet, as indicated by 
absence of the B allele of the AZFc-yellow-palindrome SNV I. 
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Note Added in Proof 
Recently, a reduced number of DAZ gene copies in subfertile and 
infertile men has also been reported by de Vries et al. (2002, Fértil. 
Steril., 77, 68-75), using DAZ-SNV deletion and ZMZ-Fibre-FISH 
experiments. Surprisingly, the Fibre-FISH experiments did not support 
their SNV deletion analyses and Fibre-FISH was also not able to 
distinguish between the deletion of one DAZ gene copy and the 
deletion of a complete DAZ gene cluster (DAZI/DAZ2 or DAZ3/ 
DAZ4, respectively). To confirm partial DAZ gene deletions, the use 
of D YS1 blot experiments instead of Fibre-FISH, as proposed in this 
paper, is therefore strongly recommended. 
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Human spermatogenesis is regulated by a network of genes located on autosomes and on sex chromo-
somes, but especially on the Y chromosome. Most results concerning the germ cell function of the Y 
genes were obtained by genomic breakpoint mapping studies of the Y chromosome of infertile pa-
tients. Although this approach has the benefit of focussing on those Y regions that contain most 
likely the Y genes of functional importance, its major drawback is the fact that fertile control samples 
were often missing. In fertile men, molecular and cytogenetic analyses of the Y chromosome has 
revealed highly polymorphic chromatin domains especially in the distal euchromatic part (Yqll.23) 
and in the heterochromatic part (Yql2) of the long arm. In sterile patients cytogenetic analyses 
mapped microscopically visible Y deletions and rearrangements in the same polymorphic Y regions. 
The presence of a Y chromosomal spermatogenesis locus was postulated to be located in Yqll.23 
and designated as Azoospermia Factor (AZF). More recently, molecular deletion mapping in Yqll 
has revealed a series of microdeletions that could be mapped to one of three different AZF loci: 
AZFa in proximal Yql 1 (Yql 1.21), AZFb and AZFc in two non-overlapping Y-regions in distal Yql 1 
(Yqll.23). This view was supported by the observation that AZFa and AZFb microdeletions were 
associated with a specific pathology in the patients' testis tissue. Only AZFc deletions were associated 
with a variable testicular pathology and in rare cases AZFc deletions were even found inherited from 
father to son. However, AZFc deletions were found with a frequency of 10-20% only in infertile men 
and most of them were proved to be "de novo", i.e. the AZFc deletion was restricted to the patient's 
Y chromosome. Based mainly on positional cloning experiments of testis cDNA clones and on the Y 
chromosomal sequence now published in GenBank, a first blueprint for the putative gene content of 
the AZFc locus can now be given and the gene location compared to the polymorphic DNA domains. 
This artwork of repetitive sequence blocks called AZFc amplicons raised the question whether the 
AZFc chromatin is still part of the heterochromatic domain of the Y long arm well known for its 
polymorphic extensions or is decondensed and part of the Yqll.23 euchromatin? We discuss also the 
polymorphic DAZ gene family and disclose putative origins of its molecular heterogeneity in fertile 
and infertile men recently identified by the analyses of Single Nucleotide Variants (SNVs) in this 
AZFc gene locus. 
Key words: AZF locus; Yqll ; DAZ locus; chromatin folding code. 
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POLYMORPHIC HUMAN Y 
CHROMOSOME: NO GENES FOR 
SPERMATOGENESIS? 
Human spermatogenesis is regulated by a net-
work of genes located on autosomes and on the 
sex chromosomes, but especially on the Y 
chromosome. This has been known in Droso-
phila for nearly 80 years. In mammals it was 
revealed only recently, as it was hidden by the 
sex determination function of the Y chromo-
some. However, the human Y chromosome 
seemed to be an exception because its chroma-
tin structure has a highly variable length (1). 
This length polymorphism could be mapped to 
the long Y arm after staining the chromosomes 
with quinacrine (Fig. 1) (2). The length of the 
fluorescent chromatin block is constant in fam-
ily pedigrees and therefore useful as a family 
marker. Despite of these large Y chromosomal 
rearrangements, no effects on the fertility 
statues of these men have ever been reported, 
even when the fluorescent Y marker was com-
pletely absent indicating large deletions in Yq. 
This was unexpected since in other chromo-
somes deficiencies or duplications of only small 
segments most often led to severe phenotypic 
damages. Consequently, the human Y chromo-
some was first considered to be only functional 
for sex determination but would have no genes 
for spermatogenesis. 
AZOOSPERMIA FACTOR (AZF) IN Yqll 
IS GENETICALLY SPLIT IN 3 
SUBINTERVALS (AZFa, AZFb, AZFc) 
A straight-forward strategy for the identifi-
cation of protein encoding Y genes with a puta-
Fig. 1. The human Y chromosome has a variable 
staining pattern with quinacrine marking the distal 
long arm with different intensities (2). 
tive function in spermatogenesis would be the 
isolation of Y chromosomal cDNA clones and 
the study of their expression profiles in human 
testis tissue. However, in human the isolation of 
testis tissue for experimental reasons is usually 
not possible because humans are not experi-
mental species. Therefore, most results support-
ing a germ cell function of the human Y 
chromosome were first collected from genomic 
breakpoint mapping studies of the Y chromo-
some of sterile patients. Cytogenetic analyses 
mapped microscopically visible deletions and 
rearrangements of the Y chromosome found in 
sterile patients always in Yqll (3, 4). This Y 
deletions were characterised by a complete ab-
sence of the fluorescent heterochromatin. Mon-
ocentric Yq-chromosomes, dicentric double Y 
chromosomes (iso-Yp), Y with a ring structure 
(ring-Y), or translocation of the Y to an auto-
some were most often identified (Fig. 2). A 
polymorphic Y rearrangement in the patients' 
families were excluded because the Y chromo-
somes of their fathers had a normal fluorescent 
heterochromatin block. These Y deletions could 
therefore be associated with the occurrence of 
the men's infertile phenotypes (5). Most of them 
were azoospermic, meaning that no mature 
sperm cells were detectable in their semen fluid. 
Tiepolo and Zuffardi (1976) therefore desig-
nated this Y fertility factor as Azoospermia 
Cytogenetic analyses of Y abnormalities 
found de novo only in infertile men 
46,X,Yq-f 46,X,r(Y) 
(45,X0) 
B. 
46, X,dicYp 
(45,X0) 
J p 46,X,t(Yqll-pter; 
D. 
Yp 
autosome 
Fig. 2. Cytogenetically analysed Y chromosomal re-
arrangements and deletions observed in men with 
idiopathic sterility. Breakpoint-fusion-regions of each 
of these Y chromosomal rearrangements include part 
of the euchromatic part of the Y-long arm (Yql 1). 
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Factor (AZF) and mapped it in the distal part 
of the euchromatic Yqll region, the G-light 
band Yql 1.23, flanking the heterochromatic 
chromatin block, since the fluorescent hetero-
chromatin domain was expected to be genetic-
ally inert. Nevertheless, because of the observed 
polymorphic deletion events observed in Yq in 
fertile men (see Fig. 1), for a long time nobody 
believed in a functional AZF locus on the poly-
morphic Y long arm and it was considered to 
be impossible to distinguish Y chromosomal 
variabilities which are indeed associated with 
disruption of an essential Y chromosomal AZF 
locus. 
A novel and more promising approach to-
wards the location and identification of the pro-
posed AZF locus was introduced then by the 
analyses of molecular microdeletions in the Y 
chromosomes of sterile men with a normal 
karyotype (46,XY). In the first large sample 
study using this molecular approach, deletion 
mapping in Yql 1 revealed a series of microdele-
tions which all of them could be mapped to one 
of 3 different genomic Y regions (6). Since they 
were only observed in men with azoospermia or 
severe oligozoospermia and were not present in 
the patients' fathers, it was proposed that not 
only one but at least 3 AZF loci are present in 
Yqll: AZFa in proximal Yqll (Yql 1.21), 
AZFb and AZFc in two non-overlapping Y-re-
gions in distal Yqll (Yql 1.23) (Fig. 3). This 
view was supported by the observation that 
AZFa and AZFb microdeletions were associ-
ated with the occurrence of a specific pathology 
in the patients' testis tissue. Complete AZFa de-
letions were always associated with a complete 
absence of germ cells also called Sertoli-cell-
only (SCO) syndrome. Complete absence of 
AZFb was always associated with a meiotic 
maturation arrest, i.e. spermatogonia and sper-
matocytes were present in the patients' testis tu-
bules in normal amounts but postmeiotic germ 
cells were completely absent. Only AZFc de-
letions in distal Yqll were associated with a 
variable testicular pathology and in rare cases 
AZFc deletions were found to be inherited from 
father to son. Since AZFc was located near the 
polymorphic heterochromatic Y chromatin 
block, it was first argued that the patient's 
AZFc deletion was indeed not associated with 
the occurrence of infertility in this patient but 
would be one of the polymorphic deletion 
events encompassing different lengths of the 
flanking heterochromatic Y-DNA. However, 
AZFc deletions are now known as the most 
common genetic lesion found in men with azoo-
spermia or severe oligozoospermia in a fre-
quency of 10-20%. Moreover, most of them 
were proven to be "de novo", i.e. most AZFc 
deletions were restricted to the patient's Y 
chromosome (7-9). 
The fact that each Y microdeletion was part 
of the AZF locus functional in human sperma-
togenesis became obvious after the molecular 
isolation and structural characterisation of its 
gene content. A first rough estimation of the de-
leted DNA length in the 3 AZF loci ranged be-
tween 1-3 million nucleotides (6), thus large 
enough to accommodate more than one sper-
matogenesis gene in each of them. And this is 
exactly the case. Based on the knowledge of the 
Y chromosomal sequence, now published in 
GenBank (10) and extensive testes cDNA 
screening programs (11-13). a first blueprint for 
the putative gene content of each AZF locus can 
be given (Fig. 3): AZFa contains 2 Y genes 
(USP9Y and DBY), AZFb 7 Y genes (CDY2. 
EIF1AY, PRY, RBMY1, SMCY, TTY5. 
TTY6), and AZFc 7 Y genes (BPY2, CDYl. 
CSPG4LY, DAZ, GOLGA2LY, TTY3, TTY4). 
First the RBMY gene family in AZFb was des-
ignated as the most significant AZF gene (14). 
secondly than the DAZ gene family became en 
vogue although first identified only as a single 
copy gene in AZFc (15). However, as it is now 
obvious that multiple genes expressed in testis 
tissue were present in each AZF locus, the desig-
nation of the RBMY or DAZ genes as the only 
AZF genes can not be preserved anymore and 
each Y gene of the AZF loci should be con-
sidered as a similar strong candidate for the Y-
AZF function. 
Only the identification of gene-specific muta-
tions found in men with a distinct testicular 
pathology are suited to reveal the functional 
state of each of these AZF-Y genes in human 
spermatogenesis. In AZFa. a 4bp deletion in the 
splice-donor site of exon 8 of USP9Y was iden-
tified as "de novo" mutation in one patient with 
spermatid arrest (16). This suggests a functional 
contribution of USP9Y\o human spermatogen-
esis, but as the AZFa pathology, a complete 
SCO syndrome, did not occur in this patient, 
the DBY gene or other genetic factors in AZFa 
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Human Y chromosome 
AZFa USP9Y 
DBY 
Testicular histology associated 
with complete AZF deletions: 
// CDY2,EIF1AY 
I AZFb PRY, RBMY, SMCY, 
AZFc BPY2, CDY1, CSPG4LY 
DAZ, GOLGA2LY 
TTY3, TTY4 
SCO 
SMA 
Variable histology: 
focal spermatogenesis 
Low sperm count 
SCO-tubules 
Fig. 3. Three different microdeletions in Yql 1 found "de novo" in men with idiopathic infertility split the AZF 
locus in AZFa associated with the occurrence of a complete Sertoli-cell-only-syndrome (SCO), in AZFb associ-
ated with the occurrence of a complete spermatocyte arrest (SMA) and in AZFc associated with the occurrence 
of a variable testicular pathology. In each AZF microdeletion a series of genes were identified expressed in 
human testis tissue. For their nomenclature and further details see Lahn & Page 1997; Vogt et al. 1997; Kawagu-
chi-Kuroda et al. 2001. 
must also contribute to the AZFa function. In 
AZFb, gene-specific mutations were found in 
the RBMY gene locus in infertile men but also 
in fertile men, revealing a polymorphic nature 
of the copy number of this gene family (17). In 
AZFc, gene specific mutations are difficult or 
even impossible to map because all AZFc genes 
have multiple copies with a 99.9% sequence 
homology (see below). 
In summary, it is now well established that 
the human Y chromosome is essential for sper-
matogenesis and it seems to have evolved a 
friendly harbour (i.e. the AZF locus) especially 
for genes expressed in.testis tissue. It is most 
likely that evolutionary benefits have selected 
this Y chromosomal location for the testis ex-
pressed genes probably because only the Y 
chromosome is male specific. Now it lost most 
of its ancient sequence domains homologous to 
the X chromosome and therefore the Y genes 
are protected from their lost by the decreasing 
rate of X-Y recombinations along most of the 
length of Yql 1. Since the mouse Y chromosome 
only contains homologues of the AZFa Y genes 
( Usp9y and Dby) and AZFb-Y genes (Smcy, Ei-
fayl, Rbm), the AZFc locus can be also con-
sidered as an evolutionarily very young Y sper-
matogenesis locus. All the ancestor genes of its 
gene families were transposed from different 
autosomes to the Y chromosome (13) probably 
first during evolution of the primates (18, 19). 
POLYMORPHIC AZFc STRUCTURE IN 
HUMAN Y CHROMOSOME 
Polymorphic lengths of the euchromatic part of 
the Y long arm (Yqll) were first reported 30 
years ago (20) and molecular Y DNA analyses 
have then mapped 2 DNA loci with polymor-
phic restriction fragments in AZFc (DYS1; 
DYS7). The genomic DNA locus DYS7 is rec-
ognised by the cognate probe 50f2, which cross 
hybridises to 5 genomic Y-DNA fragments (A-
E), after EcoRl restriction (21). 50f2/A,B was 
mapped to proximal Yp, 50f2/C to proximal 
AZFc, 50f2/D to the Y centromer and 50f2/E 
to AZFb (6). After analyses of 859 men from 
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Fig. 4. A. Schematic view of the AZFc RPCI­11 BAC contig between the STS loci sY142 and sY167 (i.e. 4.94 
Mb). Their continuous overlap was guaranteed by GenBank data and own BLAST2 alignments of the proposed 
overlapping end fragments. BAC428D10 including the DYZ1 border of the Yql2 heterochromatin overlapped 
to the distal AZFc border sequence in BAC557B9 (shown at the right). The GenBank accession number of 
each BAC sequence (blue colour) is given above the corresponding BAC clone (red colour). B. Schematic view 
on the repetitive amplicon structure of the AZFc BAC contig according to the colour code of Kawaguchi­
Kuroda et al. (2001). With aid of a series of novel STSs (see text) the authors were able to narrow the molecular 
extension of the AZFc locus to 4.5 Mb. SY1192 and sY1054 were always absent in men with AZFc deletions. 
The molecular lengths of the 3 palindromes (PI, P2, P3) identified in the repetitive Y amplicon structure are 
3Mb for PI, 270 kb for P2 and 990 kb for P3. For further details see text. 
46 different populations, absence of the 50Í2/C 
fragment was found in 55 of them and duplica­
tion was found in 8 men (22). Obviously, the 
genomic EcoRI fragment in AZFc designated 
as 50f2/C is part of a polymorphic deletion­in­
sertion DNA locus in AZFc. With knowledge 
of the AZFc sequence (see Fig. 4) 50Í2/C could 
now be mapped to proximal AZFc since some 
50Í2/C deletions were found to be associated 
with deletions of neighboured RBMYgem cop­
ies but not with DAZ gene copies. However, 
most polymorphic 50Í2/C deletions were re­
ported to be smaller not including other DNA 
loci (22). The frequency of 50Í2/C deletions is 
variable in the 12 human populations analysed 
and was found with the highest frequency in 
Finns: 11 of 20 men had this deletion (22). This 
suggests the occurrence of multiple founder de­
letions in the proximal AZFc locus including 
the 50Í2/C EcoRI fragment. 
Interestingly, the first interstitial microdele­
tion in Yql 1 supposed to be associated with the 
occurrence of germ cell aplasia in the patient's 
testis tubule was marked by a deletion of the 
polymorphic genomic 50Í2/C fragment (23). 
Obviously, at that time the authors were not 
aware of the 50Í2/C deletion polymorphism, al­
though they would have easily detected it, if 
their study would have included an analysis of 
the Y chromosome of the patient's father. 
The molecular structure of the AZFc locus is 
now established by a contig of 44 BAC clones 
in distal Y q l l with all the sequences published 
in GenBank (Fig. 4A). Between the STSs (Se­
quence Tagged Sites), sY142 and sY167, always 
present in men with AZFc deletions, the mol­
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ecular extension was roughly estimated in 4.94 
Mb (24). This was not only confirmed but also 
improved by similar deletion analyses with a 
series of novel STSs (sY1054, sY1192, sY1197, 
sY1125), which further narrowed the extension 
of the AZFc locus to 4.5 Mb (Fig. 4B). SY1192 
and sY1054 were always absent in men with 
AZFc deletions (13). The molecular extensions 
of AZFc deletions seem therefore to be rather 
uniform. With the aid of sophisticated BLAST 
alignment tools Timoko Kuroda-Kawaguchi 
was able to show that the complete AZFc se-
quence consists of a series of homologous large 
repetitive sequence blocks, which she designated 
as "amplicons" and which are mainly organised 
in two palindromes (Fig. 4B). Interestingly, this 
artwork of repetitive sequence blocks is com-
parable with the locus-specific repetitive se-
quence structures usually found in pericentrom-
eric heterochromatin domains of autosomes 
(25). Since the first DYZ1 block of the Yq 
heterochromatin block has been mapped im-
mediately adjacent to the distal border of AZFc 
(24), the question is now raised whether at least 
part of the chromatin structure of the AZFc lo-
cus is still part of the Yq heterochromatin block 
and not yet part of the decondensed euchromat-
in domain proposed earlier and marked by the 
G-light band called Yql 1.23 (4). 
Several earlier cytogenetic studies have dem-
onstrated that the heterochromatic chromatin 
domain on the distal long Y arm is not homoge-
neous, but that it consists of a complex suc-
cession of distinct subbands with a narrow gap 
in the middle of the fluorescent heterochromatin 
block (26). In C-banded prometaphases the Y 
chromosome is less condensed and up to five 
small chromatin domains could be dis-
tinguished (27). By restriction with the endo-
nuclease Taql, the proximal part of the Y-
heterochromatin could be differentiated from 
the distal part also indicating a different 
chromosome structure in the proximal Yq 
heterochromatin (28) and after incorporation of 
5-bromodeoxyuridine the same chromosome 
region stains differentially with quinacrine plus 
Giemsa (FPG) (29). Obviously that the hetero-
chromatic chromosome block of the human Y 
is not uniform and the possibility exists that the 
proximal heterochromatic chromatin domain 
distinguished by the earlier cytogenetic Y ex-
periments at least overlaps with the chromatin 
domain of the repetitive amplicon structure in 
the AZFc locus. The DNA structure of the 
AZFc locus can be also compared with the re-
petitive DNA structures found in the Y chro-
mosomal fertility genes of Drosophila. In all 
Drosophila species analysed so far, the Y 
chromosome is completely heterochromatic and 
the structures of the male fertility genes are 
composed of a complex organisation of repeti-
tive sequence blocks with a Y-specific "library 
code" comparable with that of the AZFc locus 
(30). This chromosome-specific so-called "li-
brary code" is a general and conserved struc-
tural feature of tandem repetitive sequence 
blocks and can be found in heterochromatic do-
mains of Drosophila, mouse and plant chromo-
somes as well (31). It was therefore proposed 
that the "library code" in tandem repetitive se-
quence blocks is an essential part of a highly 
conserved "chromatin folding code" (31). This 
folding code would be not only based on the 
DNA primary sequence, but also on the poten-
tial of this DNA sequence to form a specific 
helical secondary structure and on its potential 
to bind specific proteins which are needed to 
stabilise a locus-specific chromatin folding 
structure (32). 
We know now that complete AZFc deletions 
are caused after intrachromosomal recombi-
nations between the b2/b4 amplicons located in 
a distance of about 4.5 Mb in distal Yqll (13). 
However, more large repetitive sequence blocks 
with the same polarity exist in AZFc (Fig. 5). 
We therefore expect that intrachromosomal re-
combinations will also occur between gl/g2, rl/ 
r3 and r2/r4 amplicons. These partial AZFc de-
letions will not delete all gene copies of the 
AZFc gene families but onlv pan of them (F12. 
5). 
All homologous AZFc amplicons have a sur-
prisingly high sequence homology (>99.9° 0) 
which could be only distinguished by small se-
quence nucleotide variants (SXVs) and some se-
quence tagged sites (STSs). Such a high se-
quence homology suggests frequent sequence 
alignments and gene conversions between them. 
The formation of palindromic structures during 
some replication of the .AZFc DNA sequence 
would mediate these alignments by the inverted 
orientation of the duplicated 135 kb sequence 
block (rl/r2) in proximal .AZFc (P2 palindrome) 
and the duplicated and inverted 1.5 Mb se-
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Potential intrachromosomal recombinations in AZFc locus 
between amplicons with high homology (>99.9%) and the same polarity: 
b2 u3 gl r l r2 grl b3 P1.2 g2 r3 r4 g3 Pl.l b4 gr2 
Number of functional AZFc gene copies after 
recombinations and internal AZFc deletions 
b2/b4 
DAZ 0 
gl/g2 rl/r3 
2 7 
CSPG4LY 0 
GOLGA2LYB 
TTY3 0 
1 
Î 
1 
Fig. 5. Potential deletions in the AZFc locus due to intrachromosomal recombinations of four different am-
plicons organised in AZFc with the same polarity. The number of gene copies of each of the AZFc genes which 
are still present after occurrence of one of these AZFc deletions is listed on the right. Their colour code 
correpond to that of the AZFc amplicons where they were mapped by Kawaguchi-Kuroda et al. (2001). Note 
that only after deletion of the complete AZFc sequence (b2/b4 recombination) all AZFc genes are deleted. For 
further details see text. 
quence block in the distal AZFc sequence (PI 
palindrome) (Fig. 4B). 
POLYMORPHIC DAZ GENE 
STRUCTURE 
The DYS1 polymorphic DNA region in AZFc 
(DYS1) is now known to be part of the DAZ 
gene locus. The DAZ gene family was trans-
posed to the Y chromosome after divergence of 
New World Monkeys and Old World Monkeys, 
i.e. during primate evolution 35 million years 
ago (18, 19). It has been shown to originate 
from DAZL1 located on the short arm of 
chromosome 3 (3p25). Sequence analyses of the 
DYS1 cognate probe 49f, a 2.5 kb genomic Eco-
RI fragment of the Y chromosome has revealed 
that this fragment contains the exons 4, 5, 6 and 
7 of the DAZ1 gene copy (GenBank accesssion 
no. 414183). After restriction of genomic male 
DNA with Taql or Pvull and hybridisation 
with the 49f probe, a complex repetitive pattern 
of cross hybridising Y fragments was obtained 
(33, 34). Today we know that these lengths vari-
abilities are most likely due to a variable num-
ber of exon 7 copies in DAZ2, DAZ3, and 
DAZ4. When we compared structures of each 
DAZ gene copy, mapped in the 7 DAZ-BAC 
clones screened from the GenBank database 
(RPCI-11 BAC donor) (24) with the homo-
logous structures isolated from the BAC contig 
of two other male donors (CTA and CTB) (35) 
only the DAZ1 gene structure was conserved 
(Fig. 6). It contains 3 tandem repeats of 10.8 
kb including exon 2 till exon 6, encoding the 
functional RNA-Recognition Motif, RRM, be-
sides a tandem repetitive structure of 2.4 kb 
with nine exon 7 copies. According to the no-
menclature of Yen et al. (36) the sequence vari-
ants of exon 7 were designated as A, B, C, D, 
E, F, X, Y, Z with the Y variant as the most 
prominent consensus sequence. Eight variants 
were found in DAZ1 and organised in the order: 
5'-B-C-D-E-F-E-X-Y-Z-y (Fig. 6). Typical for 
DAZ2 is the presence of the A variant and ab-
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/ / F/g. 5. Detailed view on the exonstructures of the two Z>/4Z­doublets: DAZ1IDAZ2 and DAZ3IDAZ4 identified 
in the Y chromosome of the RPCI­11 man (BAC donor for GenBank BAC sequences) and the CTA/CTB men 
(BAC donors for CTA and CTAB BAC libaries; Saxena et al. 2000) for inspection of their different exon 
structures described in detail in the text. The letters above the exon 7 variants correspond to the nomenclature 
given by Yen et al. (1997) with exception of the G and H variants. These exons were not found in testicular 
DAZ transcripts. The contigs are drawn to scale with a 20 kb gap in the DAZ promoter regions. 
sence of the B variant in the repetitive exon 7 
structure besides 6 tandem Y variants (Fig. 6). 
DAZ2 transcripts with this exon 7 variant struc­
ture have been found in testicular DAZ cDNA 
sequences. However, no DAZ2 testis transcripts 
were reported containing a duplicated E-F vari­
ant motif as would be predicted by the genomic 
DAZ2 sequence in the RPCI­11 BAC donor. 
Such DAZ2 transcripts might therefore be rare 
polymorphisms or do not exist. The structure 
of the DAZ2-BAC sequence of the CTB library 
contains an A and 7 tandem Y variants in the 
repetitive exon 7 structure and the duplicated E-
F motif found in the RPCI­11 DAZ2 sequence 
is absent. 
Substantial differences were found in the re­
petitive exon structures of DAZ3 and DAZ4 
located in the r3/r4 amplicons in the distal 
AZFc region. Typical for DAZ3 on the Y 
chromosome of the CTB­donor was the absence 
of the Y variants and a triplication of the E-X 
motif in the repetitive exon 7 structure (35). 
This was also found in the DAZ3 gene of the 
RPCI­11­donor (Fig. 6). However, a E-F motif 
present in the CTB-DAZ3 gene was not present 
in DAZ3 of the RPCI­11 donor. Since testicular 
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DAZ cDNA sequences were found with both 
exon 7 variant compositions (see e.g. 36), we 
can assume that the repetitive exon7 region of 
the DAZ3 gene structure is polymorphic on dif-
ferent Y chromosomes and, therefore, a part of 
the polymorphic DYS1 locus. Another part is 
the DAZ4 gene structure which is substantially 
different in the Y chromosome of the RPCI-11-
donor and of the CTB-donor. Both DAZ4 genes 
are recognised by their 10.8 kb repeat unit 
(RRM-repeat), however, three copies of this 
RRM repeat were found in the RPCI-1 \-DAZ4 
gene and only two RRM repeats in the CTB-
DAZ4 gene (Fig. 6). The number and compo-
sition of the exon 7 variants in both DAZ4 
genes were also different. In the RPCI-11-
DAZ4 gene we found 15 exon 7 copies with the 
composition: 5'-B-C-D-E-F-E-X-E-X-Y-Y-Y-Y-
Y-Z-y whereas only 9 exon 7 repeats with the 
composition: 5'-B-C-D-E-F-E-X-Y-Z-V were 
identified in the DAZ4 gene of the CTB-BACs 
(Fig. 6). 
DELETION OF SINGLE DAZ GENE 
COPIES 
The polymorphic DAZ gene structures suggest 
that not all DAZ gene copies might have the 
same functional capacity for human spermato-
genesis and that the deletion of single DAZ gene 
copies as a familiar polymorphic deletion event 
in men with normal fertility can be expected. 
The DAZ gene locus restriction maps and se-
quence analyses have shown that the genomic 
structures of the 4 DAZ genes were more than 
99% homologous to each other. Therefore, be-
fore we could analyse putative DAZ gene copy 
deletions, we had to establish 6 ZUZ-Single-
Nucleotide-Variants (SNV I-VI) spanning the 
5' end till the 3' end of these DAZ gene se-
quences and 2 DAZ gene copy specific STSs 
(DAZ-RRM3, Y-DAZ3). The various deletion 
patterns of these SNV/STS markers distinguish 
each type of DAZ gene and defined deletion of 
one of the possible 13 DAZ deletion haplotypes 
(Table 1). On the Y chromosome of men with 
normal fertility, the presence of 4 DAZ gene 
copies is indicated by the presence of the A and 
B alleles for each of the 6 D,4Z-SNVs as well as 
the STSs DAZ-RRM3 and Y-DAZ3. Absence 
of all DAZ markers would indicate the absence 
of the complete DAZ gene family on the Y 
chromosome. 
When we analysed the presence of one of the 
13 Z)yáZ-deletion-haplotypes of Table 1 in the 
genomic DNA samples of 63 men with severe 
oligozoospermia (OZ samples) and of 107 men 
with proven fertility (FM samples) surprisingly, 
3 D^Z-deletion haplotypes were found in both 
men groups with similar frequencies (DAZ-del-
hap: 2, 4, 9) (24). These variabilities are there-
fore most likely polymorphic familiar variants 
in the DAZ gene locus of the Y chromosome of 
all men of the patients' pedigree. Interestingly, 
ZX4Z-del-hap 2, was always associated with ab-
sence of the B allele for SNV VI. Most likely, 
this is an additional gene conversion event for 
SNV VI in the DAZ locus of this men group, 
although a deletion of the distal part of DAZ4 
including the SNV VI AflUI restriction site can 
not be excluded without appropriate DNA blot 
DAZ gene deletions 
TABLE 1. 13 DAZ-deletion haplotypes are specified by 8 DAZ SNV/STS markers  
SNV I SNV II SNV III SNV IV SNV V SNV VI DAZ- Y-DAZ3 DAZ del. 
RRM3 haplotype 
DAZ1 A+B B A+B A+B A+B A+B + + 1 
DAZ2 A+B A+B B B A+B A+B + + 2 
DAZ3 A+B A+B A+B A+B A+B A+B + — 3 
DAZ4 A A+B A+B A+B A+B A + + 4 
DAZ1+DAZ2 A+B B B B A A+B + + 5 
DAZ1+DAZ3 A+B B A+B A+B A+B A+B + — 6 
DAZ1+DAZ4 A B A+B A+B A+B A — + 7 
DAZ2+DAZ3 A+B A+B B B A+B A+B + — 8 
DAZ2+DAZ4 A A+B B B A+B A + + 9 
DAZ3+DAZ4 A A+B A+B A+B B A + — 10 
DAZ1+DAZ2+DAZ3 B B B B A B + — 11 
DAZ1+DAZ2+DAZ4 A B B B A A — + 12 
DAZ2+DAZ3+DAZ4 A A B B B A + — 13 
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experiments. Absence of only the A allele of 
SNV III, or only the A allele of SNV IV (with 
or without absence of the B allele of SNV VI 
and absence of the Y-DAZ3 STS marker) was 
also identified in both men groups with the 
ZX4Z-deletion haplotype 2 (24). Although not 
yet proven, we like to suppose that the most 
easiest explanation for these variabilities are not 
local SNV microdeletions but frequent gene 
conversion events in the inverted rl/r2 am-
plicons probably mediated by the formation of 
the P2 palindrome as discussed above. Similar 
patterns of allelic SNV and STS deletion events 
were also observed for men with DAZ-del hap 
4 (indicative for deletion of DAZ4) and DAZ-
del-hap 9 (indicative for deletion of DAZ2 and 
DAZ4) in both men groups (24). Gene conver-
sion events are probably therefore also mediated 
by formation of the P2 palindrome in the r3/r4 
amplicons. If this holds true, we can take the 
observed variabilities of the allelic A and B pat-
terns in the SNVs of each DAZ gene copy as 
the first experimental indication that indeed 
palindromes are formed within the repetitive 
genomic DNA structure of the AZFc locus. 
Contrasting with these results we found a de-
letion of the DAZ1 gene linked to a deletion of 
the DAZ2 gene (i.e. Z)^(Z-deletion-haplotype 5) 
only in 5 DNA samples of the oligozoospermic 
men group (24). 
DAZ gene copy specific restriction fragments 
were only found for the DYS1 locus after re-
stricting the genomic DNA samples with EcoR 
V and Taq I (24). In this way, a deletion of the 
DAZ1 and DAZ2 genes was confirmed in all 
samples with D^Z-del-hap 5 and we could 
show, that this deletion is most likely due to an 
intrachromosomal recombination event be-
tween the gl/g2 amplicons in AZFc as suspected 
in Fig. 5. One copy of the AZFc genes: BPY2, 
CDY1, CSPG4LY, GOLGA2LY, TTY3 and 
TTY4 should then be included in this partial 
AZFc deletion (Fig. 5). However, in contrast to 
the polymorphic structures of the DAZ genes, 
all these AZFc genes have an identical exon 
structure in each of their gene copies. A deletion 
of only one of their copies after a gl/g2 based 
partial AZFc deletion is therefore not expected 
to contribute significantly to the patients' path-
ological phenotype, since all copies will have the 
same functional capacity. A polymorphic struc-
ture has been exclusively found in the DAZ gene 
family. We, therefore, assume that in contrast to 
the other AZFc candidate genes, not all DAZ 
genes might be essential for human spermato-
genesis. 
SUMMARY 
With aid of the detailed molecular picture of the 
AZFc locus and its gene families it can now be 
shown that the early observation of polymor-
phic chromatin domains in the human Y 
chromosome can not be taken as indicative for 
a non-functional state of this chromosome or of 
the Y genes being part of it. However, it is in-
deed mandatory to study each Y gene mutation 
identified in AZFc, whether deletion or point 
mutation, also for its possible presence in the 
AZFc locus of the patients' father, in the AZFc 
locus of men with normal fertility, before one 
associates this AZFc gene mutation with the oc-
currence of the patients' testicular pathology. 
If the proposed structural dynamic arrange-
ments really would occur in the AZFc locus, it is 
the first spermatogenesis locus in the human ge-
nome with a locus-specific chromatin folding 
code according to our predictions postulated 12 
year ago (31, 32). In AZFc this code is based on 
a unique repetitive sequence structure which is 
organised in palindromes to stabilise the func-
tional AZFc gene content. Local instabilities 
usually inherited with tandem repetitive se-
quence blocks and especially with palindromic 
sequence structures (37) should become inhibited 
by this folding code in the AZFc amplicons. This 
let the AZFc structure look as a structural art-
work probably evolved step by step in an ances-
tral polymorphic heterochromatic Y domain. 
In contrast to mouse, rat and bull, human 
spermatogenesis looks highly disorganized and 
even healthy and fertile men ejaculate a high 
percentage of spermatozoa with abnormal mor-
phology and motility. Perhaps this might also 
explain the variable testicular pathologies found 
in testis tissue sections of sterile men with AZFc 
deletions which in rare cases can be inherited. In 
these familiar AZFc deletions the number and 
quality of sperms should be still sufficient for 
the men' fertility. Most likely, the primary effect 
of the AZFc deletions is therefore only a sig-
nificant reduction in the number of mature 
sperms which then leads secondarily to an in-
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creased loss of germ cells and a Sertoli-cell-only 
syndrome (7). 
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Ken McElreavey (Paris, France): How can 
you distinguish between a true partial deletion 
of the AZFc gene, and a gene conversion 
event? 
Peter Vogt: Deletions and conversions can 
only be distinguished using specific Y-DNA 
probes for genomic blot hybridisation. This 
can detect a partial deletion it if the probe se-
quence overlaps a specific restriction fragment 
which is only present in the AZFc region. For 
example, DAZ1 is the only gene with a 10.8 
kb EcoBN genomic fragment of the DYS 1 lo-
cus (Fernandes et al. 2002, Mol Human Re-
prod Vol.3. 286-98). 
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Ragnhild Lothe (Oslo, Norway): How are the 
CpG sites in the Y chromosome genes distrib-
uted? Do you think that abnormal methylation 
may be related to their expression in germ cell 
tumours? 
Peter Vogt: Some gene families are clustered in 
one of the AZF regions, others are spread along 
the long and short Y chromosome arms. We do 
not yet know whether methylation processes are 
involved in the regulation of the expression of 
the AZF genes. 
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Abstract 
2 
Deletion of the entire AZFc locus on the human Y chromosome leads to male 
infertility. The functional roles of the individual gene families mapped to AZFc are, 
however, still poorly understood since the analysis of the region is complicated by its 
repeated structure. We have therefore used Single Nucleotide Variants (SNVs) across ~3 
Mb of the AZFc sequence to identify 15 AZFc haplotypes and examined them for 
deletion of individual AZFc gene copies. We found five individuals who lacked SNVs 
from a large segment of DNA containing the DAZ3/DAZ4 and BPY2.2/BPY2.3 gene 
doublets in distal AZFc. Southern blot analyses showed that the lack of these SNVs was 
due to deletion of the underlying DNA segment. Typing 118 binary Y markers showed 
that all five individuals belonged to Y haplogroup N, and 15/15 independently-
ascertained haplogroup N men carried a similar deletion. Haplogroup N is known to be 
common and widespread in Europe and Asia and there is no indication of reduced 
fertility in men with this Y chromosome. We therefore conclude that a common variant 
of the human Y chromosome lacks the DAZ3/DAZ4 and BPY2.2/BPY2.3 doublets in 
distal AZFc and thus that these genes cannot be required for male fertility: the gene 
content of the AZFc locus is likely to be genetically redundant. Furthermore, the 
observed deletions cannot be derived from the GenBank reference sequence by a single 
recombination event: an origin by homologous recombination from such a sequence 
organization must be preceded by an inversion event. These data confirm the 
expectation that the human Y chromosome sequence and gene complement may differ 
substantially between individuals and more variations are to be expected in different Y-
chromosomal haplogroups. 
AZFc deletions in distal Yql 1 are the most frequent known genetic cause of human 
male infertility, leading to azoospermia or severe oligozoospermia. They occur in different 
populations with a frequency of 10-20% of infertile men (Vogt 1998; Krausz and McElreavey 
1999; Krausz et al. 2000; Simoni 2001). AZFc contains eight gene families expressed only in 
testis tissue, three of which code for proteins, but the importance of each individual gene for 
fertility is not understood. The underlying AZFc sequence is composed mainly of large 
repeated sequence blocks called amplicons (Kuroda-Kawaguchi et al. 2001) organized into 
palindromic structures showing high (>99.9%) sequence identity between the arms (see fig. 
1). Such structures may undergo frequent inversion and gene conversion events (Skaletsky et 
al. 2003), as well as duplications and deletions (Repping et al. 2003). We therefore set out to 
investigate the structure and gene content of this region in normal individuals, using SNVs 
(Single Nucleotide Variants) and STSs extending along 3 Mb of the AZFc sequence, 
supplemented by Southern blot analyses. 
The assays for analyses of specific variants within the DAZ genes [MHVI400003, 
400026,400027] were described recently (Fernandes et al. 2002): three STSs (DAZ-RRM3 
and sY152 in DAZ1 and DAZ4; Y-DAZ3 in DAZ3) and six DAZ-SNVs (I-VI). Typing the 
SNVs involves coamplification of two or more similar loci followed by restriction enzyme 
digestion to reveal the absence (A-allele) or presence (B-allele) of a given restriction enzyme 
site. Since the locations of the A and B-SNV alleles are known from the sequence, loss of the 
A and/or B pattern indicates a loss of specific DAZ gene copies. Some markers outside the 
DAZ gene locus were already available: 50f2/C or DYS7/C (GenBank accession no. Y07728) 
and sYl 192 (GenBank accession no. G67166), which both lie in the proximally-located u3 
block; and AZFc-PI, an SNV marker which distinguishes the yellow Pl . l amplicon from the 
PI.2 amplicon (table 1). In addition, we used the AZFc sequence data published in GenBank 
to look for SNVs in the seven other gene families within this region: BPY2 (Basic Protein Y2 
[MIM 400013]), CDY1 (Chromo-Domain Yl [MIM 400016]) CSPG4LY (Chondrotin-sulfate 
proteogylcan-4-like Y), GOLGA2LY (Golgi-Antigene 2 Like Y), TTY3, TTY4, and TTY17 
(Testis-Transcript Y 3, 4, 17). We found no suitable variants in the CDY1, CSPG4LY, TTY3 
and TTY17 genes located in the yellow and green amplicons P1.1/P1.2 and gl-3, 
respectively. However, SNVs were found for the genes BPY2 and TTY4 located in the green 
amplicons (gl-3), and for GOLGA2LY located in the yellow (Pl.l/ PI.2) amplicons, and 
assays were established (table 1). These markers, together with the DAZ-STS/SNVs, provided 
assays for 37 positions in eight loci spread over -3000 kb in the AZFc region (fig. 1). 
With this marker set, we analyzed the AZFc region in 31 individuals (Inl-In31). 
Fifteen different 'AZFc haplotypes' were present, 14 of which showed loss of variants in our 
set (table 2). In most cases, one or a small number of variants were missing, and the missing 
loci were not located adjacent to one another on the physical map (fig. 1). These were 
interpreted as likely to have arisen in multiple ways such as mutations in the restriction 
enzyme or primer binding sites, gene conversion events, or small deletions, but do not seem to 
involve the loss of large segments of DNA. In contrast, two AZFc region haplotypes, 
containing a total of five individuals (16%), stood out. They lacked the two STSs from u3 and 
also all SNVs from a large contiguous region in distal AZFc extending from P1.2 and g2, 
through DAZ3 and DAZ4 to g3 (fig. 1) suggesting loss of a large AZFc segment in distal 
Yqll . 
Local gene conversions or other changes involving small numbers of nucleotides in 
the DAZ locus can be distinguished from large DAZ deletions by Southern blot experiments 
using probes of DYS1-DNA from the DAZ gene (Fernandes et al. 2002). Despite the 
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similarity of the DAZ gene sequences, EcoRV or Taql digests produce patterns in which 
fragments specific for the DAZ gene copies can be distinguished. Similar analyses on a larger 
scale can be also performed after genomic Sfil restriction digestion. Scoring the DAZ-BAC-
contig in GenBank for rare-cutter restriction sites identified -450 kb and -350 kb genomic 
Sfil fragments carrying the DAZ1/DAZ2 gene doublet and DAZ3/DAZ4 gene doublet, 
respectively (Floridia et al. 2000). We therefore performed such experiments to investigate 
whether men lacking the SNVs carry a deletion, and the results are shown in Figure 2. A 
deletion of the DAZ3 and DAZ4 genes of In29 and In30 is indicated by absence of the DAZ3-
specific 19.6 kb-Taql fragment and of the DAZ4-specific 7.3 kb-EcoRW fragment (Figure 
2A). Deletion of the DYSl-Sfil fragment specific for the DAZ3/DAZ4 gene doublet (-350 
kb) is seen in Figure 2B for sample In37. Southern blot hybridization therefore shows that 
substantial DNA segments are missing, and we conclude that the absence of the P1.2-g2-
DAZ3-DAZ4-g3 markers in the Y chromosome of these individuals is due to a large DNA 
deletion in this part of the AZFc region. We therefore refer to these chromosomes as carrying 
a DAZ3/DAZ4 deletion. 
In parallel, the same DNA samples were typed with 118 Y-chromosomal binary 
markers to establish their haplogroup (Paracchini et al. 2002). Results are given according to 
the Underhill-haplogroup numbering (hi-hi 16; (Underhill et al. 2000) and the current 
haplogroup nomenclature of the Y Chromosome Consortium (Y-Chromosome-Consortium 
2002) (table 2, fig. 3). Only 10 of the 116 haplogroups found worldwide were present in our 
samples, as would be expected from their predominant origin from Europe. Eight of the 10 
haplogroups are common in Europe; the other two (03* and Q3*), found in one individual 
each, are common in the countries of origin of these individuals, China and Costa Rica, 
respectively. There were striking (although not total) correspondences between the AZFc 
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haplotypes and the Y-SNP phylogeny (table 2) and some of the AZFc variants could be 
placed on the Y phylogeny as unique mutations while others were recurrent. The 
DAZ3/DAZ4 deletion chromosomes all belong to haplogroup N3* and thus suggest a single 
origin for this AZFc deletion. 
To investigate the relationship between this deletion polymorphism and the phylogeny 
further, we carried out the reciprocal study, testing 15 individuals (In32-In46), who had 
initially been ascertained as belonging to the N lineage, for their AZFc deletion haplotype 
(table 2). There was some variation in DAZ-SNV II, but, most strikingly, all except one had 
lost both u3 and the same P1.2-g2-DAZ3-DAZ4-g3 markers lacking from the five haplogroup 
N individuals in the first sample set. The amplification of sYl 192 in the one exceptional 
individual is most likely due to cross-reaction with the related Yp sequence block (Skaletsky 
et al. 2003). We therefore conclude that a common Y lineage, haplogroup N, lacking 
numerous AZFc markers, carries a deletion of two segments of the GenBank AZFc reference 
sequence. 
Intrachromosomal deletions commonly arise by homologous recombination between 
repetitive sequence blocks lying in the same orientation (Chen et al. 1997). For example, 
complete AZFc deletions were accounted for by intrachromosomal recombination between 
the b2 and b4 amplicons (Kuroda-Kawaguchi et al. 2001) and, similarly, deletions of the 
DAZ1/DAZ2 gene doublet were accounted for by intrachromosomal recombination between 
the gl and g2 amplicons (Fernandes et al. 2002). We therefore investigated whether the 
lineage N DAZ3/DAZ4 deletions could be explained in a similar way. There were, however, 
no obvious candidates for directly repeated amplicons flanking the two deleted regions of the 
N lineage Y chromosome (fig. 1). If the deletion substrate in the pre-N-lineage Y 
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chromosome resembled the GenBank sequence, two independent deletions must have 
occurred, neither based on long regions of homology, but one removing u3 and the other the 
P1.2-g2-DAZ3-DAZ4-g3 region. The deletion, however, was an ancient event (see below) 
and did not occur in a modern sequence. The deletion substrate could therefore differ from the 
GenBank AZFc sequence with an organization in the Y chromosomes of the pre-N lineage, 
that carries u3 adjacent to the P1.2-g2-DAZ3-DAZ4-g3 region, so that a single deletion event 
would remove all of the sequence missing in the N lineage by an intrachromosomal 
recombination event between homologous amplicons similar to that seen for complete AZFc 
deletions with the GenBank AZFc sequence. 
The GenBank sequence, which is largely derived from the RPCI-11 donor (Kuroda-
Kawaguchi et al. 2001), belongs to Y chromosome haplogroup R because it carries the 
derived state of the marker M207 (position 139,206 in the RPCI-11 BAC clone 386L3; 
GenBank accession no. AC006376). The finding that the AZFc-PI genotype A+B, present in 
the RPCI-11 donor, is restricted to haplogroup Rl* (table 2) also supports this assignment. 
Haplogroups N and R are not closely related, and their most recent common ancestor 
probably lived around 36,000 ± 6,000 years ago (Hammer and Zegura 2002), so substantial 
differences in structure, including inversions, could have accumulated especially in the large 
palindromic structure in distal AZFc where homologous recombination could lead to 
inversions of the intervening DNA (Zhou et al. 2001). A rearrangement of the GenBank AZFc 
structure could place u3 adjacent to the P1.2-g2-DAZ3-DAZ4-g3 region: inversion between 
the b2 and b3 amplicons (fig. 4). Then a gl/g3 recombination could delete all the sequences 
found to be absent from lineage N chromosomes in a single step (fig. 4). If this holds true, we 
must consider that the GenBank AZFc amplicon structure of the R-lineage Y chromosome is 
only one of many possible arrangements, and that proposed here for the AZFc structure in the 
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N-lineage Y chromosome is only one other example. Indeed, the large PI palindrome in distal 
AZFc was proposed to originate by duplication and inversion of an ancestral AZFc sequence 
similar to that proposed here for the pre-N lineage AZFc sequence (Kuroda-Kawaguchi et al. 
2001). 
Y chromosomes carrying a large AZFc deletion variant removing the DAZ3 and 
DAZ4 genes may be common. In our sample, they corresponded precisely to haplogroup N 
chromosomes, including members of both the lineages N3* and N*(xN3). It therefore seems 
likely that all haplogroup N chromosomes carry this deletion. If so, we can use the known 
distribution of haplogroup N to deduce their frequency and distribution. This haplogroup is 
common throughout northern Europe and Asia, making up -12% of Y chromosomes in one 
worldwide survey and forming the majority in some populations such as the Finns (-52%) 
and Yakuts (Sakha, -86%) (Zerjal et al. 1997). It forms a subset of the chromosomes 
previously identified as lacking 50f2/C (Jobling et al. 1996) but was erroneously considered 
to carry intact DAZ genes in this early study. The most recent common ancestor of 
haplogroup N chromosomes is estimated to have lived about 8,800 ± 3,200 years ago 
(Hammer and Zegura 2002). It is therefore an ancient and successful lineage, and the lack of 
DAZ3 and DAZ4 has no detrimental effect on these men's fertility. Other large Y deletion 
variants are for example a -3 Mb segment of Yp containing the AMEL and PRKY genes 
which also appears to be neutral as it was absent from some normal males (Santos et al. 
1998). Another partial AZFc deletion designated the "gr/gr" deletion seems however not to be 
neutral since it was described as a significant risk factor for spermatogenic failure (Repping et 
al. 2003). This AZFc structure can arise by recombination between gl and g2, but also 
between rl and r3, or r2 and r4, respectively, in the AZFc GenBank sequence. No inversions 
are needed to arrange these amplicons into the same polarity (fig. 4). All gr/gr deletions 
therefore create an AZFc structure which is different from that proposed here for Y-
haplogroup N men. This is further illustrated by the gr/gr deletion's retention of u3 but lack of 
the rl, r2, b3 and grl amplicons; in contrast, in Y haplogroup N u3 is deleted and rl, r2, b3 
and grl are present with reverse polarity (fig. 4). Interestingly, gr/gr deletions were not 
reported in men with Y-haplogroup N, although they were found in 14 other Y haplogroups 
(Repping et al. 2003). AZFc gr/gr deletions therefore appear to have arisen on many 
occasions and be continually eliminated by natural selection because of their modest negative 
impact on men's fertility (Repping et al. 2003) while the gl/g3 deletion described here seems 
to be associated only with Y-haplogroup N. It is not known whether the gr/gr deletion 
underlies the reduced sperm count associated with one haplogroup in Danish males (Krausz et 
al. 2001), or includes the gl/g2 deletions found in the AZFc structure of some men with 
oligozoospermia and deletion of the DAZ1/DAZ2 gene doublet (Fernandes et al. 2002). If 
not, yet more deletions may be found in the future. 
If the proposed gl/g3 recombination event is the origin of the AZFc deletion in the N-
lineage Y chromosomes, the length of the AZFc sequence in these men is reduced by more 
than 50% (-3.7 vs. -1.5 Mb) and with this two copies of the BPY2 gene family and also one 
copy each of the probably non-coding GOLGA2LY and TTY4 gene families are deleted (fig. 
4). The functional contribution of the AZFc gene families to human spermatogenesis 
therefore appears to be genetically redundant and the roles of the individual genes may be 
most readily understood by investigating mutations in populations like the Finns where many 
men carry fewer AZFc genes. Much further work is needed to understand the complete 
spectrum of normal and pathogenic variations in the structure of the Y-chromosomal AZFc 
region. The present study and forthcoming ones have implications for interpreting the results 
of Y STS deletion analyses in the infertility clinic, illustrating the care that must be taken 
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when deletions are discovered and their phenotypic consequences for male fertility need to be 
predicted. 
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Table 1 : AZFc-SNVs and STSs 
SNVs AZFc site GenBank SNV AZFc- Ensembl SNV Restricted 
accession restriction amplicon Y-DNA allele fragments 
no. enzyme seq. position 
(bp) 
(bp) 
AZFc-Pl P1.1/P1.2 G73351 PLI 26.709.824 - A 467 
SNVI 26.710.291 
Ddel P1.2 25.556.438-
25.556.845 
B 284+183 
GOLY GOLGA2LY BVO12731 PLI 26.763.718- A 531 
SNVI genes 
(2 copies) 
Hhal 26.764.249 
P1.2 25.501.889-
25.502.420 
B 289+242 
BPY2 BPY2 genes BVO12732 g2 25.930.869 - A 470 
SNVI (3 copies) 
g3 
25.931.339 
26.335.746-
26.336.216 
A 
EcoRV gl 24.388.898 -
24.389.368 
B 289+181 
TTY4 TTY4 genes BV012733 g3 26.368.272 - A 540 
SNVI (3 copies) 
Haelll 
gl 
g2 
26.368.812 
24.356.372 -
24.356.912 
25.898.343 -
25.898.883 
B 
B 
323+218 
STSs AZFc site GenBank BAC BAC Ensembl Anne PCR 
accession ni-. clone(s) seq.- Y-DNA al. product 
in position seq. position temp. (bp) 
GenBank (bp) °C 
sY1192 u3 G67166 BAC5C5; 
ACO10080 
52109-
52362 
24.019.703 -
24.020.304 
64 255 
50f2/C u3 Y07728 BAC5C5; 
AC010080 
65711-
66830 
24.033.305 -
24.034.424 
65 1119 
15 
Table 2. Summary of AZFc-STS and SNV analyses and Y-haplogroup typing in 46 genomic DNA 
samples 
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Inl A+B A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 1 104 RI* 
In2 A+B A+B A+B A+B A+B A+B + + + A+B A A+B B 2 108 Rial* 
In3 A+B A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 1 104 RI* 
In4 A+B A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 1 104 RI* 
In5 A+B A+B A+B A+B A+B A+B + + + A+B A A+B B 2 108 Rial* 
In6 A+B A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 1 104 RI* 
In7 A+B A+B B B A+B A + + + A+B A A+B B 3 52 I* 
In8 A+B A+B B B A+B A + + + A+B A A+B B 3 52 I* 
In9 A+B A+B B B A+B A + + + A+B A A+B B 3 52 I* 
InlO A+B A+B B A+B A+B A + + + A+B A+B B B 4 58 J2* 
Inll A+B A+B B A+B A+B A + + + A+B A A+B B 3 35 E3bl* 
Inl2 A+B A+B B A+B A+B A + + + A+B A+B A+B B 5 56 J2P 
Inl3 A+B A+B B B A+B A + + + A A A+B B 6 58 J2* 
Inl4 A+B A+B B A+B A+B A + + + A+B A A+B B 3 32 E3b3a* 
Inl5 A+B A+B A+B B A+B A - + + A+B A A+B B 7 52 I* 
Inl 6 A+B A+B A+B B A+B A - + + A+B A A+B B 7 35 E3bl* 
Inl7 A+B A+B A+B B A+B A - + + A+B A A+B B 7 32 E3b3a* 
Inl 8 A+B A+B A+B B A+B A - + + A+B A A+B B 7 35 E3bl* 
lnl9 A+B A+B A+B B A+B A - + + A+B A A+B B 3 35 E3bl* 
In20 A A+B A+B A+B A+B A+B + + A+B A+B A+B A+B 8 104 RI* 
In21 A A+B A+B A+B A+B A+B + + + A+B A+B A+B A+B 8 104 RI* 
In22 A+B A+B A+B A+B A+B A + + + A+B A+B A+B B 9 115 Q3* 
In23 A A+B A+B A+B A+B A+B + + + A+B A+B A+B B 10 108 Rial* 
In24 A A+B A+B A+B A+B A - - - B B A B 11 92 N3* 
In25 A A+B A+B A+B A+B A - - - B B A B 11 92 N3* 
In26 A A+B A+B B A+B A + + + A+B A+B A+B B 12 76 03* 
In27 A A+B A+B B A+B A + + + A+B A A+B B 13 52 I* 
In28 A A+B B A+B A+B A + + + A+B A+B A B 14 58 J2* 
In29 A A+B A+B A+B B A - - - B B A B 15 92 N3* 
In30 A A+B A+B A+B B A - - - B B A B 15 92 N3* 
In31 A A+B A+B A+B B A - - - B B A B 15 92 N3* 
Summary of AZFc-STS and SNV analyses in 15 genomic DNAs; amples from Y-hap] logroup N 
In32 A A+B A+B A+B B A - - + B B A B 15 87 N*(xN3} 
In33 A A+B A+B A+B B A - - - B B A B 15 87 N*(xN3} 
In34 A A+B A+B A+B B A - - - B B A B 15 87 N*(xN3; 
In35 A A+B A+B A+B B A - - - B B A B 15 87 N*(xN3) 
In36 A A+B A+B A+B B A - - - B B A B 15 87 N*(xN3) 
In37 A A+B A+B A+B B A - - - B B A B 15 92 N3* 
In38 A A+B A+B A+B B A - - - B B A B 15 92 N3* 
In39 A A+B A+B A+B B A . _ _ B B A B 15 92 N3* 
16 
In40 A A+B A+B A+B B A 
Iii4l A A+B A+B A+B B A 
In42 A A+B A+B A+B B A 
In43 A A+B A+B A+B B A 
11)44 A A+B A+B A+B B A 
In45 A A A+B A+B B A 
In46 A A A+B A+B B A 
B B A B 15 92 N3* 
B B A B 15 87 N*(xN3 
B B A B 15 87 N*(xN3 
B B A B 15 87 N*(xN3 
B B A B 15 87 N*(xN3 
B B A B 16 92 N3* 
B B A B 16 92 N3* 
Figure Legends 
Figure 1. Schematic view of the AZFc locus showing its gene content and the locations of the 
STSs and SNVs used in this study. The AZFc amplicon structure is drawn according to the 
color code of Kuroda-Kawaguchi et al. (2001). AZFc genes are listed below the amplicon 
structure, with their 5'-3' polarities indicated by directions of the arrows. The STSs and SNVs 
used in this study are shown below the gene map. Their GenBank accession numbers and 
molecular data are listed in Fernandes et al. (2002) and table 1, respectively. All AZFc 
markers and genes were mapped onto the Ensembl Y-chromosome-sequence 
(http://www.ensembl.org) between 23.79 and 27.49 Mb. Including the complete b2 and b4 
amplicons, a length of ~3.7 Mb for the AZFc sequence was estimated. The presence or 
absence of an STS or SNV in the genomic DNA samples analyzed could be grouped into 16 
patterns (AZFc deletion haplotypes 1-16). These are symbolized below the STS/SNV map by 
rows of filled or empty circles, with the gene copies numbered at the bottom of the figure. 
Thick lines represent deletion haplotypes belonging to haplogroup N. The pale colors of some 
circles indicates that these multi-locus SNVs were inferred to be absent because all 
unambiguously-typed flanking and intervening markers were absent. 
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Figure 2. A: EcoRV and Taql DAZ deletion analyses. According to Fernandes et al. (2002) 
the DAZ3/DAZ4 deletion in the genomic DNA samples of In29 and In30 is shown by 
absence of the ZX4Z5-specific 19.6 kb Taql fragment and the DAZ4-specific 7.3 kb EcoRV 
fragment. Some genomic DYSl-Taql fragments only visible in the male controls ( 9.6 kb, 5 
kb, 4 kb) are common in all DAZ genes but reduced in intensity in the In39 and In30 samples 
because of the DAZ3/DAZ4 deletion. The length of the 19.6 kb Taql fragment in the DAZ3 
gene is known to be polymorphic, as shown here for the male control samples Mconl (with a 
19.6 kb Taql fragment) and Mcon2 (with a 24 kb Taql fragment) in the DAZ3 gene. B. Sfil 
DAZ-blot deletion pattern of the genomic DNA sample of In37. The Sfil site at the proximal 
end of each fragment is partially resistant to cleavage (Floridia et al. 2000), so pulsed-field gel 
electrophoresis produces a pattern in which hybridization is also seen to partially-cleaved 
products containing the adjacent -196 kb fragment: -649 kb and -543 kb respectively. Both 
Sfil fragments specific for the DAZ3/DAZ4 gene doublet (-350 and -550 kb) are deleted in 
In37, confirming the complete loss of these DAZ genes. The genomic male (M) and female 
(F) control samples display the normal Sfil fragments associated with the two DAZ gene 
doublets DAZ21/DAZ2 and DAZ3/DAZ4 (M control) and with the autosomal DAZL1 gene 
on chromosome 3 (-380 kb Sfil fragment) in M and F control sample due to cross-
hybridisation. Molecular lengths of the X-Hindlll (A) and ^-multimer (B) size markers are 
given on the left. 
Figure 3. Phylogeny of the Y chromosomes analyzed in this work. Selected Y-SNPs are 
shown in boxes, and the haplogroup names according to the YCC (2002) or Underhill et al 
(2000) are shown at the bottom. Only the haplogroups present in the samples analyzed are 
included. The phylogeny represents the branching order, but not timescale. In accordance 
with the YCC convention, haplogroups that may not be monophyletic (paragroups) are 
labelled with an *. 
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Figure 4. Schematic representation of putative genomic rearrangements in the amplicon 
structure of the AZFc sequence in men with Y-haplogroup R (GenBank reference sequence) 
that could lead to an AZFc amplicon structure with u3 adjacent to the P1.2-g2-DAZ3-DAZ4-
g3 AZFc segment. After the proposed inversion, mediated by b2/b3, the gl and g3 amplicons 
flank the contiguous u3-P1.2-g2-DAZ4-DAZ3 AZFc segment with direct polarity. 
Recombination between the gl/g3 amplicons in this proposed pre-N AZFc sequence would 
then lead to deletion of an AZFc segment in men with Y haplogroup N as indicated. This 
AZFc structure is different from that proposed by Repping et al. (2003) for structures with 
gr/gr deletions found in 14 different Y haplogroups but not in N (see above GenBank 
reference sequence). Recombinations of gr/gr deletions can take place between gl/g2 
amplicons, rl/r3 amplicons, and r2/r4 amplicons, respectively, as indicated by the 3 brownish 
lines but not between the gl/g3 amplicons as found in men with Y haplogroup N. For further 
details see text. 
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